Synthesis of the originally proposed structure of palmerolide C by Wlochal, Joanna
SYNTHESIS OF THE ORIGINALLY PROPOSED STRUCTURE 
OF PALMEROLIDE C 
Joanna Wlochal 
 
A Thesis Submitted for the Degree of PhD 
at the 
University of St Andrews 
 
 
  
2012 
Full metadata for this item is available in                                                                           
St Andrews Research Repository 
at: 
http://research-repository.st-andrews.ac.uk/ 
 
 
 
Please use this identifier to cite or link to this item: 
http://hdl.handle.net/10023/3663  
 
 
 
This item is protected by original copyright 
 
 
  
Synthesis of the Originally Proposed 
Structure of Palmerolide C 
 
Joanna Wlochal 
School of Chemistry  
 
 
 
 
 
June 2012 
Thesis submitted to the University of St Andrews for the  
degree of Doctor of Philosophy 
Supervisor: Dr. Gordon J. Florence
 I
 
Declarations 
 
I, Joanna Wlochal, hereby certify that this thesis, which is approximately 45000 words in 
length, has been written by me, that it is the record of work carried out by me and that it 
has not been submitted in any previous application for a higher degree.  
 
I was admitted as a research student in May, 2008 and as a candidate for the degree of PhD 
in April 2012; the higher study for which this is a record was carried out in the University 
of St Andrews between 2008 and 2012  
 
 
Date      Signature of Candidate  
 
Supervisor’s declaration 
 
I hereby certify that the candidate has fulfilled the conditions of the Resolution and 
Regulations appropriate for the degree of Doctor of Philosophy in the University of St 
Andrews and that the candidate is qualified to submit this thesis in application for that 
degree.  
 
Date    Signature of Supervisor 
 
 
 
 
 
 
 
 
 
 II 
 
Copyright Declarations  
  
Restricted Access  
 
In submitting this thesis to the University of St Andrews I understand that I am giving 
permission for it to be made available for use in accordance with the regulations of the 
University Library for the time being in force, subject to any copyright vested in the work 
not being affected thereby. I also understand that the title and the abstract will be 
published, and that a copy of the work may be made and supplied to any bona fide library 
or research worker, that my thesis will be electronically accessible for personal or research 
use unless exempt by award of an embargo as requested below, and that the library has the 
right to migrate my thesis into new electronic forms as required to ensure continued access 
to the thesis. I have obtained any third-party copyright permissions that may be required in 
order to allow such access and migration, or have requested the appropriate embargo 
below.  
 
The following is an agreed request by candidate and supervisor regarding the electronic 
publication of this thesis: publication would preclude future publication. 
 
Embargo on both all of printed copy and electronic copy for the same fixed period of two 
years on the following ground: publication would preclude future publication. 
 
  
 
Date     Signature of Candidate   
 
Date      Signature of Supervisor 
 III 
 
 
 
 
 
“Believe that you can do it, under any circumstances” 
- Maria Skodowska-Curie 
 
 IV
 
 
Dedicated to my mother and father
 V
Preface 
This thesis describes the work carried out during my three and a half years as a 
Ph.D. student at the School of Chemistry, University of St Andrews under the supervision 
of Dr. Gordon J. Florence. There are numerous people that have contributed and been 
involved in the projects I have worked on in the last few years and I would like to thank 
the following people for their help and collaboration. 
 
I am deeply grateful to Dr. Gordon J. Florence for giving me the confidence to 
explore my research interests and the guidance to avoid getting lost in my exploration 
through sharing with me his vast knowledge of chemistry. Gordon was a fabulous advisor: 
sharp, cheery, perceptive, and mindful of the things that truly matter. He has always 
motivated and inspired me and during the hard times, remained optimistic and led me in 
the right direction. Thanks for believing in me.  
 
I would also like to thank my assessor Prof. David O’Hagan for continuous interest 
in my progress, encouragement and support. I owe many thanks to Dr. Andrew Smith for 
providing me with scientific insight on numerous occasions, particularly during joint group 
meeting sessions. Dr. Iain Smellie also deserves a special thanks; he was always full of 
sound advice when proof-reading this thesis, and was always able to foster a great learning 
environment for undergraduate students during the time I assisted in his lab-courses.  
 
During my graduate studies I have had the privilege of working with a number of 
interesting and exceptional people and I would like to take the opportunity to thank them 
individually. When I first came to the BMS 4
th
 floor, the older students and staff at the 
School of Chemistry helped to shape me as a scientist. In particularly Dr. Ross G. Murray 
provided a great deal of guidance during the early years; his work ethic, expertise and 
music taste kept me coming back every morning, believing my chemistry would start 
working… and it eventually did! Agnieszka Kosinska took great care of me in and out of 
the lab, ever since I came for an interview and then through out the first year. I would like 
to collectively thank the GJF group for making our laboratory a great working 
environment. There are also a number of people whom I would like to acknowledge 
individually: the witches from Florence/Florence witches as you like (yes that’s about you 
 VI
Jo and Katy) thanks for all the sabbatical sessions helping to keep in balance with work, all 
the support, encouragement, and friendship. Katy deserves all the credit for any coherence 
in the following pages; Jo, I bet… she would have proof-read your thesis too, if she 
wouldn’t be finishing sooner. The later group members, especially Greg for sharing my 
‘joy’ when I saw the spectra for my final product; to both you and Lloyd, thanks for being 
understanding lab- and office-mates. Dr. Lik Ren Tai thanks for possibly the most easy 
going post-doc attitude I have ever come across. I had the good fortune to work with one 
outstanding undergraduate; Euan, despite sharing my fume-hood and not working on my 
project, you were by far the best and most cheerful student I have worked with. Guys, 
having supportive bay mates, and walking this rocky way with me, made a significant 
difference in my postgraduate experience.  
 
The list of people I would like to thank goes on and on. The Botting, O’Hagan and 
Smith labs have all been extremely helpful in sharing their lab resources and knowledge. 
Thank God I had Su one step ahead of me, reminding of any upcoming deadlines for 
reports and PG bureaucracy to be dealt with; Nikos, for cheering me up when it was 
needed. I have many fond memories, especially from time spent with Jason, thanks mate. 
Thanks also to the Polish crew, whom I was fortunate to meet in St Andrews especially 
Ola, Lila, Artur, Piotr, Ilonka, Gosia and Kris; not a single one of them has ever refused to 
lend a hand my way. I would also like to thank my friend far away from Scotland, Alma, 
studies at Lund was the first period in my life where I was living away from my entire 
family. Fortunately, I met you and you made me feel at home. Your friendship is one of a 
kind, forgive my negligence over the past years. Thanks for helping me get through the 
difficult times, and for all the emotional support, camaraderie, entertainment, and care you 
provided. 
 
For facilities, I would like to thank Dr Tomas Lebl and Melanja Smith in the NMR 
lab. Caroline Horsburgh and the National Mass Spectrometry Centre in Swansea for mass 
spectrometry analyses. This project would not be realised without the generous financial 
support of the University of St Andrews and the EPSRC research council. 
 
At this point, I would like to thank the most important people in my life, my family. 
I am nothing without them. As much as my time at St Andrews has shaped me as a 
scientist over the past three-plus years, the continuous support of my parents and sisters 
 VII 
have helped define me over more than a quarter of a century. My mother, Danuta, is the 
backbone of our family. She has sacrificed everything to ensure that my sisters and I would 
always be able to strive for our goals. If there would be a Ph.D. in life in general she would 
definitely earn summa cum laude. My father, Adam, who I want to thank for showing me 
the big world, for telling me that nothing is impossible, just further away to reach. He has 
also taught me the value of hard work. My older sister, Marlena-Zocha, as the eldest paved 
the way, making my life easier on many occasions, thanks for keeping me up-to-date with 
everything else beside chemistry, I wish you all the joy and happiness, and remember you 
are always welcome wherever I go. My younger sister, Alicja, for always bringing good 
news, tak for al jeres støtte og opmuntring, hvad der går rundt kommer tilbage omkring ;-)  
Finally, I want to thank Josep for never giving up on me. It happened to be a distant 
journey for both of us, the journey that I learnt to cherish, more than a destination…  
What else could I write? I don’t have the right 
 
 
Joanna Wlochal 
St Andrews, 15
th
 June 2012 
 
 
 VIII
Abstract 
 
The palmerolides are an emerging class of polyketide natural products isolated 
from marine organisms inhabiting the Antarctic Sea. Although there has been a substantial 
effort to prepare the most active family member palmerolide A, no synthetic work has been 
performed in the area of the other members of the family; palmerolides B and C of 
different ring structure. These compounds are particularly interesting due to their complex 
structures with undefined stereochemistry and both display high selectivity towards human 
melanoma cancer cell lines. 
A highly convergent strategy to access palmerolide C has been developed, relying 
on the assembly of three fragments using key bond couplings at C6-C7 (boron-mediated 
aldol reaction/dehydration) and C14-C15 (Julia-Kocienski olefination), followed by a 
suitable macrolactonisation step and Buchwald enamide formation. Prior to subunit 
synthesis, the relative configuration of the C8-C10 stereotriad was resolved via the 
synthesis of diastereomeric degradation fragments by the application of organocatalytic 
cross aldol reactions and a suitable 1,3-selective reduction.   
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 IX
Compound Numbering 
 
All compounds intended toward the structure elucidation or total synthesis of 
palmerolide C will be numbered according to the carbon chain of the natural product. This 
numbering is given on the structure and is used in the 
1
H NMR assignment.  
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The naming of the compounds in the experimental section uses the IUPAC convention.
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Chapter 1 
 
1.1   Discovery of the palmerolides 
The Antarctic polar region is one of the least explored places on our planet due to 
its inaccessibility. Nevertheless, what is known about its fauna and flora has significantly 
contributed to our general knowledge of life and uncovered amazing examples of 
evolutionary adaptation for survival in extreme environmental conditions.
1
 Importantly, 
this ecosystem has remained undisturbed for millions of years. As a result, the unique 
phylogenesis of the marine fauna of the Antarctic seas offers distinct structural and 
functional properties in the secondary metabolites produced by the indigenous species.
2
  
In 2006 Baker and co-workers reported the discovery of a family of marine 
macrolides, which were isolated from the tunicate Synoicum adareanum (Figure 1.1.1) 
inhabiting the shallow waters in the vicinity of Palmer Station, the only US station on 
Antarctica north of the Polar Circle.
3
 The isolated compounds were named the 
palmerolides in recognition of Palmer Station, where they were found. This particular 
tunicate, found in abundance on the benthos of the Antarctic Sea grows from a common 
base to multiple fist-sized groups of colonies providing sufficient biomass for collection 
without harm to the ecosystem. The fact that even a single colony could deliver hundreds 
of milligrams of palmerolides after processing limited the harvest to a minimum. However, 
the yields of isolates were variable between colonies, as was the distribution of over a 
dozen different palmerolides identified.
4
 With the discovery of the palmerolides, Baker has 
drawn more attention to the potential of Antarctica’s remote and unexplored resources.  
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Figure 1.1.1 Synoicum adarenum collected at Palmer Station, Antarctica (Photograph supplied by Bill 
J. Baker, University of South Florida, USA) 
1.2  Isolation and structure determination 
The collected material was phytochemically processed by first freeze-drying the 
harvested tunicates to provide 520 g of dry biomass. The initial extraction with 
dichloromethane and methanol took three days and resulted in a reddish-brown semi-solid 
upon evaporation. The crude extracts were then partitioned between ethyl acetate and 
water. The organic layer was washed, dried and evaporated to provide material for flash 
column chromatography. The initial isolation gave several separate fractions, which were 
then purified by reversed-phase HPLC to deliver pure compounds for analysis. 
Assessment of the biological activity of the palmerolides began with a 60-cell line 
panel screen at the National Cancer Institute which revealed unique biological profiles in 
targeting human cancers. Selectivities towards UACC-62 and M14 melanoma cancer were 
determined with IC50 of 18 and 76 nM for palmerolide A (1), rendering the isolated 
compounds potential candidates for future drug development. In this light the structures of 
isolated natural products had to be determined.  
Investigation of the structural composition of palmerolides by Baker and co-
workers culminated in detailed elucidation of the planar structure of twelve family 
members along with the proposed configurational assignment of palmerolide A (1). The 
structural characteristics were determined by NMR spectroscopic and HRMS 
spectrometric experiments.
4
  
Structurally, the isolated compounds comprise a 20-membered macrolactone ring 
bearing a carbamate group at one of the oxygenated positions and four E-configured 
double bonds including an (E,E)-diene motif at C14 within the macrolide. In addition, a 
single side chain of varied length and functionality has been identified attached to the C19 
Introduction 
 3 
carbon. The palmerolides were then grouped according to the macrolide core structure 
(Figure 1.2.1). The three different ring systems were distinguished by the structural 
variation spanning the C6-C11 region of the macrolactone with altering 
hydroxylation/unsaturation patterns. All the elucidated compounds within these groups 
bear one of the five different side chains and will be presented in the following sections 
(1.2.1-1.2.3). It was found that the first compounds isolated, named palmerolide A (1), B 
(2) and C (3) each represented one of the three unique ring systems (Figure 1.2.1).
4
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Figure 1.2.1 Three unique ring systems found in the palmerolide family with preliminary 
stereochemical assignment. 
1.2.1 A - ring system  
Palmerolide A was found to be the primary isolate both in quantity (200 mg, 0.02% 
dry wt.) and biological activity (melanoma UACC-62, IC50 = 18 nM). As a result it has 
received the majority of the attention from the synthetic organic community.
5-8
 The first 
total synthesis of palmerolide A, achieved by De Brabander within a year from the 
isolation report, reassigned the proposed relative configuration of 1 and established the 
absolute stereochemistry to be as shown in 4 in Table 1.2.1. Elucidation of the planar 
structure by Baker and co-workers revealed a distinct macrolide with a hydroxyl at C7 
separated by a di-substituted olefin from the dihydroxyl motif at C10 and C11. The relative 
configuration of palmerolide A (1) was established by chemical derivatisation with chiral 
reagents (MTPA esters of C7, C10 hydroxyl-bearing stereocentres analysed using the 
Introduction 
 4 
Mosher method, as discussed further in section 2.2.1) and NMR experiments (J-based 
configurational analysis of C11 using the Murata method).
3
 While the Murata analysis
9
 
was conducted correctly, it was realised after the first synthesis of 1 by De Brabander that 
the Mosher ester derivatives were incorrectly assigned. The incorrect interpretation of the 
C7 and C10 configuration arose as a direct consequence of the applied derivatisation 
method with (R)-MTPA acid chloride, where change in priority of substituents relative to 
(R)-MTPA acid went unnoticed and resulted in the formation of the (S)-MTPA ester, not as 
assigned (R)-MTPA ester.
3
  
R1
R2
19
O 1
O
7
O O
NH2
OH
HO
 
Entry Compound R
1 
R
2 
1 Palmerolide A (4) 
 
-CH3 
2 Palmerolide D (5) 
 
-CH3 
3 Palmerolide E (6) CHO -CH3 
4 Palmerolide F (7) 
 
-CH3 
5 Palmerolide G (8) -CH3 
 
Table 1.2.1 The palmerolides with ring system A with corrected stereochemical assignment. 
Structural analogues of palmerolide A (4) have been identified based on the 
comparison of the collected NMR data. Four palmerolides were found to have the same 
ring type but varied in the composition of the side chain (Table 1.2.1). The primary isolate 
(4) comprised of conjugated enamide. Further palmerolides of this ring type presented 
isomerisation, extension or disruption in conjugation in their side chains (Table 1.2.1).
10
 
Palmerolide D (5) was found to contain an elongated side chain with one (Z)- and one 
terminal double bond, in contrast palmerolide E (6) bears a side chain truncated by one 
carbon at C-23 terminating in an aldehyde. Shift from conjugation in the enamide to a 
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terminal double bond was identified in palmerolide F (7) and the isomeric (Z)-geometry of 
the C21/C22 olefin distinguished palmerolide G (8).  
1.2.2 B - ring system  
A distinctive pattern of hydroxyls at C7 and C8 separated by an olefin from the 
C11 hydroxyl constitute the B-ring macrolide system. The presence of a sulfate group, not 
found in the other palmerolides substantially affects the properties of the compounds with 
this core structure, making them very polar and prone to hydrolysis (Table 1.2.2). 
Determination of the planar structure of palmerolides B (2) and H (9) by NMR 
spectroscopy proved difficult due to their instability in dimethylsulfoxide. Although, the 
first attempt to obtain spectroscopic data for 2 and 9 ended with decomposition of the 
isolates, further NMR experiments carried out in methanol allowed their structure 
elucidation. It was found that the side chains of palmerolides B (2) and H (9) correspond to 
the previously described structural motifs found in palmerolide A (4) and D (5).  
R
19
O 1
O
7
O
11
O
HO
NH2
O
S
O
O
O  
Entry R
 
1 Palmerolide B (2) 
 
2 Palmerolide H (9) 
 
Table 1.2.2 The palmerolides with ring system B with preliminary stereochemical assignments. 
Determination of the relative stereochemistry of the C7-C11 stereocentres proved 
challenging. Chemical derivatisation resulted in the elimination of the sulfate group and 
hydrolysis of the carbamate. Nevertheless, the C8-Mosher esters were formed and the 
absolute configuration of the C8 hydroxyl was established. Advanced spectroscopic 
experiments (gHSQMBC) provided information on the homo- and hetero-nuclear J-
coupling constants and allowed the determination of the syn arrangement of the C7-C8 
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stereocentres. Unfortunately, based on the available data, the configuration of the isolated 
C11 stereocentre could not be deduced.
10
   
1.2.3 C - ring system  
The final two palmerolides representing the C-ring system, were identified as 
regioisomers of palmerolide A (4) and E (6). A motif of three contiguous stereocentres at 
C8-C10 distinguishes palmerolide C (3) and K (10) (Table 1.2.3) from the other family 
members. Spectroscopic parameters for the C19-C20 positions were found to closely 
match data reported for the analogous centres in palmerolide A (4). Consistent with a 
common biogenesis and supported by NMR comparison, the C19-C20 stereogenic centres 
were determined to have the same configuration within the entire family.
11
 The side chain 
identified in palmerolide C (3) corresponds to the (E,E)-1,3-dienamide found in 
palmerolide A (4). Palmerolide K (10) is truncated at C23 with an aldehyde similar to 
palmerolide E (6). The assignment of the relative and absolute stereochemistry of the 
remaining centres was not available until recently.
4
 The stereochemical assignment of the 
C8-C10 stereotriad became one of our major objectives and will be discussed further in 
Chapter 2.   
R
19
O 1
O
8 OH
OH
10
O
NH2
O
 
Entry R 
1 Palmerolide C (3) 
 
2 Palmerolide K (10) CHO 
Table 1.2.3 The palmerolides with ring system C. 
 
Characteristic structural features of palmerolides, namely carbamate and enamide 
side chain suggest involvement of, as yet unknown, bacterial organism in production of 
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these natural products in host tunicates. It has been hypothesised that a biosynthesis occurs 
by hybrid polyketide synthase (PKS)/nonribosomal peptide synthetase (NRPS) pathway.
12
 
The macrocyclic part of the molecule could be composed by modular Type I polyketide 
synthase operative e.g. in the biosynthesis of epothilones (Figure 1.2.2).
13
 Formation of the 
side chain present in palmerolides may be initiated by NRPS-catalysed incorporation of an 
amino acid such as glycine (Gly)
14
 and/or valinylglycine (Val-Gly).
15
 Amide portion of the 
side chain could originate from acetate via an HMG-CoA (3-hydroxy-3-methylglutaryl-
CoA) synthase-type methyltransferase.
16,17
 
H
N
19
1
O
OH
9
OH
O
O
O
NH2
O
SAM 
methylation
carbamoyl 
phosphate carbon
glycine unit
acetate C2
 
Figure 1.2.2 Hypothesised biosynthetic origin of palmerolide C. 
1.3  Biological activity and SAR studies 
Baker reported that the toxicity profile of the palmerolides correlates with those of 
several known vacuolar-ATPase inhibitors (salicylhalamide A (11),
18,19
 bafilomycin A 
(12),
20
 Figure 1.3.1).
10
 Therefore, it was suggested that palmerolides mode of action might 
be related to an already known inhibition mechanism and undertaking further biological 
studies would provide relevant information supporting this hypothesis.  
Vacuolar-ATPases (v-ATPases) operate as pH modulators and are widely 
expressed in eukaryotic cells, as well as metastatic cancer cells. The regulation of the inter- 
and intra-organellar acidity within various mammalian cell types is required for a variety 
of physiological functions including membrane and organellar protein sorting, 
neurotransmitter uptake, cellular degradative processes, and receptor recycling.
18
 Being 
responsible for vast molecular regulatory functions, this proton pump system is an 
interesting target for pharmaceutical research and development. New biological agents, 
such as the palmerolides, aiming at the control or inhibition of v-ATPase enzymes are of 
great interest and might serve as potential cancer therapeutics.  
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OH
OH
HN
O
O
O
11: (-)-Salicylhalamide A
O OH
O
OH
OHO
OMe
HO
OMe
12: Bafilomycin A  
Figure 1.3.1 Inhibitors of the v-ATPase enzyme. 
 
Studies undertaken by Baker on the molecular mode of action revealed that 
palmerolide A (4) affects genes regulating the cholesterol and fatty acid biosynthetic 
pathway in malignant cells. As this was consistent with published changes in gene 
expression for bafilomycin A (12), they measured the transcriptional consequences of 
bafilomycin treatment on the melanoma cell lines (UACC-62 and LOX), and found 
correlations between the 900 genes dysregulated by palmerolide A (4) and bafilomycin A 
(12). Bafilomycin has been reported to inhibit cholesteryl ester synthesis through 
sequestration of free cholesterol in the endosomal/lysosomal compartment as a 
consequence of v-ATPase inhibition. The high degree of coherence between their gene 
profiles supports the premise that palmerolide A is a v-ATPase inhibitor, and consequently 
has an effect on cholesterol sequestration.
10
  
On the other hand, De Brabander performed studies on the in vitro inhibition 
mechanism of v-ATPase by salicylhalamide A (11),
19
 which contains a conjugated 
enamide, a structural motif shared with palmerolides. This research established several 
important features regarding interactions of 11 with v-ATPase enzymes. Salicylchalamide 
A follows a distinctive mechanism of action from bafilomycin A
20
 in that it does not 
compete with it for binding to v-ATPase. In addition, the recognition and binding site for 
salicylhalamide A was identified to be within the membrane embedded V0 domain of v-
ATPase enzyme. Interestingly, without the enamide side chain salicylhalamide A loses 
activity. Further biological assays provided evidence that 11 does not inhibit the ATP 
hydrolysis activity of the dissociated V1 domain of the v-ATPase but instead affects the 
ATPase activity of the holoenzyme by inhibiting the V0 domain. Salicylihalamide A causes 
a dramatic redistribution of cytosolic V1 from a soluble to a membrane-associated form, a 
change not observed in cells treated with either bafilomycin A (12) or NH4Cl.  
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Further studies are underway to fully establish the mode of action displayed by the 
palmerolides, as investigations to date provided some insight but do not answer all the 
questions in this aspect. In addition, the structure-activity relationship of the palmerolides 
clearly indicates the importance of the carboxamide side chain for biological activity 
(Table 1.3.1). Palmerolide A (4) displayed remarkable activity in both targeting v-ATPase 
enzyme and three orders of magnitude greater selectivity towards human melanoma cancer 
UACC-62 than other cancer cell lines. In contrast, palmerolide E (6), with a terminal 
aldehyde at C23, showed a significant loss in specific enzyme activity but relative 
cytotoxity towards melanoma cells was retained at reduced levels (Table 1.3.1). Following 
the structural analysis, palmerolide D (5) with an extended side chain and ring system A 
proved to be more cytotoxic in comparison to (4), although slightly less selective towards 
v-ATPase. Terminal double bond shifted from conjugation in palmerolide F (7), 
consequently reduces the cytotoxicity and diminished enzyme activity. Palmerolide B (2) 
displayed potent enzyme selectivity, but cytotoxicity was compromised. Palmerolide C (3) 
showed reduced selectivity and cytotoxicity, however remaining in the nanomolar range 
(Table 1.3.1). Overall, structure-activity investigation might be inconclusive as even within 
the same ring type selectivity and cytotoxicity significantly fluctuates.
4,21
 
 V-ATPase (M)  Cytotoxicity IC50 (M) 
Compound 
Mammalian UACC-62 melanoma 
Palmerolide A (4) 0.002 0.024 
Palmerolide B (2) 0.023 0.250 
Palmerolide C (3) 0.150 0.062 
Palmerolide D (5) 0.025 0.002 
Palmerolide E (6) >10.000 5.000 
Palmerolide F (7) 0.063 0.758 
Table 1.3.1 Bioactivity data for palmerolides. 
Since its initial disclosure palmerolide A (4) was identified as a very potent 
melanoma cancer inhibitor, it received considerable synthetic attention with several total 
syntheses and formal approaches published to date
5-8
 and selected syntheses will be 
presented in the following section (1.4). Palmerolide C (3) and palmerolide B (2), on the 
other hand, have not been investigated synthetically as their relative stereochemistry 
remained unknown and selective cytotoxicity was moderately reduced compared to 
palmerolide A. 
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1.4   Synthetic studies on palmerolide A 
In the six years since the discovery of the palmerolides, a number of approaches to 
the synthesis of palmerolide A (4), have been reported.
5-8
 The first synthesis of 1 with the 
incorrect structure was accomplished by De Brabander’s group.
5
 They then revised the 
stereochemical assignment proposed by Baker in the isolation paper to 4 and validated this 
by total synthesis. Shortly after the first synthesis, Nicolaou and Chen reported their 
approach towards the natural palmerolide A 4 and its analogues.
6
 Hall accomplished the 
next total synthesis of 4.
8
 Following these investigations several formal synthetic efforts 
have been published.
22-29
 The successful approaches are presented herein.  
1.4.1 The first synthesis of palmerolide A by De Brabander 
In 2007 De Brabander and co-workers synthesised the proposed structure of 
palmerolide A (1). Their strategy relied on a Suzuki coupling
30
 of vinyl iodide 13 and 
vinylboronate 14 to construct the advanced diene 15 (Scheme 1.4.1). Yamaguchi 
esterification with fragment 16
31
 and subsequent silyl deprotection gave diol 17. Selective 
oxidation
32
 of the primary alcohol, followed by an intramolecular Horner-Wadsworth-
Emmons (HWE) macrocyclisation
33
 and subsequent silyl protection gave macrolactone 18. 
Corey-Bakshi-Shibata reduction of the enone 18 introduced the C7 stereocentre,
34
 which 
was subsequently protected as the TBS ether. Ester hydrolysis
35
 and formation of azide 19 
set the stage to introduce the enamide side chain. Curtius rearrangement of 19 and trapping 
of the intermediate isocyanate with 2-methyl propenylmagnesium bromide completed the 
enamide side chain. Selective TMS deprotection at C11 allowed for the introduction of the 
carbamate. Global deprotection furnished the target molecule 1. Unfortunately, the NMR 
data was inconsistent with the reported 
1
H and 
13
C spectra of palmerolide A, indicating that 
the initial stereochemical assignment was incorrect. After thorough investigation, De 
Brabander chose to invert the configuration of the C19-C20 centres of the initially 
synthesised isomer 13 and subject it to the developed synthetic strategy. Gratifingly, the 
NMR spectra and remaining analyses matched the data reported for palmerolide A. 
However, the CD spectra of the synthetic and natural compounds were mirror images. 
Ultimately, the synthesised structure proved to be the ent-palmerolide A (4) and allowed 
the definition of the absolute stereochemistry of the natural product. The total synthesis of 
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4 was completed in thirty-three steps, with a longest linear sequence of 23 steps and 2.9% 
overall yield.  
MeO2C
I
OH
TESO
OTIPS
TESO
PinB
MeO2C
OH
OTES
OTIPS
OSiEt3
O
O
OH
OTIPS
OH
O
P(O)(OMe2)
MeO2C
O
O
OTMS
RO
O
MeO2C
O
O
OTMS
RO
OTBS
N3
O O
O
O
HO
OH
O
NH2
H
N
O
HO
O O
P(O)(OMe2)
+
Pd(Ph3)4, 
Tl2CO3
  
79%
i) 16, 2,4,6-Cl3BzCl, 
Et3N, DMAP, 69%
ii) PPTS, 95%
i) PhI(OAc)2, TEMPO,  
ii) K2CO3, 18-crown-6, 
70%
 iii) TMSCl, Et3N, 
cat. DMAP, 91%
i) (S)-CBS, BH3, 99%
ii) TBSOTf, 2,6-lut, 94%
       i) C6H6, reflux 
      iii) HF•py, py, 95%
  iv) Cl3CC(O)NCO, 91%
        v) TBAF, 41%.
MgBrii)
          76%
18: R = TIPS
16
15
17
13 14
119: R = TIPS
iii) (Bu3Sn)2O, 81%
iv) (PhO)2P(O)N3, NEt3, 92%
 
Scheme 1.4.1 Synthesis of the initially proposed structure of palmerolide A by De Brabander. 
1.4.2 Nicolaou and Chen synthesis of palmerolide A 
Shortly after De Brabander published the synthesis of ent-palmerolide A, Nicolaou 
and Chen presented their approach towards palmerolide A (4).
6
 Their strategy for the 
assembly of the key subunits began with Stille coupling between vinyl iodide 20 and vinyl 
stannane 21 providing tetraene 22 (Scheme 1.4.2).
36
 Carboxylic acid 23 was esterified with 
alcohol 22 under Yamaguchi conditions to give ester 24.
31
 Subsequent desilylation and 
oxidation set the stage for Takai olefination to introduce the vinyl iodide.
37
 Removal of the 
two MOM groups from 25 gave the intermediate diol, which underwent ring-closing 
metathesis to form a macrocycle 26. The installation of the enamide moiety was achieved 
through the application of a Buchwald Cu(I)-mediated coupling,
38
 completing the synthesis 
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of 4. The synthesis of the naturally occurring palmerolide A 4 was achieved in 28 steps, 
with a longest linear sequence of 15 steps and 1.7% overall yield. Thereafter, Chen 
published the complete synthetic efforts towards the palmerolide A,
7
 followed by the 
synthesis of analogues, which were subsequently subjected to further SAR studies.
39,40
  
20
TBSO
I
OH
SnBu3
O
OH2N
O
MOM
TBSO OH
O
O
NH2
RO
O
O
O NH2
RO
HO2C
OMOM
OR
O
O
O
O
NH2
HO
OH
O
I
O
H
N
O
O
O O
NH2
OH
HO
21
[Pd(dba)2], 
AsPh3
 67%
22: R = MOM
2,4,6-Cl3BzCl, 
Et3N, DMAP 
61%
23
i) TBAF
ii) DMP, 79% 
 
iii) CrCl2, CHI3, 
80% (>95:5 E/Z);
TBSO
O
O
O NH2
RO
OR
O
I
i) BF3·Et2O, 
Me2S, 46%  
ii) Grubbs II, 76%
CuI, Cs2CO3, 
50%
MeHN NHMe
NH2
O
25: R = MOM 24: R = MOM
26 4
 
Scheme 1.4.2 Synthesis of natural palmerolide A by Nicolaou and Chen. 
1.4.3 Hall synthesis of palmerolide A 
The Hall approach utilised his organoboron methodology to construct the advanced 
intermediates (Scheme 1.4.3). At first, fragment 27 was formed using a [4+2] hetero-Diels-
Alder reaction of 28 and 29,
41
 followed by allylboration and subsequent [3,3] Ireland-
Claisen rearrangement of the alkenylboronate 30 to form 31.
42
 The left side of the 
molecule, C14-C25 subunit 32 was accessed by applying enantioselective crotylboration 
methodology where a tin tetrachloride-based catalyst, developed within the Hall group, 
was used to install the C19/C20 stereocentres.
43
 Coupling of the fragments 32 and 33 was 
accomplished via a boron-alkyl Suzuki reaction providing access to the advance 
intermediate 34. Hydrolysis of the methyl ester with a trimethyltin hydroxide and 
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subsequent macrolactonisation under Yamaguchi conditions delivered macrolactone 35. 
Introduction of the enamide side chain providing 36 was accomplished following  
De Brabander’s approach via Curtius rearrangement of the azide, which was installed after 
tert-butyl ester hydrolysis. Cleavage of the PMB group and carbamate formation at C11 
preceded final deprotection with TBAF, which completed the natural palmerolide A (4).  
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32
33
MeO 1
O
7
10
OPMB
OTIPS
TIPSO
MeO 1
O
7
10
OPMB
OR
RO
34: R = TIPS
PdCl2(dppf), 
AsPh3, Cs2CO3, 
50-77%
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Scheme 1.4.3 Synthesis of natural palmerolide A by Hall. 
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1.5  Methods for the determination of the absolute stereochemistry in 
complex molecules 
1.5.1 Degradation studies to confirm the absolute stereochemistry of 
palmerolide A  
Following the stereochemical re-assignment of palmerolide A by the first synthesis, 
Baker and co-workers re-investigated their data for the initially proposed structure 1. In 
order to clarify all uncertainty, they employed another powerful method used in 
determination of the absolute stereochemistry of complex molecules. Degradation studies 
were undertaken to access fragments of the natural palmerolide A with questionable 
stereochemistry. This approach was found to be a viable method for solving the 
stereochemical errors in 1.
44
 Their strategy used reductive ozonolysis to access the C3-C8 
fragment 37 of palmerolide A, with the ambiguous C7 stereocentre (Scheme 1.5.1). The 
obtained data for the 1,2,6-hexanetriol 37 was then compared to the literature records for 
(R)-1,2,6-hexanetriol
45
 revealing an inconsistency in the optical rotation values, both in 
magnitude and sign.  
O
H
N
19
O 1
O
7
O O
NH2
OH
HO
1
HO 7
OH
OH
37: C3-C8 degradation
 fragment
O3
NaBH4
 
Scheme 1.5.1 Degradation studies of the palmerolide A. 
 
Therefore, they decided to prepare synthetic (R)-1,2,6-hexanetriol 37 starting from 
the (R)-acetonide of 1,2,4-trihydroxybutane 38. Following a sequence of Wittig reaction, 
reduction of enoate 39 and subsequent deprotection gave (R)-1,2,6-hexanetriol (Scheme 
1.5.2), which identity was confirmed by spectroscopic and spectrometric analysis. 
However, comparison of the optical rotation in methanol for synthetic (R)-1,2,6-
hexanetriol (+11.1) with the optical rotation of the natural C3-C8 degradation fragment 37 
(-9.0) revealed they were opposite in sign, providing evidence for the C7 centre being (S)-
configured. 
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1) Dess-Martin
2) Wittig
O
O
OH
O
O
O
OEt
HO
OH
OH1) LAH
2) AcOH
38 39 37  
Scheme 1.5.2 Synthesis of the (R)-degradation fragment 37. 
 
To provide a final proof, the synthesis of the ent-degradation fragment 37 starting 
from the (S)-acetonide of 1,2,4-trihydroxybutane was carried out. In this case, the optical 
rotation of the (S)-triol (-11.6) matched the optical rotation of the degradation product of 
the natural sample (-9.0) confirming the absolute stereochemistry of the C7 centre of the 
palmerolide A bearing (S)-configuration. 
1.5.2 Degradation studies in determining the absolute stereochemistry of 
complex molecules 
The synthesis of degradation fragments of complex molecules is a well-established 
technique enabling the elucidation of relative and absolute stereochemistry. It is often 
applied when spectroscopic experiments fail to provide unambiguous information, 
crystallographic data is not accessible and chemical derivatisation is difficult. However, 
the presence of functionalities susceptible to controlled fragmentation is essential for 
making this approach viable.  
This technique is well documented in the literature and provides a practical handle 
for addressing stereochemical issues prior to embarking on the total synthesis.
46
 
Rychnovsky employed this approach to determine the relative and absolute 
stereochemistry of roflamycoin 40 (Scheme 1.5.3), a polyketide macrolide antibiotic 
consisting of repeating 1,3-diol motifs with 2048 possible stereoisomers.
46
 This remarkable 
work comprises most of the techniques available for a synthetic chemist to establish the 
stereo-structure of a complex molecule. The relative stereochemistry of 40 was determined 
based on the combination of the chemical derivatisation studies and spectroscopic 
techniques (Scheme 1.5.3). The arrangement of C13/C15 and C19/C21 was found to be 
anti upon the inspection of the 
13
C NMR data obtained for the derivative 41. Based on 
these findings, next derivative 42 was studied and provided evidence by 
1
H NMR and nOe 
experiments of the syn relation of C15/C19 stereocentres. The 
13
C-enriched compound 43 
showed 
13
C NMR signals consistent with the syn relative configuration of the C23/C25 and 
C29/C31 stereocentres in the acetonides.  
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Scheme 1.5.3 Assignment of the relative configuration of the fungal metabolite roflamycoin 40 by 
chemical derivatisation and 
13
C NMR spectroscopic analysis. 
 
This observation was supported by the earlier studies within the Rychnovsky 
group,
47,48
 where 
13
C-NMR spectroscopic data for a wide range of 1,3-diol acetonides were 
investigated (Figure 1.5.1). Due to the conformational preferences of syn and anti diol 
acetonides, their methyl and acetal carbons appear at particular chemical shifts in their 
respective 
13
C NMR spectra. Their analysis revealed, that 1,3-syn acetonides prefer to 
adopt chair like conformation, resulting in a specific 
13
C resonances at 19 and 30 ppm for 
methyl groups and 98 ppm for acetonide. In comparison, the 1,3-anti acetonides were 
found to favour a twist-boat conformation with 
13
C resonances at 23, 25 and 100 ppm for 
respective carbons.  
O
O
Me
Me
H
H
R1(H)  Me
(Me)  H
R2
O
O
H
H
Me  (H)
H  (Me)
R1
R2
Me
Me
19.4 ± 0.2
30.0 ± 0.2
98.1 ± 0.8
24.6 ± 0.8
100.6 ± 0.3
1,3-anti1,3-syn  
Figure 1.5.1 
13
C shifts in 1,3-syn/anti acetonides. 
 
Reduction of the hemiacetal of 40 gave a mixture of C-17 epimers (Scheme 1.5.4), 
which were separated by chiral HPLC and further protected to furnish the acetonides 44 
and 45. Spectroscopic analysis of 44 and 45 established the anti relationships at the 
C13/C15, C21/C23, and C25/C27 stereocentres. 
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Scheme 1.5.4 Derivatisation of roflamycoin 40. 
 
To determine the relative stereochemistry of the C27/C29, C31/C34, and C34/C35 
centres the parent molecule 40 was subjected to degradation studies (Scheme 1.5.5). The 
polyene fragment was cleaved by ozonolysis and subsequent sodium borohydride 
reduction provided access to the advanced intermediate. Following sequence of synthetic 
operations resulted in the formation of peracetylated spiro-acetal 46 enabling the 
assignment of the pyran C31, C34 and C35 stereocentres. In conjunction with 
spectroscopic data, computer modeling was employed to elucidate the relative syn 
stereochemistry at C31/C34 and C34/C35 centres. In order to find the final relative 
relationship of C27/C29, degradation fragment 47 was prepared. The analysis of the NMR 
data proved the relative stereochemistry of C27/C29 to be syn.  
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OROROROR
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35
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13 15 ORRO
1. TBSOTf, 2,6-lut
2. O3, then NaBH4
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4. LAH
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O
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OAc
OOAc
25
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1931
O
13 15 OAcAcO
35
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Scheme 1.5.5 Assignment of the relative configuration by degradation fragment studies. 
 
The relative stereochemistry assigned so far was confirmed by analysis of the  
13
C-enriched compound 48, which NMR showed presence of the one anti and four syn 
acetonides as established previously (Scheme 1.5.6). Determination of the absolute 
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stereochemistry of roflamycoin 40 was achieved by preparation of the Mosher ester 
derivatives of the C35 hydroxyl of the advanced degradation fragment 48 derived from 44 
(Scheme 1.5.6). Detailed analysis according to the Mosher method confirmed the S 
configuration of the C35 stereocentre. Rychnovsky decided then to synthesise degradation 
fragment 49 instead of the entire molecule 40, as 49 contains the entire stereostructure.  
The synthetic approach to 49 was based on the cyanohydrin and bromo-acetonide 
building blocks (50, 51, 52, 53) developed within the Rychnovsky group (Scheme 1.5.6). 
Their strategy involved the coupling of these pieces using standard alkylation chemistry 
followed by a stereoselective reductive de-cyanation to give pentaacetonide 49.
46
 Final 
comparison of the synthetic and natural material by 
1
H NMR, 
13
C NMR, HRMS, and TLC 
showed identical parameters, verifying the relative and absolute stereochemistry of 
roflamycoin 40 as in the fully protected fragment 49.   
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Scheme 1.5.6 Assignment of the absolute stereochemistry by Mosher ester analysis and a synthesis of 
the degradation fragment 49. 
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1.5.3 J-based configurational analysis developed by Murata 
Traditional NMR methods provide very reliable information for the elucidation of 
the planar structure. However, configurational analyses often require a combination of 
various techniques. A method for the determination of the relative configuration of 
adjacent stereocentres was recently developed by Murata
49
 and instantly has found wide 
interest and application in establishing the stereochemistry of complex natural products. 
This method is based on a detailed investigation of hetero- and homo-nuclear spin-
coupling constants (
2,3
JC,H and 
3
JH,H). Commonly employed nOe-based techniques are not 
reliable in assigning the stereochemistry of highly flexible carbon chains. The observed 
signal intensities are affected by the presence of multiple conformers, where even minor 
populations could have a disproportionately large effect, leading to incorrect 
interpretations. In these systems with conformational flexibilities, the observed coupling 
constants exist as a weighted average of those associated with each conformer, 
consequently the most populated one will dominate. Correlation of the vicinal protons 
spin-couplings (
3
JH,H) depends on the dihedral torsion angle and is described using the 
Karplus equation. Vicinal carbon-proton spin-coupling constants (
3
JC,H) also follow a 
Karplus-type relationship and complements the stereochemical information obtained from 
3
JH,H. Additional information from 
2
JC,H further expands the utility of the coupling 
constants in the configurational analysis (Figure 1.5.2). Advances in the instrumentation 
and spectroscopic techniques facilitated the calculation of more accurate values of the 
coupling constants in complex molecules, making the method highly reliable.
50
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Figure 1.5.2 Coupling constant size dependence on dihedral angle. 
 
This method was applied to establish the configuration of palmerolide A 1.
3,4,21
 
Although it provided a great amount of detailed conformational information the absolute 
configuration was affected by the incorrect interpretation of the MTPA-esters.   
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1.6   Retrosynthetic strategy for palmerolide C 
As part of our programme to develop efficient synthetic strategies towards potential 
drug candidates we embarked on a journey into the total synthesis of palmerolides. This 
family of marine polyketides with unique chemical and biological properties have already 
entered the drug discovery arena, however still remaining relatively unexplored. Our 
contribution towards the studies on palmerolides unveils a detailed investigation of the 
stereostructure of palmerolide C (3) together with a convergent synthetic approach 
culminating in the total synthesis of the proposed structure.  
The focus was initially set on the elucidation of the relative and absolute 
stereochemistry of palmerolide C (3). Due to the stereochemical uncertainty of the 
contiguous C8-C10 stereocentres, this would impose the potantial synthesis of up to 
sixteen different isomers of the natural product. Drawing from the previous studies on 
palmerolide A (4), where the absolute stereochemistry was verified by the synthesis of one 
of the degradation fragments,
44
 we decided to follow a similar approach. Using olefins as 
the functional handles, 3 would be cleaved by ozonolysis and subsequent reduction to 
provide poly-hydroxylated fragment 54 (Scheme 1.6.1). The synthesis of diastereomeric 
degradation fragments (55-58) would then become the primary goal of this project. The 
relative and absolute stereochemistry would then be defined in collaboration with 
Professor Bill Baker (University of South Florida, USA) by detailed comparison of the 
spectroscopic and specific rotation data of the synthetic and natural fragments.  
O
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24
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7 OH
OH
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O
NH2
3
assigned 
configuration
unassigned 
C8-C10 
stereotriad
OH
OH
OH
OH
HO
OH
OH
OH
OH
HO
OH
OH
OH
OH
HO
OH
OH
OH
OH
HO
OH
7 OH
OH
OH
14HO
54: C7 - C14 
degradation fragment
O3
NaBH4
55: 8R 9R 10S syn-syn 56: 8S 9R 10S anti-syn 57: 8R 9S 10S anti-anti 58: 8S 9S 10S syn-anti  
Scheme 1.6.1 Strategy towards stereochemical assignment of the relative and absolute configuration of 
palmerolide C (3).  
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Following this phase, our focus would be the synthesis of the diastereoisomer 
identified in the degradation fragment studies and the incorporation of the required subunit 
into a convergent synthetic strategy outlined in Scheme 1.6.2. Initial retrosynthetic 
disconnection of the C24 and enamide functionality revealed the carbon framework of 
palmerolide C (3), which was divided into three key segments after the opening of the 
macrolactone. The assembly of the C6-C7 and C14-C15 olefins was envisaged to arise 
from cross-metathesis and Julia-Kocienski olefination, respectively.  
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Scheme 1.6.2 Retrosynthesis and degradation fragment of palmerolide C (3).  
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2 Chapter 2 
 
2.1 Synthesis of C7-C14 degradation fragments 
The determination of the relative and absolute stereochemistry of the natural  
C7-C14 degradation fragment 54 would require the synthesis of a minimum of four 
diastereomeric poly-hydroxylated compounds for spectroscopic comparison. We reasoned 
that such hydroxylated compounds could be obtained from the 1,3-stereocontrolled 
reduction of aldol products of type 59, which in turn could arise from dihydroxyacetone-
derived building block 60 and a suitable aliphatic aldehyde 61 via organocatalysis (Scheme 
2.1.1).  
OH
7 OH
H
O
PO OP
OH
54 59 60 61
OH
OH
14HO
*
*
*
O
HO OH
O OH
1,3-reduction
+
OH
 
Scheme 2.1.1 Retrosynthesis of the degradation fragment 54. 
In construction of the 9,10-anti aldol product 62 methodology developed by 
Enders
51
 would be explored where (S)-proline is used in aldol reaction between  
2,2-dimethyl-1,3-dioxane-5-one (dioxanone) 63 and an aldehyde. Following substrate 
directed 1,3-syn and 1,3-anti reduction, this would provide access to the two degradation 
fragments 57 and 58 (Scheme 2.1.2).  
O O
O
63
H R
O
OH OH
OH OH
OH
OH OH
OH OH
OH
8
8
10
10
N
H
O
OH
O O
O
R
OH
1,3-syn, H+
1,3-anti, H+
57: 8R, 9S, 10S anti-anti
58: 8S, 9S, 10S syn-anti
62
 
Scheme 2.1.2 Synthetic strategy to construct anti-anti and syn-anti products. 
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An organocatalytic approach would also be explored in the corresponding 9,10-syn 
series towards 64, where O-t-Bu-threonine-catalysed aldol reaction developed by Barbas 
would serve as a primary event involving dihydroxyacetone derivative 65. Remaining 
degradation fragments 55 and 56 (Scheme 2.1.3) would be completed applying the same 
approach developed in the 9,10-anti series. 
TBSO OTBS
O
65
H R
O
OH OH
OH OH
OH
OH OH
OH OH
OH108
108
1,3-syn, H+
1,3-anti, H+
H2N
OtBu
CO2H
TBSO OTBS
O OH
R
55: 8R, 9R, 10S syn-syn
56: 8S, 9R, 10S anti-syn
64
 
Scheme 2.1.3 Synthetic strategy to construct syn-syn and anti-syn products. 
2.2 Construction of the 9,10-anti aldol  
To test the viability of our strategy for the synthesis of fragment 54, work 
commenced with the construction of a system for the cross-aldol condensation. One-step 
syntheses of poly-oxygenated motifs utilising organocatalytic transformations have been 
extensively studied over the past decade.
51-53
 Enders and Grondal utilised the proline-
catalysed aldol reaction to effectively synthesise D-psicose (66) with excellent diastereo- 
and enantio-control over the newly formed stereogenic centres (Scheme 2.2.1). Their 
optimised conditions employed 30 mol% of (R)-proline, equimolar amount of substrates in 
dimethylformamide. The reaction mixture was then stored at 2 ºC for a period of six days. 
Upon cleavage of the acetonides in 67 cyclisation was induced to furnish a mixture of ,-
D-psicofuranose 66 and ,-D-psicopyranose 68.51  
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68
Dowex
quant.
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67: > 98:2 dr,
      > 98% ee
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Scheme 2.2.1 Organocatalytic formation of D-psicose. 
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Guided by the reported examples, we embarked on the investigation of the  
(S)-proline-catalysed cross aldol reaction between the dioxanone 63 and aldehyde 69. 
Ketone 63 was readily prepared in a two-step procedure from commercially available 
Trizma® salt 70. Formation of the 1,3-acetonide 71 followed by oxidative cleavage with 
sodium periodate furnished ketone 63 in good overall yield (Scheme 2.2.2).  
 
NH2
OH
OH
HO
2,2-DMP, CSA
DMF, rt, 90%
NaIO4
KH2PO4, 
H2O, 5 ºC, 60%
O O
O
63
O O
HO
71
HCl
70
NH2
 
Scheme 2.2.2 Ketone 63 preparation for proline catalysed aldol reaction. 
 
Preparation of aldehyde 69 started with the mono-silyl protection of  
1,5-pentanediol 72. Subsequent oxidation of 73 under Swern conditions afforded aldehyde 
69 in 68% yield over two steps (Scheme 2.2.3).  
 
H
O
HOHO OTBSOTBSOH
TBSCl, Et3N, DMAP,
CH2Cl2, 0 ºC, rt
85%72
(COCl)2, DMSO,
CH2Cl2, -78 ºC,
Et3N, rt
80% 6973  
Scheme 2.2.3 Preparation of the aldehyde 69. 
 
Under Enders’ conditions (dioxanone 63 1 eq, 30 mol% (S)-proline, aldehyde 69  
1 eq, DMF 1.9 M, 6 days at 2 ºC) formation of the aldol product 74 was not detected,
51
 but 
instead self-condensation of ketone 63 was observed (Table 2.2.1, entry 1). Enders also 
reported this side reaction, where in absence of the aldehyde dioxanone 63 reacts with 
itself to form protected (S)-dendroketose 75 in 57% yield (Scheme 2.2.4). 
 
O O
O
63
(S)-proline
30 mol% 
DMF, 2 ºC 
57%
O O
O OH
O
O
75 94% ee  
Scheme 2.2.4 Formation of protected (S)-dendroketose. 
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Further investigations into catalyst loading and substrate equivalents did not deliver 
the desired product 74. In addition, solvent and temperature were screened. Unfortunately 
none of the performed operations led to the formation of the cross-coupled product 74. 
However, upon changing the protecting group of the aldehyde 69 to 76, which was readily 
prepared in two steps from 72 via mono protection with BnBr, followed by Swern 
oxidation of 77 in 43% overall yield (Scheme 2.2.5), the desired aldol product 78 was 
isolated, albeit in a low 19% yield (Table 2.2.1, entry 2).  
 
H
O
HOHO OBnOBnOH
NaH, BnBr,
THF, 0 ºC - rt
66%72
(COCl)2, DMSO,
CH2Cl2, -78 ºC,
Et3N, rt
65%
7677  
Scheme 2.2.5 Formation of the aldehyde 76. 
 
Upon attempts to optimise the reaction conditions 78 was formed in only 23% yield 
after carrying out the reaction at room temperature. However, long reaction times and a 
range of side products in the attempted cross-aldol reactions prompted a search for a 
suitable aldehyde compatible with an organocatalytic approach.   
 
H
O
O
63
O O
O OH
OR
ORO
O
+
(S)-proline
69: R = TBS
76: R = Bn
74: R = TBS
78: R = Bn
 
Entry R Conditions Yield (%) 
1 TBS 30 mol% cat, DMF, 2 ºC --- 
2 Bn 30 mol% cat, DMF, 2 ºC 19 
3 Bn 30 mol% cat, DMF, rt 23 
Table 2.2.1 (S)-proline-mediated aldol reaction. 
 
Encouragingly, Grondal and Enders have provided an example of proline catalysed 
aldol reaction where the pentadecanal 79 was employed in the synthesis of sphingoids 80 
and 81 (Scheme 2.2.6).
54
 They found that critical to that system was the nature of solvent 
and temperature. The best results were obtained when the reaction was performed in 
chloroform at room temperature for four days (60% isolated yield, > 99:1 dr, 95% ee). 
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Scheme 2.2.6 Synthesis of sphingoids using proline aldol. 
 
With their findings in mind, unbranched heptanal 82 was used in the reaction with 
dioxanone 63 and (S)-proline (30 mol%) in chloroform. Gratifyingly, the cross-aldol 
product 83 was isolated as a single diastereoisomer in 45% yield after storing the reaction 
for five days at room temperature (Scheme 2.2.7). The apparent difference between the 
initially examined system and the revised reaction with heptanal 82, was not only the 
solvent, but also the unexplained influence of the terminal oxygenation of the aldehydes 69 
and 76 in the cross-aldol reaction. 
63 82
H
O O
O
+
(S)-proline
30 mol% 
CHCl3, rt, 5 d 
45%
83: dr > 95%
O O
O OH
O
 
Scheme 2.2.7 Formation of the aldol product 83 catalysed by (S)-proline.  
 
Having established the viability of the proline-catalysed system, 4-pentenal 84 was 
deemed a suitable precursor for the introduction of the terminal C14 hydroxyl functionality 
at a later stage of the synthesis. 4-Pentenal 84 was readily accessed via Claisen 
rearrangement of allyl vinyl ether 85 under microwave irradiation (Scheme 2.2.8).55  
W, neat, 160 ºC,
200 W, 2h
98%
O O
85 84  
Scheme 2.2.8 Claisen rearrangement of the allyl vinyl ether 85. 
 
Aldehyde 84 was then added at room temperature to a mixture of ketone 63 and  
30 mol% (S)-proline in chloroform (Scheme 2.2.9). After five days the desired aldol 
adduct 86 was isolated in 44% yield with excellent diastereoselectivity (>95:5 dr).  
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Scheme 2.2.9 Formation of the aldol product 86.  
2.2.1 Determination of the absolute configuration at C10 stereocentre  
To establish the absolute configuration at the newly formed C10 stereocentre and 
determine enantiomeric purity of 86, the respective (R)- and (S)-Mosher esters 87 and 88 
were prepared. The derivatisation with chiral reagents such as -methoxy--trifluoro-
methylphenyl acetic acid (MTPAA or Mosher’s acid) is an established method for the 
assignment of the absolute configuration of secondary alcohols and amines by 1H NMR 
spectroscopy. It was introduced in 1973 by Mosher et al.
56
 The presence of a defined chiral 
group (i.e. aromatic) in the derivatising reagent induces an anisotropic effect on the 
covalently bound secondary alcohol. Depending on the absolute configuration of the 
reagent, the planar arrangement of the trifluoromethyl and carbonyl groups with the 
hydrogen of the carbinol centre, the substituents are shielded/deshielded accordingly to the 
aromatic group present (Figure 2.2.1). The shielding/deshielding can be measured by 
1
H 
NMR spectroscopy. In addition, 
19
F NMR can be used to determine the enantiomeric 
excess as the (S)- or (R)-MTPA esters give rise to two distinct signals for derivatised 
enantiomers.  
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O
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  
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O
H
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Hx
Hy
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Hc
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Figure 2.2.1 Preferred conformations of the (S)-MTPA and (R)-MTPA esters of 86 in CDCl3. 
 
Analysis of the 
1
H NMR and 
19
F NMR spectra of the (R)- and (S)-MTPA esters 87 
and 88 were conducted according to the advanced Mosher method.
57
 The experimental 
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data correlated with the expected 10S configuration shown in 86, the MTPA-aromatic 
group shielded protons placed on the same face H10-H14 (Hx, Hy, Hz in Figure 2.2.1) in 
the (S)-MTPA ester 88 as evident by 
1
H NMR spectroscopy. Consequently, the phenyl 
group in (R)-MTPA ester 87 shielded the H7-H9 protons (Ha, Hb, Hc in Figure 2.2.1) 
situated on the same face. This shielding moves affected protons upfield in the 
1
H NMR 
spectrum. The subtraction of the chemical shift values for the particular protons (S – R) 
gave negative values in the H10-H14 region and positive in the H7-H9 (Table 2.2.2). 
Analysis of the data obtained for the (S)- and (R)-MTPA esters 87 and 88 confirmed the 
predicted 10S configuration and also 
19
F NMR of 87 (Figure 2.2.2) provided evidence for 
97% enantiopurity of 86. 
O
CF3
MeO Ph
O O
8
O
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O(R)/(S)-MTPAA
DCC, DMAP
CH2Cl2, rt
87: (R)-MTPA ester (45%), 
          19F 97% de
88: (S)-MTPA ester (60%)O O
8
O
10
OH
86
 
Assignment S/ppm R/ppm S – R/ppm 
H-7a 4.20 4.13 0.07 
H-7b 3.98 3.93 0.05 
H-9 4.57 4.43 0.14 
H-10 5.48 5.52 -0.06 
H-13 5.71 5.76 -0.05 
H-14 4.95 5.01 -0.05 
Table 2.2.2 
1
H NMR analysis of the (R)- and (S)-MTPA esters of -hydroxy ketone 86. 
 
Figure 2.2.2 
19
F NMR of the (R)-MTPA ester 87. 
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 2.2.2 Mechanism of proline-catalysed aldol reaction 
The mechanistic aspects of the proline-catalysed transformations have been widely 
studied.
58-60
 The high levels of enantioselectivity obtained in aldol reactions with this 
amino acid is attributed to its pyrrolidine ring, which upon treatment with a carbonyl 
compound forms the enamine 89. Iminium ion 90, formed by attack of the enamine on the 
re-face of the aldehyde is subsequently hydrolysed to afford chiral -hydroxyketone 91.60 
The proposed reaction mechanism (Scheme 2.2.10) was initially based on the established 
mechanism of class-I aldolases,
61
 which proceed via similar intermediates. In addition, 
density functional theory (DFT) calculations
62
 supported the hypothesis of this analogy. 
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Scheme 2.2.10 Mechanism of (S)-proline-catalysed aldol reaction. 
 
The proposed transition state TS I illustrates (Figure 2.2.3) that in the aldol 
reaction, the enamine attack occurs on the re-face of the aldehyde. This facial selectivity is 
dictated by minimising steric interactions between the substituents on the aldehyde and 
enamine (Figure 2.2.3). Moreover, hydrogen transfer between the carboxylate on proline 
and the oxygen of the aldehyde controls the enantioselectivity by directing which face of 
the enamine attacks the aldehyde. One of the most attractive features of proline-catalysed 
aldol reactions is that both D- and L-proline are readily available, so both enantiomeric 
products can be accessed. DFT calculations supported the proposed transition state shown 
in Figure 2.2.3, TS I. Based on these calculations it was postulated that an N—H hydrogen 
bond does not lower the energy of transition state TS I.
58
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Figure 2.2.3 Houk’s proposed transition state for aldol reaction.  
2.2.3 Reduction of the 9,10-anti aldol product 86 
With the 9,10-anti aldol product 86 in hand, the investigation of the substrate-
directed 1,3-reduction to install the C8 stereocentre commenced with a screening of 
borohydride reducing agents, which are summarised in Table 2.2.3. Initial reduction of 86 
was performed with sodium borohydride and delivered mixture of diols 92 and 93 in good 
yield with moderate diastereoselectivity (3 : 1), in favour of the 1,3-syn product. 
Considering this result, standard reduction protocols were employed to explore the 
possibility of directing selectivity. Reduction with zinc borohydride proceeded in 54% 
yield to give 1,3-syn diol 92 in good selectivity (Table 2.2.3, entry 2).  
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Entry Conditions Yield (%) 92 : 93  
1 NaBH4, MeOH, -78 ºC 54 3 : 1 
2 Zn(BH4)2, Et2O, -78 ºC 54 5.2 : 1 
3 Me4NBH(OAc)3, CH3CN, AcOH, -78 ºC – 0 ºC 56 1 : 1 
Table 2.2.3 Studies of the reduction of -hydroxy ketone 86. 
 
The predominant formation of the 1,3-syn product 92 can be explained by the 
proposed transition state TS II shown in Figure 2.2.4. The metal centre coordinates to the 
free hydroxyl and carbonyl groups placing the molecule in a locked conformation, with 
hydride attack from a bottom face, giving rise to the formation of 1,3-syn diol.  
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Figure 2.2.4 Transition state for Zn(BH4)2 reduction. 
 
We then examined Evans’
63
 procedure employing Me4NBH(OAc)3 to exert 1,3-anti 
selective reduction, as extensively documented for acyclic substrates. To our surprise, we 
did not observe good selectivity (Table 2.2.3, entry 3). We reasoned, supported by earlier 
studies by Enders
64
 that due to the dioxanone unit adopting a twisted boat conformation 
with the side-chain located in a pseudo-equatorial position, the internal-hydride delivery 
with preferred axial attack, imposes syn-selectivity, as shown in TS III in Figure 2.2.5. 
H
H
TS III
O
O
O
O
R
B
H
OAc
OAc  
Figure 2.2.5 Enders transition states for 1,3-reduction with Me4NBH(OAc)3. 
 
In all of the presented reductions, column chromatography on silica gel enabled 
separation of the diastereomeric diols 92 and 93. The 1,3-anti diol 93 was isolated as a 
white solid and recrystallisation provided material for a single crystal X-ray analysis 
(Figure 2.2.6). The acquired data provided evidence for the 1,3-anti relation of the diol 93. 
In conjunction with Mosher ester analysis of the C10 hydroxyl, the relative and absolute 
stereochemistry of 93 was established to be 8S, 9S and 10S. Consequently, the 
corresponding major diastereoisomer 92 had the anti-anti arrangement with the 8R, 9S and 
10S configuration.  
O O
OH OH
XX
93  
 
Figure 2.2.6 The 1,3-anti diol 93 and ORTEP representation of its solid-state structure. 
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2.2.4 Completion of the 9,10-anti series 
Having established access to the two required diastereomeric diols 92 and 93, the 
introduction of terminal hydroxyl functionality was addressed. The anti-anti diol 92 was 
examined first to find the optimal conditions. Several reagents to introduce the terminal 
hydroxyl including dimethylsulfide borane (BH3•SMe2),
43
 9-borabicyclo-[3.3.1]nonane (9-
BBN)
65
 and thexyl-borane (thexylBH2)
66
 were tested and it was found that the latter 
reagent provided the best results, delivering the desired product 94 after oxidative work-up 
in 85% yield (Scheme 2.2.11).  
9492
O O
OH OH
O O
OH OH
OH
ThexylBH2, THF, 0 ºC,
then H2O2, NaOH
85%
 
Scheme 2.2.11 Hydroboration to introduce a terminal hydroxyl. 
 
At this point acetonide cleavage would complete the (8R, 9S, 10S)-polyol 57. 
Various conditions were investigated to cleave the isopropylidene group including a screen 
of organic acids such as camphorsulfonic acid, pyridinium-p-toluenesulfonate and  
p-toluenesulfonic acid, which all turned out to be ineffective. The isolation of the highly 
polar product from aqueous work-up was troublesome. Gratifyingly, using acidic  
Dowex-50 resin, aqueous work-up was eliminated and simple filtration delivered pure 
product. The resin was first washed with water, 3M HCl and excess methanol before 
adding to the solution of triol 94 in methanol. When starting material 94 was fully 
consumed, as indicated by TLC, the suspension was filtered and evaporated to deliver  
8R, 9S, 10S anti-anti degradation fragment 57 in excellent yield (98%), without the 
requirement for further purification (Scheme 2.2.12).  
57
OH OH
OH OH
OH
Dowex-50, MeOH,
  65 ºC
98%O O
OH OH
OH
94  
Scheme 2.2.12 Dowex-50 resin mediated deprotection. 
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The conditions established for 57 were then applied to the diastereomeric diol 93. 
Accordingly, hydroboration with thexylBH2 provided product 93 in 77% yield, following 
removal of the acetonide protecting group to deliver the diastereoisomeric polyol 58 with 
the (8S, 9S, 10S) configuration and syn-anti arrangement (Scheme 2.2.13). 
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Scheme 2.2.13 Hydroboration and deprotection providing degradation fragment 58. 
 
2.3 Alternative route to syn-anti degradation fragment 58 
The difficulties in obtaining the 1,3-anti diol 93 were overcome by introducing a 
bulky TBS protecting group on the free hydroxyl of 86 to form 96 (Scheme 2.3.1). 
Subsequent reduction with L-Selectride (lithium tri-sec-butylborohydride) afforded the 
1,3-anti product 97.  
9686
TBSOTf, 2,6-lutidine, 
CH2Cl2, -78 ºC
95%
L-Selectride, 
THF, -78 ºC
93%
O O
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Scheme 2.3.1 Direct reduction of the TBS-protected aldol product 96. 
 
The observed selectivity can be rationalised upon consideration of the transition 
state TS IV shown in Figure 2.3.1. The -OTBS orientating perpendicular to the  
-framework of the carbonyl moiety and minimisation of steric interaction between the  
R-substituent and the cyclic dioxanone leading to preferential addition of the hydride from 
the re-face of the carbonyl.
67
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Figure 2.3.1 Enders transition state for a direct hydride delivery in reduction of 96. 
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The strategy developed for the synthesis of degradation fragments 57 and 58 
allowed for further advancement of the compound 97. Hydroboration with thexylBH2 
delivered intermediate triol in 88% yield (Scheme 2.3.2). The silyl ether and acetonide 
cleavage was efficiently accomplished using Dowex-50 resin in methanol to provide the 
syn-anti degradation fragment 58 identical to material prepared from 93. 
58
1) ThexylBH2, THF,
H2O2, NaOH, 0 ºC 
88%
2) Dowex-50, MeOH, 
65 ºC, 88%
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Scheme 2.3.2 Hydroboration and deprotection providing degradation fragment 58. 
2.4 Construction of the 9,10-syn aldol via an organocatalytic approach 
Attention was now directed towards the construction of the second set of 
diastereomeric degradation fragments 55 and 56 with the 9,10-syn configuration. An 
organocatalytic aldol reaction utilising C3 dihydroxyacetone building block 65 was 
developed by Barbas.
68,69
 Application of O-tBu-threonine as a catalyst in the cross-aldol 
reaction leads to the stereoselective formation of the 1,2-syn aldol product. This 
methodology was developed primarily for aromatic aldehydes.
70
 However, our system 
requires the use of an aliphatic aldehyde. Building on previous experience with the proline-
catalysed aldol reactions, 4-pentenal 84 was consequently chosen for investigation with  
O-tBu-threonine. Ketone 65 was prepared by reacting dihydroxyacetone dimer 98 with an 
excess of TBSCl and imidazole to produce 65 in 95% yield (Scheme 2.4.1). 
TBSO OTBS
O
65
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O
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HO
TBSCl, Im-H,
DMF, rt, 
95%
98  
Scheme 2.4.1 Formation of the bis-TBS ketone 65. 
 
With the starting materials in hand, investigation of the O-tBu-threonine-catalysed 
aldol reaction began. The initial reaction was performed under conditions developed by 
Barbas, where ketone 65 was dissolved in N-methylpyrrolidone (NMP), and 4-pentenal 84 
was added, followed by water and O-tBu-threonine. The resulting mixture was stirred for 
three days (Table 2.4.1, entry 1). After work-up the crude mixture was analysed and traces 
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of the corresponding aldol product 99 were detected. Upon changing the solvent to 
dimethylformamide the aldol product 99 was formed in good selectivity, albeit in low yield 
(Table 2.4.1, entry 2). However, when the reaction was carried out in chloroform an 
acceptable, for the purpose of this study, 28% yield of 99 and good levels of 
diastereoselectivity (9 : 1) were obtained (Table 2.4.1, entry 3).  
 
TBSO OTBS
O
7
TBSO OTBS
9
O
10
OH
H
O
65 9984
20 mol% O-tBu-L-Thr,
+
 
Entry Conditions Yield (%) syn : anti  
1 NMP, 3 vol% H2O, 0 ºC – rt, 3 days traces — 
2 DMF, 3 vol% H2O, 0 ºC – rt, 3 days 19 9 : 1 
3 CHCl3, 3 vol% H2O, 0 ºC – rt, 5 days 28 9 : 1 
Table 2.4.1 Synthesis of the aldol product 99 and optimisation of the reaction. 
2.4.1  Determination of the absolute configuration at the C10 stereocentre  
The absolute configuration of C10 stereocentre was confirmed by the preparation 
of the corresponding (R)- and (S)-MTPA esters 100 and 101, and subsequent analysis by 
advanced Mosher method as described in section 2.2.1. Investigation of the 
1
H NMR shifts 
of the Mosher ester 100 and 101 (Table 2.4.2) confirmed the expected (S)-configuration at 
the C10 hydroxyl-bearing centre. From the 
19
F NMR (Error! Reference source not 
found.) enantiomeric excess of the major 9,10-syn diastereoisomers of 99 was calculated 
to be 90% ee. 
7
TBSO OTBS
9
O
10
OH
TBSO OTBS
9
O
10
O
O
CF3
MeO Ph
99
*
(R)/(S)-MTPAA
DCC, DMAP
CH2Cl2, rt
100: (R)-MTPA ester (73%), 
          19F 90% de
101: (S)-MTPA ester (53%)
 
Assignment s/ppm r/ppm s – r/ppm 
H-7a 4.49 4.35 0.14 
H-7b 4.28 4.28 0.00 
H-9 4.67 4.56 0.11 
H-10 5.35 5.38 -0.03 
H-13 5.69 5.77 -0.08 
H-14 4.94 5.03 -0.09 
Table 2.4.2 Synthesis of the (R)- and (S)-MTPA esters of -hydroxy ketone 99 and 1H NMR analysis.  
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Figure 2.4.1 
19
F NMR of the (R)- and (S)-MTPA esters. 
2.4.2  Mechanism of O-tBu-threonine-catalysed aldol reaction  
When O-tBu-threonine is employed as a catalyst, the formation of a (Z)-enamine is 
preferred (Figure 2.4.2, TS V), which is dictated by hydrogen bonding between the amine 
hydrogen and oxygen of the alkoxy group. Facial selectivity of the approaching acceptor is 
controlled by the steric hindrance of the aldehyde and enamine substituents as well as 
proton transfer from the carboxylate onto the aldehyde oxygen (Figure 2.4.2, TS VI).
68
  
TS V TS VI
RO
H OR
H
N
OtBu
H
O
OH
R H
O
RO
H OR
H
N
OtBu
H
O
OH
 
Figure 2.4.2 Barbas transition states for O-tBu-threonine-catalysed aldol reaction. 
2.4.3  Reduction of the 9,10-syn aldol product  
With ample quantities of the 9,10-syn configured aldol product 99 in hand, the 
investigation of the 1,3-reduction commenced. Initial reduction with sodium borohydride 
gave 1,3-diol 102 in good yield (80%). However it was observed, that the silyl ether was 
labile under the reaction conditions returning a range of side products which were difficult 
to identify (Table 2.4.3, entry 1).  
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TBSO OTBS
O OH
99
H-
TBSO OTBS
OH OH
TBSO OTBS
OH OH
+
102 103  
Entry Conditions Yield (%) syn : anti  
1 NaBH4, MeOH, -78 ºC 80 nd 
2 i) cHex2BCl•NEt3, LiBH3OMe, THF, -78 ºC, ii) H2O2, MeOH, pH 7 buffer 0 ºC 84 10 : 1 
3 Me4NBH(OAc)3, CH3CN, AcOH, -78 to -30 ºC — — 
4 NaBH4, CeCl3•7H2O, MeOH, -78 ºC 61 10 : 1 
Table 2.4.3 Studies of the reduction of -hydroxy ketone 99. 
 
Next, modification of the Narasaka-Prasad
71,72
 protocol was investigated where  
-hydroxyketone borinate chelate was reduced with LiBH3OMe73 (Table 2.4.3, entry 2). 
The reaction is believed to proceed via a chair-like transition state (Figure 2.4.3) in which a 
silyl substituent on the -carbon prevents the approach of a reducing agent from the 
bottom side. Hence, hydride attacks preferentially from the si-face giving rise to the 1,3-
syn diol 102 in excellent yield (84%) with good diastereoselectivity (10:1).   
B
O
O
H
R
OTBS
H
L
L
TBSO
B
O
O
L
L
TBSO
H
R
H
TBSO
H H
TS VII TS VIII  
Figure 2.4.3 Proposed transition states for the reduction of the -hydroxy ketone 99. 
 
The 1,3-anti reduction of -hydroxy ketone 99 was then required to access 103. It 
was decided to apply the Evans protocol employing Me4NBH(OAc)3.
63
 However, the acid-
sensitive nature of compound 99 and the instability of the silyl groups in consequence led 
to degradation of the starting material (Table 2.4.3, entry 3).  
The next possibility explored was the Luche reduction (Table 2.4.3, entry 4), which 
was a cleaner reaction compared to the one with sodium borohydride, and upon inspection 
of the 
1
H NMR, the observed selectivity correlated to the results of reaction with 
LiBH3OMe. At this point one of the side products, also observed in the reaction with 
sodium borohydride was isolated and analysed. It was assigned by COSY 
1
H-
1
H NMR to 
be compound 104 in which the secondary silyl group had migrated from the C9 position to 
the neighbouring C8 hydroxyl (Scheme 2.4.2). Faced with these results, it was necessary to 
search for an alternative plan to reach the 1,3-anti configured diol 103. 
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TBSO OTBS
O OH
99
H-
TBSO OTBS TBSO OH
TBSO OH
102 104
OH OH
+
 
Scheme 2.4.2 Reduction of the -hydroxy ketone 99. 
 
Progress towards the degradation fragment 56 with the anti-syn arrangement and 
8S, 9R, 10S configuration was now hampered, nonetheless the syn-syn 8R, 9R, 10S 
configured degradation fragment 55 was within reach.  
2.4.4  Hydroboration and deprotection of the syn diol 102 
The hydroboration protocol employing thexylBH2 successfully installed the C14 
hydroxyl in 102. However, it was observed by 
1
H NMR that the silyl groups were 
displaced during the reaction. Therefore, Dowex-50 deprotection was instantly carried out 
to provide the syn-syn 8R, 9R, 10S configured degradation fragment 55 in excellent yield 
(80%) over two steps (Scheme 2.4.3).  
TBSO OTBS
OH OH
HO OH
OH OH
OH
102 55
1) ThexylBH2, THF,
H2O2, NaOH, 0 ºC 
2) Dowex-50, MeOH, 
65 ºC 
80% over two steps
 
Scheme 2.4.3 Formation of C8R C9R C10S degradation fragment 55. 
2.5 Meso-tartaric acid route 
Due to the difficulties encountered in obtaining the 1,3-anti reduction product 103, 
a synthesis starting from meso-tartaric acid was designed to access the fourth degradation 
fragment 56 as a racemate. Employing the protocols developed by Napoli et al,
74
 aldehyde 
105 was synthesised in four steps via a series of simple transformations in 66% yield 
(Scheme 2.5.1). The methyl ester of meso-tartaric acid 106 was first protected with 
dimethoxypropane and catalytic p-toluenesulfonic acid, followed by lithium-aluminium 
hydride reduction to afford diol 107. Mono-TBS protection of 107 and oxidation under 
Swern conditions furnished aldehyde 105. 
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HO CO2Me
O
O OTBS
O
H
O
HO CO2Me
1) 2,2-DMP, TsOH, 
DMF, 150 ºC, 
2) LiAlH4, Et2O, rt
79% over 2 steps
O OH
OH
1) NaH, TBSCl, 
THF, 0 ºC - rt
2) Swern ox.
84% over 2 steps
106 107 105  
Scheme 2.5.1 Synthesis of the aldehyde 105 from meso-tartaric acid. 
 
Addition of the freshly prepared homoallyl magnesium bromide to aldehyde 105 
provided a separable mixture of C10-alcohols 108 and 109 (Scheme 2.5.2), which 
corresponded to the data reported by Napoli for saturated analogues. The isolated alcohol 
108 was next subjected to hydroboration with thexylBH2 to provide the intermediate diol, 
which was deprotected with Dowex-50 resin to furnish the racemic anti-syn degradation 
fragment 56.  
O
O OTBS
OH HO OH
OH OH
OH
O OTBS
O
H
105 108 2.5 : 1 dr
MgBr
56 racemic
O
THF, 
-40 - -20 ºC, 1h
0 ºC, 2h, 98%
1) ThexylBH2, THF, 0 ºC,
 H2O2, NaOH, 95%
 
2) Dowex-50, MeOH, 
65 ºC, 98%
 
Scheme 2.5.2 Formation of the racemic degradation fragment 56 via Grignard reaction. 
 
The diastereomeric alcohol 109 was also subjected to hydroboration with 
thexylBH2 and Dowex-50 deprotection to yield the racemic form of the previously 
reported anti-anti degradation fragment 57 (Scheme 2.5.3).  
O
O OTBS
OH HO OH
OH OH
OH
109
1) ThexylBH2, THF, 0 ºC,
H2O2, NaOH
 
2) Dowex-50, MeOH, 
65 ºC 
70% over two steps 57 racemic  
Scheme 2.5.3 Synthesis of the racemic degradation fragment 57. 
 
As a result, investigation based on the meso-tartaric acid route provided additional 
justification for the assignment of the relative configuration of the degradation fragments 
56 and 57. Assignment of the anti-anti racemic degradation fragment 57 obtained in this 
way was supported by the corresponding 
1
H and 
13
C NMR data of the enantiopure product 
57 synthesised in 9,10-anti series. Consequently, product 56 derived from (S)-alcohol 108 
would bear anti-syn configuration. 
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2.6 Structural assignment 
At this stage, the first phase of the project was concluded with the synthesis of four 
diasteroisomeric C7-C14 polyols. The synthetic strategy employed highlights the 
effectiveness of organocatalysis for the construction of contiguous hydroxylated 
stereocentres from simple achiral building blocks. The collected 
1
H and 
13
C NMR and 
optical rotation data (Table 2.6.1) were sent to Prof. Bill Baker for comparison with the 
natural degradation fragment 54. In due course we received confirmation of the relative 
and absolute stereochemistry of the C7-C14 fragment. Our collaborator identified the 
arrangement of the triad present in the macrocycle as the syn-anti 8R, 9R, 10R isomer, 
which was the enantiomer of the degradation fragment 58 (Figure 2.6.1). At this point, 
attention was directed towards the synthesis of the C7-C14 fragment with the proposed 
stereochemistry and its incorporation into the total synthesis of palmerolide C (3a).  
OH OH
OH OH
OH
OH OH
OH OH
OH
OH OH
OH OH
OH
OH OH
OH OH
OH
O
H
N
19
O 1
O
8
OH
OH
10
O
O
NH2
8
10
8
8
1010
108
57: 8R, 9S, 10S anti-anti 58: 8S, 9S, 10S syn-anti
55: 8R, 9R, 10S syn-syn 56: rac anti-syn
OH
OH
OH
OH
HO
8
10
54
3a
OH OH
8
OH
10
OH
OH
ent-58: 8R, 9R, 10R syn-anti
 
Figure 2.6.1 Comparison studies, performed by Prof Bill Baker, University of South Florida.
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3 Chapter 3 
3.1 Retrosynthetic strategy for the synthesis of C1-C14 fragment 
The retrosynthetic strategy for the C1-C14 fragment 110 of palmerolide C is 
outlined in Figure 3.1.1. Based on the stereochemical information obtained from the 
degradation studies a highly convergent synthetic strategy was envisaged with 
disconnections of the C6-C7 alkene revealing two key fragments. The C1-C6 subunit 111, 
could be derived from Horner-Wadsworth-Emmons reaction (HWE) of 4-pentenal 84 and 
triethyl phosphonoacetate 112. The C7-C14 fragment 113 would be assembled via a boron 
aldol reaction between chiral ketone 114, derived from the L-ascorbic acid and aldehyde 
69.  
EtO 1
O
7 OTBS
OTBS
OPMB
14
TBSO
O
OTBS
PMBO
113: C7 - C14 subunit
7
TBSO
14
O
EtO
6
1
111: C1 - C6 subunit
H
O
110
114 69
EtO
P
O
OEt
O
EtO
O
H
OTBS
O
BzO
BzO
84 112
metathesis
aldol
HWE
OTBS
 
Figure 3.1.1 Retrosynthesis of the C1-C14 fragment 110. 
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3.2 Synthesis of the C1-C6 fragment 111 
Preparation of the C1-C6 fragment 111 began with HWE olefination. Under 
Masamune-Roush conditions, treatment of 4-pentenal 84 with triethyl phosphonoacetate 
ester 112, lithium chloride and Hunig’s base, provided the E-enoate 111 exclusively in 
81% yield (Scheme 3.2.1).75  
EtO P
O
OEt
O
EtO
O
LiCl, DIPEA
MeCN,
81%
O
EtO
+
84 112 111  
Scheme 3.2.1 Synthesis of the C1-C6 subunit 111 via HWE olefination. 
3.3 Synthesis of the C7-C14 fragment  
3.3.1 Synthesis of the chiral ketone 
The construction of the key bond in the C7-C14 fragment relies on the boron-
mediated aldol reaction of -chiral ketone 114.76,77 The synthesis of 114 began with the 
introduction of the isopropylidene acetal on L-ascorbic acid 115 (Scheme 3.3.1). Oxidative 
cleavage of the resulting intermediate and subsequent esterification provided hydroxy-ester 
116. Reduction of the ester and protection of the resulting diol with benzoyl chloride was 
followed by the deprotection of the acetal, which provided 117. Selective silyl protection 
of the primary hydroxyl and oxidation under Swern conditions provided access to the 
chiral ketone 114. A total of eight steps from L-ascorbic acid was required to complete the 
synthesis of 114 in 23% overall yield.  
O
HO
HO O
OHHO O
OHO
O
EtO
1) Acetone, AcCl
2) K2CO3/H2O2
3) EtI, K2CO3
75% over 3 steps
1) LiAlH4
2) BzCl, Et3N
3) TFA/H2O
55% over 3 steps
OBz
OBzHO
OH
OBz
OBz
TBSO
O
1) TBSCl, Im-H
2) (COCl)2, DMSO,
    CH2Cl2, Et3N
56% over 2 steps
115 116
114 117
H
 
Scheme 3.3.1 Preparation of chiral ketone 114 from L-ascorbic acid. 
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Given the lengthy synthetic sequence required to prepare 114 which ultimately only 
provides two carbons, an alternative -oxygenated chiral ketone was sought. Carda and 
Marco78 demonstrated the potential of the L-erythrulose-derived ketone 118 in the 
formation of the poly-oxygenated chiral motifs of type 119, which then were used in the 
synthesis of the bioactive metabolite (+)-goniothalesdiol 120 (Scheme 3.3.2).78 Good 
levels of selectivity79 and high yields of product 119 prompted exploration of the L-
erythrulose derived ketone 118 in our approach towards C7-C14 subunit 113. 
OTBS
O
OBz
TBSO
c-Hex2BCl, Et3N,
PhCHO, 
Et2O, -78 ºC
then LiBH4, 
THF, -78 ºC
pH 7 buffer, 
MeOH/H2O2
OTBS
OH
OBz
TBSO OH
Ph
118 119 120
OTBS
O
OHC
O
Ph
O
HO OH
Ph CO2Me
 
Scheme 3.3.2 Synthesis of (+)-goniothalesdiol 120 from ketone 118. 
 
Marco developed a two-step protocol utilising L-erythrulose 121 as a starting chiral 
ketone. The synthesis began with TBS-protection of the primary hydroxyl groups in 121, 
further esterification of the secondary hydroxyl with benzoyl chloride completed 118 in 
good yield (Scheme 3.3.3).  
OTBS
O
OBz
TBSO
OH
O
OH
HO
1) TBSCl, Im-H
DMF, rt, 70%
2) BzCl, Et3N, 
DMAP, CH2Cl2, 
     rt, 60%121 118  
Scheme 3.3.3 Preparation of the chiral ketone 118 from L-erythrulose. 
 
3.3.2 Boron-mediated aldol reaction 
3.3.2.1 Stereocontrol in boron aldol reactions 
The aldol motif is one of the most commonly occurring patterns within molecules 
derived from natural sources, particularly those of polyketide origin. The construction of 
the 1,3-hydroxy-ketone pattern presents chemists with a challenge that has been 
successfully tackled for over thirty years. As a result, examples of well-defined enolisation 
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protocols,80 chiral auxiliaries,81 and also ligands and catalysts82 for use as stereochemical 
determinants have been developed. 
One of the key factors in predicting the relative configuration of an aldol product 
(syn or anti) is the geometry of the enolate component; syn-aldol product being generated 
from (Z)-enolates, and anti products arising from (E)-enolates. Enolisation protocols using 
boron as a metal centre give access to defined enolate geometries, where under specific 
circumstances, factors such as electronic effects and steric effects govern the selectivity. 
The generation of the (E)-boron enolate under kinetic conditions can be achieved 
employing dicyclohexylboron chloride, which preferentially complexes the ketone C=O 
lone pair cis to the alkyl group allowing stabilisation of a negative charge (Me > Et > iPr) 
(Scheme 3.3.4). As a result of this complexation, a proton on the activated centre can be 
abstracted by a relatively small amine base such as triethylamine, which consequently 
gives rise to the (E)-boron enolate. Kinetic conditions promoting the formation of the  
(Z)-enolate typically involves the use of small ligands (e.g. n-butyl) on boron and a good 
leaving group such as triflate, in combination with a bulky amine (e.g. 
diisopropylethylamine), leading to deprotonation of the most accessible proton which 
provides (Z)-enolate (Scheme 3.3.4).80  
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H
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L
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H
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iPr2NEt
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Scheme 3.3.4 Enolisation methods to form (Z)- and (E)-enolates. 
 
When the (Z)-enolate reacts with the aldehyde, two Zimmerman-Traxler transition 
states TS I and TS II shown below can be considered (Figure 3.3.1). Due to 1,3-diaxial 
interactions between the boron-ligand (L), the enolate side chain (R1) and the aldehyde 
substituents (R3) transition state TS II is disfavoured, hence the preferred transition state 
TS I, which is lower in energy, would give rise to the 1,2-syn aldol product.  
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Figure 3.3.1 Zimmerman-Traxler transition states for (Z)-enolates. 
 
Recent DFT calculations showed that boat-like transition states predominate when 
(E)-boron enolates are used in the aldol reaction (Figure 3.3.2). However, the relatively 
small energy barrier between TS III and TS IV lowers the level of enantiocontrol.83 The 
steric interactions between the metal ligand and enolate side chain (R1) are minimised in 
the aldol reaction proceeding via a boat-like transition state. 
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TS IV  
Figure 3.3.2 Boat-like transition states for (E)-enolates. 
3.3.2.2 Boron-mediated aldol reaction using ketone 118 
Investigation of the anti-selective aldol reaction using chiral ketone 118 and 
aldehyde 69, commenced with the selective enolisation of 118 using c-Hex2BCl and Et3N 
to provide the intermediate (E)-boron enolate 122. Followed by the addition of aldehyde 
69 and oxidative work-up upon completion of the reaction, the corresponding aldol product 
123 (Scheme 3.3.5) was delivered in good yield (81%) with moderate diastereoselectivity 
(4:1). 
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Scheme 3.3.5 Boron mediated anti-aldol reaction to form -hydroxyketone 123. 
 
The stereochemical outcome of the aldol reaction of chiral (E)-enol borinate 122 is 
determined by a number of competing effects. A plausible explanation for product 
distribution in the first instance depends upon enolate geometry and its -facial selectivity. 
Favoured transition state TS V shown in Figure 3.3.3, corresponding to the enolate re-face 
attack on the aldehyde, would account for the preferred 7,9-syn-9,10-anti (natural product 
numbering) arrangement in the product 123. The 1,3-allylic strain minimisation between 
-carbon substituents and the enolate OTBS group overrides the non-reinforcing electronic 
effect of the enol oxygen and -benzoyl oxygen. The benzoyl substituent is directed in 
contrasteric fashion, nonetheless stabilising transition state TS V by hydrogen-bonding to 
the formyl hydrogen (Figure 3.3.3).79,84 To restrain the steric hindrance between the -OBz 
moiety and one of the boron cyclohexyl ligands, the boat-like transition state TS V would 
predominate over a chair-like transition state.85  
The product 124 corresponding to the enolate si-face attack on the aldehyde, would 
be formed as a consequence of a much less stable transition state TS VI. The -OBz 
substituent is now located away from the pseudo-cycle, pushing the sterically more 
demanding OTBS group inwards, however this interaction can be relieved through the 
rotation of the B—O bonds resulting in a boat-like conformation TS VI, though lacking 
the formyl hydrogen-bond stabilisation. 
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Figure 3.3.3 Rational for observed diastereoselectivity in boron-aldol reaction of chiral (E)-borinate 
122. 
 
3.3.2.3 Completion of the synthesis of C7-C14 fragment 
Having formed the aldol product 123, it was observed that it is prone to rapid 
decomposition. Therefore, immediate protection of the C10 hydroxyl was required. 
However, the introduction of most protecting groups requires strong base or acid to 
effectively induce the desired transformation. In 2003, Basu and Rai reported a mild 
procedure to protect a hydroxyl group as its p-methoxybenzyl ether.86 The protocol 
employs trichloroacetimidate of p-methoxybenzyl alcohol and a catalytic amount of mild 
Lewis acids, such as La(OTf)3 or Sc(OTf)3 to efficiently form benzyl ethers with primary 
and secondary alcohols. With the awareness that this procedure has been widely employed 
in the synthesis of complex molecules,87,88 it was attempted first. Aldol product 123 was 
treated with PMBTCA and La(OTf)3 (Scheme 3.3.6), and the reaction was completed after 
six hours. Filtration, followed by column chromatography provided 125 in 65% yield.      
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Scheme 3.3.6 Introduction of the PMB group to form 125. 
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Reduction of keto-ester 125 using lithium-aluminium hydride provided poor 
results, however using lithium borohydride a mixture of diols 126 was produced in 66% 
yield. Separation of the diastereoisomers at this point was not required as in the next step 
the newly formed stereocentre would undergo oxidative cleavage to form the aldehyde 
127.  
OTBS
O
OBz
TBSO OPMB
OTBS
125
 LiBH4, Et2O
-78 ºC 
66% OTBS
OH
OH
TBSO OPMB
OTBS
126  
Scheme 3.3.7 Formation of diol 126. 
Oxidative cleavage of 1,2-diol 126 with sodium meta-periodate was explored 
initially, however unsatisfactory results were obtained. Alternative cleavage with lead 
tetracetate provided the ,-bisalkoxy aldehyde 127 almost quantitatively (Scheme 3.3.8). 
Quick filtration and removal of solvent gave access to crude 127, which was used without 
further purification in the next step.   
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Scheme 3.3.8 Synthesis of aldehyde 127. 
The synthesis of C7-C14 allylic alcohol 128 was completed with Grignard addition 
of vinyl magnesium bromide to the aldehyde 127 (Scheme 3.3.9). The allylic alcohol 128 
was formed in 60% yield over two steps and with excellent >95 : 5 diastereoselectivity. 
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Scheme 3.3.9 Formation of C7-C14 allylic alcohol 128 
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In 2006 Evans and co-workers investigated the asymmetric induction in methyl 
ketone aldol additions to ,-bisalkoxy aldehydes and based on the experimental data, 
reported that the selectivity in acyclic substrates can be predicted upon consideration of the 
polar Felkin-Anh or Cornforth models.89 In the reactions of 4,5-anti-bis-alkoxy aldehyde 
129 preference for the formation of 3,4-anti products 130 rather than 131 was observed 
(Table 3.3.1), resulting from a -facial selectivity of the aldehyde, antiparallel arrangement 
between the C=O and -C-O groups, and minimisation of the syn-pentane interactions. 
Extrapolating these results to our system, the proposed transition state TS VII (Figure 
3.3.4) derived from a minimisation of the syn-pentane interactions, accounts for the 
observed selectivity in the 8,9-anti allylic alcohol 128.  
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O OPMB
i-PrH
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+
 
3,4-anti : 3,4-syn (yield %) 
R M = TMS/BF3•OEt2 M = 9-BBN M = Li 
Me 65 : 35 (83) 91 : 09 (88) > 99 : 01 (95) 
i-Pr 41 : 59 (95) 86 : 14 (92) > 99 : 01 (95) 
t-Bu 09 : 91 (89) 81 : 19 (90) > 99 : 01 (98) 
Table 3.3.1 Aldol addition to  ,-bisalkoxy aldehyde 129 
H
O
O
H
TBSO
R
PMB
Nu
TS VII  
Figure 3.3.4 Evans-Cornforth model for addition to  ,-bisalkoxy aldehyde. 
 
Comparison with similar allylic alcohols 132 and 133 studied by Pikho during the 
synthesis of pectenotoxin-290 supported our stereochemical assignment. The reported  
J-coupling values for 3,4-syn arrangement in the allylic alcohol 133 are around 2.0 Hz and 
in the 3,4-anti configured product 132 over 6.0 Hz (Figure 3.3.5). Inspection of the 1H 
NMR spectra of 128 provided results consistent with 8,9-anti configuration where JH8-H9 
was 5.0 Hz.   
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Figure 3.3.5 Comparison of the J values for 1,2-syn and 1,2-anti arrangement. 
 
After completing the analysis of the obtained data it became apparent that the 
allylic alcohol 128 possessed the undesired (S) stereochemistry at the newly formed C8 
stereocentre. Nevertheless, it was decided to explore the feasibility of a coupling strategy 
between C1-C6 subunit 111 and C7-C14 fragment 128, while revising the synthetic 
strategy to install the correct configuration at C8 in allylic alcohol 128. 
3.4 Installation of the C6-C7 junction via cross-metathesis  
Synthetic efforts turned towards the investigation of cross-metathesis (CM) 
between the C1-C6 111 and C7-C14 128 fragments. According to the definition, olefin 
metathesis is a unique metal-catalysed carbon skeleton redistribution in which a mutual 
exchange of unsaturated carbon-carbon bonds takes place.91 CM is one variant of that 
transformation, where two different olefins are cleaved, aided by a catalyst, and 
recombined in such a way to form the new alkene and liberate ethene. This process is 
subjected to the thermodynamic rules (Scheme 3.4.1) in which case the external delivery of 
ethene would reverse the reaction. 
CH2R
1 H2C R
2
R1
R2 H2C CH2+ +
 
Scheme 3.4.1 Cross-metathesis reaction. 
 
Despite broad interest and vast synthetic applications, the CM reaction presents 
certain limitations, with alkene selectivity being the major issue. In addition, complex 
product mixtures containing homodimers, heterodimers and side products are often 
obtained (complicating the purification and resulting in low yields).  
To systematise the utility of the particular olefins in the process, categorisation and rules 
for selective CM have been established (Figure 3.4.1) after thorough investigation of 
literature examples.91  
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Type I Rapid homodimerisation, homodimers consumable, i.e. terminal olefins, 1º allylic 
alcohols, esters. 
Type II Slow homodimerisation, homodimers hardly consumable, i.e. styrenes, acrylates, 
acrylamides, 2º allylic alcohols. 
Type III No homodimerisation, i.e. 1,1-disubstituted olefins, 3º allylic alcohols. 
Olefin 
reactivity  
Type IV Olefins inert to CM, but do not deactivate catalyst (spectator), i.e. vinyl nitro 
olefins, trisubstituted allyl alcohols (protected). 
Reaction between two olefins of Type I = Statistical CM. 
Reaction between two olefins of same type (Type II or III) = Non-selective CM. 
Product 
distribution 
Reaction between olefins of two different types = Potentially selective CM. 
Figure 3.4.1 Olefin categories according to Grubbs.
91
 
The investigation of our system began with the exploration of the second 
generation of the Grubbs catalyst92 under the standard conditions for CM (5 mol% cat., 
CH2Cl2, rt, Scheme 3.4.2). In the tentative experiment determination of 111 and 128 olefin 
categories was addressed and general information about the performance of this system 
were acquired.   
OTBS
OH OPMB
OTBS
O
EtO
O
EtO
OH
OTBS
OPMB
TBSO
128111
134 not formed
O
EtO
135
O
OEt
5 mol% Grubbs 2nd, 
CH2Cl2, rt, 24 h
 
Scheme 3.4.2 Attempted cross-metathesis between C1-C6 and C7-C14 subunits. 
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Unfortunately, under the investigated conditions formation of the heterodimer 134 
was not observed, only the homodimer of the C1-C6 fragment 135 was isolated in 30% 
yield together with unreacted 128 (40%). Upon evaluation of this experiment it was 
hypothesised that the C1-C6 fragment 111 behaves like a Type I olefin whereas the allylic 
alcohol 128, despite being inactive in the cross metathesis, was involved in undetermined 
side reactions and so its classification remains ambiguous. The complex 1H NMR spectra 
and unequal mass balance for compound 128 after the reaction suggested it was 
decomposing under the reaction conditions. Guided by these findings, considerable efforts 
were expended to achieve the cross coupled product, whilst employing different reaction 
conditions, which are summarised in Table 3.4.1. However, none of the catalysts screened 
in the different combinations of reaction parameters delivered the heterodimeric product 
134, promoting, at best the formation of the homodimer 135.  
 
  
N N
Ru
Cl
Cl
Ph
PCy3  
N N
Ru
Cl
Cl
O
 
N N
Ru
Cl
Cl
(p-CF3Ph)3P
Ph
 
Catalyst Grubbs 2nd Grubbs-Hoveyda Nolan-type 
Cat. loading 5-50 mol% cat 10 mol% cat 5-50 mol% cat 
Concen. 0.001-0.1 M/CH2Cl2 0.001 M/CH2Cl2 0.001-0.1 M/CH2Cl2 
Time 12 - 48 h at rt 24 h at rt 12 - 48 h at rt 
111:128 (eq) 1 to 10 : 1 to 2 5 : 1 1 to 10 : 1 to 2 
Result dimer 135 (30%), unreacted 128 (40%) dimer 135 (25%), complex mix 
Table 3.4.1 Investigation of different conditions for CM reaction. 
3.5 C7-C14 fragment - structural reassignment 
While revising the C7-C14 synthesis and seeking an alternative coupling strategy 
further information pertaining to the stereochemistry of palmerolide C was provided. The 
initial assignment of the C8-C10 stereotriad was incorrect and revised to syn-anti 8S, 9S, 
10S, while the 19R, 20S were the same (Figure 3.5.1). This was due to an error in the 
Mosher ester analysis arising from the use of MTPA-acid chlorides where, according to 
Cahn-Ingold-Prelog rules, (R)-MTPA acid gives the (R)-ester but (R)-MTPA acid chloride 
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provides the (S)-ester. The spectra for the (R)- and (S)-esters were transposed resulting in 
the opposite assignment (Section 2.6, Chapter 2). 
OH
OH OH
OH OH
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OH
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H
N
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OH
OH
OO
NH2
OH OH
OH OH
OH
ent-58: C8R, C9R, C10R syn-anti 58: C8S, C9S, C10S syn-anti
3a: initial assignment 3b: revised assignment
 
Figure 3.5.1 Revision of the configuration of palmerolide C. 
 
In light of this revision, a synthesis reflecting the new assignment had to be 
devised. The immediate solution would be to change the configuration of the chiral ketone 
119 to allow formation of the opposite enantiomer of the aldol product 123. However,  
D-erythrulose at the cost of $ 700 USD for 100 mg was not seen as viable. Attempts to 
invert the stereocentre in the TBS-protected L-erythrulose 136 using a Mitsunobu reaction 
were unsuccessful (Scheme 3.5.1).  
OTBS
O
OH
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136
p-BrPhCO2H, 
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Et2O OTBS
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O
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O
p-BrPh  
Scheme 3.5.1 Attempted Mitsunobu reaction to form D-erythrulose derivative. 
 
The only possibility left within the approach of changing the stereochemistry on the 
chiral ketone 114 was to elaborate the route starting from L-ascorbic acid 115. This 
unfortunately resulted in a nine-step synthesis for one of the starting materials 137 which 
was produced in 10% overall yield (Scheme 3.5.2).  
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Scheme 3.5.2 Synthesis of the (R)-configured ketone 137. 
 
Undaunted, alternatives were sought and soon a revised plan was developed 
wherein the Crimmins93 thioxazoline 138 was employed in the aldol transformation to 
control the installation of the required stereocentres (Scheme 3.5.3). A revised strategy 
would considerably reduce the number of synthetic operations towards C7-C14 fragment, 
with the N-glycolyloxazolidinethione auxiliary 138 prepared in three steps from  
(S)-phenylalanine. 
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Scheme 3.5.3 Revised retrosynthesis of the C7-C14 fragment. 
3.6 Revised synthetic strategy for the C1-C14 fragment  
Several steps into our new synthetic approach towards Crimmins’ thioauxiliary it 
was realised that the commercial supply of sparteine, a key component in this aldol 
reaction, was no longer available. Since our reserve of sparteine were quite limited, 
revision of the proposed strategy was inevitable.  Gratifyingly, it was found that the aldol 
product 86 synthesised previously could be converted to -hydroxy ester using a reaction 
developed by Stoltz.94 This study showed application of dioxanone-derived products in a 
stereoselective alkylation reaction and further elaboration of the product 139 to the 
corresponding -hydroxyesters 140 as shown in Scheme 3.6.1. 
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Scheme 3.6.1 Formation of the -hydroxy-ester 140 by Stoltz. 
 
One drawback of this approach would be regioselectivity for oxidative cleavage in 
the absence of a quaternary -centre as in 141 (Scheme 3.6.1). However, only a synthetic 
investigation could provide valuable information. Therefore, it was decided to explore the 
acetonide deprotection, periodic acid-mediated cleavage and esterification on the suitably 
protected aldol product 86.  
Bearing in mind the unsuccessful cross-metathesis studies, different coupling 
strategies were sought. As outlined in Scheme 3.6.2, the revised strategy towards 142 
would rely on a C6-C7 aldol/dehydration disconnection revealing C1-C6 aldehyde 143 and  
C7-C14 ketone 144. The synthesis of ketone 144 with C9-C10 stereocentres installed by 
the proline-catalysed aldol reaction would incorporate the acetonide deprotection and 
oxidative cleavage to form carboxylic acid. The modified C1-C6 subunit 143 would be 
accessed using a HWE reaction of aldehyde 145 and triethyl phosphonoacetate 112.   
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Scheme 3.6.2 Retrosynthesis of the C1-C14 fragment 142. 
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3.3.2 Synthesis of the modified C1-C6 fragment  
The construction of the C1-C6 subunit 143 began with the preparation of the 
aldehyde 145. 1,4-Butanediol 146 was monoprotected with TBSCl, subsequent oxidation 
under Swern conditions delivered 145 in 68% over two steps (Scheme 3.6.3). HWE 
olefination of the aldehyde 145 with triethyl phosphonoacetate 112 was performed under 
Masamune-Roush conditions.75 The enoate 147 was produced in 77% yield as a single  
(E)-isomer (Scheme 3.6.3). Following TBS-ether cleavage, Swern oxidation completed the 
synthesis of C1-C6 fragment 14395 in overall 41% yield over five steps.   
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Scheme 3.6.3 Synthesis of the modified C1-C6 subunit 143. 
3.3.3 Synthesis of the modified C7-C14 fragment  
Attention was then turned to the synthesis of the aldol product 86 under proline-
catalysis. The work commenced with the preparation of bulk quantities of the starting 
materials applying the same methods as for the small-scale synthesis. The aldehyde 84 was 
readily accessed in more than 20 g scale. Synthesis of dioxanone 63 on >50 g scale was 
more laborious; the initial acetonide 71 formation was carried out in DMF (Section 2.2), 
following a long extraction process producing high volume of solvents, which have to be 
removed. Removal of all traces of DMF before periodate cleavage was essential, as its 
similar boiling point with the final product made distillation troublesome. Consequently, 
dioxanone 63 was produced in >30 g quantity after distillation. The proline-catalysed 
reaction was then attempted on >10 g (76.9 mmol) of ketone 63 and surprisingly the cross-
aldol product was produced in very low yield together with a range of side products 
making the column chromatography purification difficult. Therefore, several reactions (5-
10) in parallel on a gram scale of ketone 63 were carried out and gratifyingly, 86 was 
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isolated typically in 40-50% yield per batch (Scheme 3.6.4).  
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Scheme 3.6.4 Synthesis of the protected (S)-proline aldol product 86. 
Following the isolation of 86, installation of the protecting group required 
application of a mild protocol (Scheme 3.6.5). Therefore, p-methoxybenzyl 
trichloroacetimidate was employed in combination with catalytic lanthanide triflate to form 
C10 PMB-ether 148 in 77% yield.  
O O
O OPMB
La(OTf)3, PhCH3, 
0 ºC - rt, 77%
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O O
O OH
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Scheme 3.6.5 Introduction of the PMB group to form 148. 
With 148 in hand, attention turned towards formation of the -hydroxy ester 149. 
The acetonide 148 was subjected to deprotection with p-toluenesulfonic acid to access 
keto-diol 150 in 92% yield (Scheme 3.6.6). Subsequent periodic acid oxidative cleavage 
afforded the intermediate -hydroxy carboxylic acid 151 together with aldehyde 152, 
which were taken as a crude mixture for alkylation with methyl iodide. Upon completion 
of the reaction, column chromatography afforded -hydroxy ester 149 in 64% yield and 
aldehyde 152 in 31%.  
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Scheme 3.6.6 Formation of the -hydroxy ester 149. 
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With -hydroxy ester 149 in hand, protection with TBSOTf and 2,6-lutidine gave 
153 in 98% yield (Scheme 3.6.7). Installation of a terminal hydroxyl functionality was then 
required, and having previously used thexylBH2 we decided to explore the optimised 
conditions. Therefore, compound 153 was added to a freshly prepared solution of 
thexylBH2 in tetrahydrofuran to furnish alcohol 154 after oxidative work-up in excellent 
96% yield (Scheme 3.6.7). Subsequent protection using TBSCl and imidazole afforded the 
intermediate 155 in 92% yield.  
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Scheme 3.6.7 Synthetic elaboration of -hydroxy ester 149. 
Having prepared compound 155, all that remained was to form methyl ketone 144 
(Scheme 3.6.8). We chose to first introduce a Weinreb amide functionality to allow 
controlled alkylation with methyl Grignard. To ester 155 and N,O-dimethylhydroxylamine 
hydrochloride was added isopropylmagnesium bromide and intermediate Weinreb amide96 
156 was isolated in 97% yield. Subsequent addition of methylmagnesium bromide 
afforded methyl ketone 144 in 96% yield.   
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Scheme 3.6.8 Completion of the synthesis of the C7-C14 subunit 144. 
The C7-C14 methyl ketone 144 was synthesised in nine steps including the proline-
catalysed aldol reaction, which installed the desired stereochemistry with an excellent 
diastereo- and enantiocontrol. However, the isolated yield of the aldol product 86 is the 
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only disadvantageous feature of this organocatalytic approach. Nonetheless, the remaining 
synthetic operations produced C7-C14 subunit 144 in 36% yield over eight steps. 
3.7 Revised fragment union 
Having synthesised C1-C6 143 and C7-C14 144 fragments, attention was turned 
towards their coupling using an aldol/dehydration sequence. Building upon previous 
experience it was decided to utilise the boron aldol reaction to unite the two carbonyl 
components.97 Selectivity was not an issue, since elimination of the newly formed 
stereocentre would immediately follows the C—C bond forming step. Thus, enolisation of 
C7-C14 ketone 144 with c-Hex2BCl and triethylamine in diethyl ether at -78 ºC, followed 
by addition of aldehyde 143, provided the corresponding aldol adducts 157 as an 
inconsequential mixture of C6 diastereoisomers (90%, 1.6 : 1 dr, Scheme 3.7.1) 
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Scheme 3.7.1 C1-C6 and C7-C14 fragment union via aldol coupling. 
 
Next, the one-pot mesylation/elimination procedure98 was explored. Even though it 
provided desired product 142, the obtained yield was unsatisfactory and extended exposure 
to DBU did not show any improvement in yield (Scheme 3.7.2). An alternative method 
utilising dehydrating agents such as the Burgess or Martin sulfurane reagents were 
considered next. Both procedures are reported to efficiently eliminate a molecule of water 
from secondary and tertiary alcohols. The first reagent methyl N-(triethyl-
ammoniumsulfonyl)carbamate (Burgess reagent), was found to proceed through E1 
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elimination pathway, abstracting hydrogen in syn relation to the leaving group due to the 
geometrical constraints on the reagent.99 Inspection of the literature showed Martin 
sulfurane reacts with secondary alcohols via E2 elimination. The antiperiplanar geometry 
in this step enables stereospecific alkene generation from chiral secondary alcohols. Hence, 
we chose to investigate dehydration with Martin sulfurane reagent. Treatment of 157 with 
a solution of the Martin sulfurane100 reagent at -10 ºC provided enone 142 in less than one 
hour in excellent 95% yield and exclusive (E)-selectivity.  
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142 157 142  
Scheme 3.7.2 Dehydration of the aldol product 157 to form enone 142. 
 
Martin sulfurane reagent 158 (Scheme 3.7.3), is a ketal analogue of  
bi-phenylsulfide, which reacts by rapid exchange of one of the alkoxy ligands with the 
reacting alcohol to yield sulfurane 159 and fluoro-alcohol. Key intermediate 
alkoxysulfonium ion 160 is formed upon extrusion of the other fluoro-alkoxy ligand, 
which comes back to attack the -hydrogen and release alkene 161 and bi-phenyl 
sulfoxide 162 (Scheme 3.7.3).  
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Scheme 3.7.3 Proposed mechanism of Martin sulfurane dehydration. 
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3.8 Advancing the C1-C14 subunit  
3.8.1 Reduction of enone 142 and configurational analysis 
With the C1-C14 fragment 142 in hand, investigation of the enone reduction began. 
Drawing upon previous experience with addition to ,-bisalkoxyaldehyde 127 high levels 
of control in the reduction of 142 were expected (see section 3.3.2.3). The selective 
conversion of enone 142 to the allylic alcohol 163 was achieved under Luche conditions 
employing cerium chloride and sodium borohydride. The reduction product 163 was 
formed in excellent 90% yield and 92 : 8 diastereoselectivity, as established by 1H NMR 
(Scheme 3.8.1).  
O
EtO
O
OTBS
OPMB
TBSO
142
O
EtO
OH
OTBS
OPMB
TBSO
CeCl3•7H2O, 
NaBH4, MeOH
90%, 92 : 8 dr
163  
Scheme 3.8.1 Reduction of enone 142 introducing C8 stereocentre. 
 
The diastereoselection can be explained by consideration of the Evans-Cornforth 
model discussed in section 3.3.2.3.89 However, in this instance direct minimisation of the 
syn-pentane interactions (TS VIII) promotes formation of the C8S configured product 163 
(Figure 3.8.1).  
O
O
8
9
OTBS
R1
PMB H
R
TS VIII  
Figure 3.8.1 Evans-Cornforth model for diastereoselective reduction. 
 
The stereochemistry of the C8 hydroxyl was confirmed after the synthesis of 
(R)/(S)-MTPA ester derivatives 164 and 165 (Table 3.8.1). Analysis of the (R)/(S)-MTPA  
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1H NMR spectra according to the advanced Mosher method, revealed the H1-H7 protons 
shielded in the (S)-MTPA ester 165 thus giving negative values after deduction, the H8-
H14 protons returned positive values due to being moved upfield in the (R)-MTPA ester 
164, providing proof for the C8S configuration. With the successful installation of the C8 
stereocentre and confirmation of its configuration, the C8-C10 stereotriad has been 
completed with high levels of diastereo- and enantiocontrol. 
 
O
EtO
OH
OTBS
OPMB
TBSO
163
O
CF3
MeO Ph
*
(R)/(S)-MTPAA
DCC, DMAP
CH2Cl2, rt
164: (R)-MTPA ester (92%),  
165: (S)-MTPA ester (75%)
O
EtO
O
OTBS
OPMB
TBSO
8 8
 
Assignment S/ppm R/ppm S – R/ppm 
H-6 5.67 5.78 -0.11 
H-7 5.44 5.54 -0.10 
H-8 5.60 5.55 0.05 
H-9 3.77 3.76 0.01 
H-10 3.31 3.25 0.06 
Table 3.8.1 Formation of the (R)- and (S)-MTPA esters 164 and 165, and 
1
H NMR analysis. 
 
3.8.2 Synthesis of the C1-C14 aldehyde 
Following the enone reduction, the newly formed C8 hydroxyl in 163 was 
protected as its TBS ether employing TBSOTf and 2,6-lutidine to provide 166 in 87% 
yield (Scheme 3.8.2). In order to minimise the number of synthetic operations on the 
advanced material and taking into consideration the challenges in removing the PMB ether 
in the presence of the C14-C17 diene encountered by Hall et al. during the synthesis of 
palmerolide A 4,8 it was decided to introduce the C10 carbamate at this stage. Therefore, 
DDQ deprotection of the PMB-ether of 166 revealed the C10 hydroxyl, providing 167 in 
88% yield (Scheme 3.8.2).  
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-78 ºC 
87%
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167
DDQ, CH2Cl2,
pH 7 buffer, 0 ºC
88%
 
Scheme 3.8.2 Protection/deprotection to form C10 alcohol 167.  
With compound 167 in hand, installation of the carbamate at the C10 position was 
required. The employed procedure utilised trichloroacetyl isocyanate101 to form the 
corresponding trichloroacetyl carbamate, subsequent hydrolysis on neutral alumina 
followed by filtration provided unsubstituted carbamate 168 in excellent 72% yield 
(Scheme 3.8.3). 
O
EtO
OTBS
OTBS
OH
TBSO
167
O
EtO
OTBS
OTBS
O
TBSO
168
CH2Cl2, rt
then Al2O3
72%
Cl3C
O
NCO
O
NH2
 
Scheme 3.8.3 Formation of the carbamate 168. 
To complete the synthesis of C1-C14 fragment 169 (Scheme 3.8.4), the primary 
TBS ether in 168 was cleaved under acidic conditions in a 6 : 1 mixture of CH2Cl2/MeOH, 
which proved optimal for selective deprotection. The alcohol 170 was obtained in excellent 
93% yield, and subsequent oxidation with Dess-Martin reagent afforded the C1-C14 
aldehyde 169 in 80% yield.  
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Scheme 3.8.4 Completion of the C1-C14 aldehyde 169. 
3.9 Summary  
The C1-C14 subunit 169 was completed in seventeen steps from the proline-aldol 
reaction of ketone 63 and aldehyde 84 in 6% overall yield. Although, the first 
organocatalytic transformation provided product 86 in moderate yield, the remaining 
synthetic operations proved to be very efficient and reliable. Further complexity elements 
such as the installation of the C8 stereocentre with required (S) stereochemistry and 
introduction of the C10 carbamate functionality were successfully achieved. 
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4 Chapter 4 
 
4.1 Retrosynthetic analysis of the C15-C24 fragment 171  
In planning the synthesis of the C15-C24 fragment 171 (Scheme 4.1.1), a 
vinylogous aldol disconnection was viewed as the most efficient approach. This required 
an -chiral aldehyde 172 bearing the sensitive dienyl-iodide functionality and the 
corresponding silyl ketene acetal 173 or enolate of acrylate 174. By choosing this 
disconnection, selective installation of the C19 stereocentre could be fully addressed. 
Either employing Yamamoto’s vinylogous aldol reaction between 172 and 174 where 
bulky Lewis acid aluminum tris-(2,6-diphenyl)-phenoxide (ATPH) would control regio-
selectivity, or a vinylogous Mukaiyama aldol reaction of 172 and 173, the stereoselectivity 
would depend on Felkin-Anh control.102,103 The synthetic design based on this 
disconnection would reveal divinyl iodo-aldehyde 172, which would be accessed via Takai 
olefination of aldehyde 175. Enal 175, would arise from a HWE reaction of aldehyde 176, 
which could be prepared from methyl (2S)-3-hydroxy-2-methylpropionate 177, commonly 
known as Roche ester.  
TESO
ArO2S
I
OMe
OTMS
O
H
I
OTBS
O
H
176
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173171: C15 - C24 subunit
+
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O
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O
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O
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Scheme 4.1.1 Retrosynthetic analysis of C15-C24 fragment 171. 
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4.2  Preparation of the vinyl iodo-alcohol 178 
The synthesis of the C15-C24 subunit 171 began with the three-step synthesis of 
aldehyde 176. Treatment of (S)-Roche ester 177 with TBSCl and imidazole in 
dichloromethane provided derivative of 177 (Scheme 4.2.1). Subsequent formation of the 
Weinreb amide 179 via reaction with Weinreb salt and i-propylmagnesium chloride in 
tetrahydrofuran, followed by DIBAL-H reduction of 179 provided aldehyde 176,73 which 
was used immediately in the HWE reaction (Scheme 4.2.1).   
N
O
OTBS
MeO
MeO
O
OH OTBS
O
H
177 179 176
1) TBSCl, ImH, 
CH2Cl2, 0 ºC, 95%
2) (MeO)NHMe•HCl,
iPrMgCl, THF, -15 ºC
84%
DIBAL-H, THF,
-78 ºC
 
Scheme 4.2.1 Preparation of TBS-protected aldehyde 176. 
 
The freshly prepared aldehyde 176 was used in a HWE reaction with triethyl  
2-phosphonopropionate 180 and barium hydroxide (Scheme 4.2.2).104 The formation of 
trisubstituted enoate 181 was achieved in 76% yield from intermediate 179 with good  
E : Z selectivity (7 : 1). Studies performed by Sinisterra provided some insight into the 
mechanism and selectivity of the reaction. He found that the interfacial solid-liquid 
interactions between the substrate and microcrystalline structure of the barium hydroxide 
were critical to that system.105  
OTBSEtO
O
EtO
O
P
O
OEt
OEt OTBS
O
H
176180 181
Ba(OH)2, THF
176 in THF/H2O 40:1
76%, E:Z  7:1
+
 
Scheme 4.2.2 Horner-Wadsworth-Emmons olefination to form enoate 181. 
 
Treatment of the enoate 181 with DIBAL-H provided alcohol 182 in 81% yield, 
which was readily separated from the remaining Z-isomer. Subsequent oxidation using 
Dess-Martin periodinane afforded aldehyde 175 in 90% yield (Scheme 4.2.3).  
HO OTBSOTBSEtO
O
181 182
 DIBAL-H, THF,
-78 ºC
 81%
H OTBS
O
175
 Dess Martin, 
NaHCO3, CH2Cl2, rt
 
90%
 
Scheme 4.2.3 Formation of the aldehyde 175. 
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The stage was now set for the introduction of the vinyl iodide moiety. Takai 
olefination would provide direct access to the vinyl iodide and it generally proceeds in 
high yield and with good (E)-selectivity.37 In principle, this process involves the 
chromium(II)-mediated one-carbon homologation of an aldehyde with haloform to provide 
the corresponding vinyl halide. Takai and Utimoto suggested that the haloform first reacts 
with chromium to form a nucleophilic geminal-dichromium species 183 which attacks the 
aldehyde (Scheme 4.2.4)37 and the (E)-alkene is formed from the -oxychromium 
intermediate 184. The rate of the reaction and selectivity are dependant on the haloform 
employed and increases in the order of Cl < Br < I. 
H
X
X
X
H
X
X
Cr(III)X2
CrX2
X
Cr(III)X2
Cr(III)X2
R H
O
OCr(III)X2
H R
Cr(III)X2
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R
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CrX2
-oxychromium species 184
geminal 
dichromium species 183
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haloform
 
Scheme 4.2.4 Proposed mechanism of Takai olefination. 
 
Thoroughly flame-dried chromium chloride was suspended in tetrahydrofuran (care 
was taken to mechanically agitate the suspension to ensure that it had not fused) and the 
mixture of aldehyde 175 and iodoform in 1,4-dioxane was added dropwise over one hour. 
Although the corresponding product 185 was formed within an hour, as indicated by TLC, 
the purification by column chromatography significantly reduced the yield of isolated 185 
(Scheme 4.2.5). In order to overcome this problem, direct deprotection with TBAF was 
performed to provide iodo-alcohol 178 in 90% yield. Upon comparison of different trials 
of a Takai olefination, it was noticed that the concentration and ratio of 1,4-dioxane : THF 
was critical to reaction yield and selectivity. The best yield with exclusive (E) product 178 
was obtained when 7 : 1 mixture of 1,4-dioxane : THF was used, under strictly anhydrous 
conditions. It is worth noting that the obtained product 178 could only be stored for short 
period of time at low temperatures, with the exclusion of light.  
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Scheme 4.2.5 Formation of the iodo-alcohol 178. 
 
4.3   Vinylogous Yamamoto aldol reaction 
With iodo-alcohol 178 in hand attention turned towards the construction of the 
C18-C19 bond. The initial plan envisioned a Yamamoto vinylogous aldol reaction using 
aluminum tris-(2,6-diphenyl)-phenoxide (Figure 4.3.1) as a Lewis acid to build up the 
required C18-C19 connection.  
 
Figure 4.3.1 Yamamoto bulky Lewis acid ATPH. 
 
This transformation is dependant on the host properties of the bulky Lewis acid 
ATPH for carbonyl guests. The ATPH and carbonyl compounds self-assemble to form 
complexes where the carbonyl can either be protected towards nucleophilic addition or 
activated towards selective transformations unattainable under normal conditions. 
Complexation of an equimolecular mixture of an unsaturated enolisable enoate 186 and an 
aldehyde 187 with ATPH encapsulates the carbonyl substrates in the cavity of the Lewis 
acid, shielding their -carbons (Scheme 4.3.1). The sterically accessible -proton can then 
be deprotonated selectively by a bulky base such as lithium diisopropylamide (LDA), 
affording an extended enolate which then adds in a -1,2-fashion to the aldehyde 187 
giving product 188 in 97% yield.106-109 
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Scheme 4.3.1 Yamamoto vinylogous aldol reaction. 
Investigation of the Yamamoto protocol began with oxidation of the alcohol 178 
using Dess-Martin reagent110,111 to provide aldehyde 172 in 90% yield. The isolation of the 
aldehyde 172 proved challenging as it readily decomposed on exposure to light. In order to 
minimise this exposure, rapid purification of the reaction mixture through a short pad of 
silica/celite gel, followed by solvent removal and drying under reduced pressure in the 
dark provided access to 172.  
Aldehyde 172 was then added to the freshly prepared mixture of ATPH and methyl 
3,3-dimethylacrylate 174 in toluene at -78 ºC. Upon complexation, a freshly prepared 
solution of LDA was added to the reaction mixture (Scheme 4.3.2). Despite several 
attempts of the reaction with the highest-purity reagents, no coupled product 189 was 
observed. Attempts to use aldehyde 190 instead of acrylate 174, also failed to deliver the 
desired product, only decomposition of the iodo-aldehyde 172 occurred.  
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Scheme 4.3.2 Attempted vinylogous Yamamoto aldol reaction to form 189. 
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4.4   Vinylogous Mukaiyama aldol reaction 
Attention was then focused on the investigation of a vinylogous Mukaiyama aldol 
reaction (VMAR) between the silyl ketene acetal 173 and aldehyde 172.112 The observed 
regioselectivity in this reaction can be rationalised upon consideration of the electronic and 
steric effects of the silyl ketene acetal 173. As described by Denmark,113 173 is a highly 
electron rich species and its reactions are governed by electrostatic interactions. Relying on 
the computational calculations for the orbital coefficients (O.C.) and electrophilic 
susceptibilities (E.S.) of 173 and similar species (silyl enol ether 190, lithium enolate of the 
methyl crotonate 191), Denmark postulated that -selectivity could be predicted due to the 
higher electron density observed around C4 rather than the C2 position (Figure 4.4.1). 
Steric effects contribute to the site selectivity; C2 in 173 is a more sterically hindered site 
owing to its proximity to the silyl group and the alkyl group of the ester. Therefore, the 
approach of the electrophile to the less sterically demanding C4 position is favoured when 
C4 is not similarly substituted.113  
 
  
silyl ketene acetal 173 silyl enol ether 190 lithium dienolate 191 
            C4       C3      C2     C1                 C4       C3      C2     C1                 C4       C3      C2     C1     
O.C: 0.302, 0.090, 0.230, 0.219 O.C: 0.280, 0.083, 0.243, 0.235 O.C: 0.289, 0.042, 0.311, 0.130 
E.S: 0.592, 0.177, 0.451, 0.429 E.S: 0.550, 0.165, 0.478, 0.461 E.S: 0.572, 0.084, 0.614, 0.257 
Figure 4.4.1 Structures of silyl ketene acetal 173, silyl enol ether 190 and lithium dienolate 191, 
reproduced from ref 
113
. 
 
With the aldehyde 172 in hand, the investigation of the VMAR began. A solution 
of 172 in dichloromethane and silyl ketene acetal 173 in the presence of calcium hydride 
was cooled down to -95 ºC. Dropwise addition of the BF3•Et2O solution in 
dichloromethane and controlled elevation of the temperature to allow the reaction to occur, 
but not above -80 ºC, promoted the formation of the aldol adduct 189 (Scheme 4.4.1). 
Under the optimised conditions, the -regioisomer was not observed and stereoisomers of 
the -product were isolated in total 70% yield with an E : Z ratio of 5 : 1 and syn : anti 6 : 1 
for the major (E)-diastereoisomer. 
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Scheme 4.4.1 Vinylogous Mukaiyama aldol reaction to form 189. 
The selectivity of the newly installed C19 stereocentre arose from Felkin-Anh 
addition to the -chiral aldehyde 172.102,114 The transition state TS I presented in Figure 
4.4.2 shows the approaching nucleophile with respect to the Bürgi-Dunitz trajectory. The 
carbonyl compound placed with the largest substituent perpendicular to the C=O group and 
excluding all possible eclipsing interactions.  
favoured
TS I
MeO OTMS
H
O Me
H
H
OH
Me
LA LA
R R
 
Figure 4.4.2 Felkin-Ahn controlled addition of silyl ketene acetal 173 to the -chiral aldehyde 172. 
Confirmation of the C19 hydroxyl stereochemistry was provided by Mosher ester 
analysis (Table 4.4.1). Accordingly shifted protons in (R)- and (S)-MTPA esters 192 and 
193 returned positive values for H16 to H18 and negative values for H20 to H24 
confirming the expected (R)-configuration of the C19 stereocentre in 189, consistent with 
the VMAR proceeding with good levels of Felkin-Anh control.  
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I
OH
OMe
O
O
CF3
MeO Ph
*
(R)/(S)-MTPA
DCC, DMAP
CH2Cl2, rt
192: (R)-MTPA ester (94%) 
193: (S)-MTPA ester (78%)
I
O
OMe
O
189
 
Assignment s/ppm r/ppm s – r/ppm 
H-16 5.68 5.61 0.07 
H-18a 2.45 2.41 0.04 
H-18b 2.43 2.42 0.01 
H-19 5.23 5.23 0.00 
H-20 2.73 2.82 -0.09 
H-21 5.14 5.26 -0.12 
H-23 6.92 7.01 -0.09 
H-24 6.23 6.28 -0.05 
Table 4.4.1 Formation and analysis of the (R)- and (S)-Mosher esters 192 and 193. 
4.5   Completion of C15-C24 fragment 171  
Having successfully installed the C18-C19 connection with requisite C19 
stereochemistry, all that remained to complete sulfone 171 was C19 protection and 
manipulation of the C15 terminus. The C19 hydroxyl of 189 was protected using 
triethylsilyl triflate and 2,6-lutidine to form enoate 194 in excellent yield (Scheme 4.5.1). 
Subsequent reduction of the ester moiety with DIBAL-H afforded allylic alcohol 195 in 
81% yield (Scheme 4.5.1). 
TESO
I
OH
OR
I
OMe
O
195
 DIBAL-H, THF, 
-78 ºC
81%
189: R = H
194: R = TES
TESOTf, 2,6-lut, 
CH2Cl2, -78 ºC, 96%
 
Scheme 4.5.1 Formation of the allylic alcohol 195. 
Introduction of the sulfide functionality was accomplished under Mitsunobu 
conditions with 1H-mercaptophenyltetrazole to provide compound 196 in 80% yield 
(Scheme 4.5.2). Given the reliable sequence to the advanced synthetic intermediate of the 
C15-C24 fragment 171, we were now approaching the oxidation of sulfide 196 to complete 
the Julia-Kocienski coupling partner.  
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Scheme 4.5.2 Mitsunobu reaction introducing sulfide 196. 
 
The ammonium molybdate-catalysed oxidation with hydrogen peroxide was 
investigated first and unfortunately it had a destructive effect on the starting material 196 
(Table 4.5.1, entry 1). We then examined different solvents in combination with hydrogen 
peroxide and molybdenum salt (Table 4.5.1, entries 2-4). In all conditions investigated 
sulfone 171 was not formed and either sulfide 196 decomposed under the reaction 
conditions or was partly recovered. Treatment of the substrate 196 with Oxone® in a 
mixture of water and methanol at 0 ºC did not promote formation of the desired product 
171, although starting material was recovered (Table 4.5.1, entry 5). The procedure 
utilising catalytic scandium triflate in combination with hydrogen peroxide was then 
attempted and resulted in sulfoxide formation, and sulfone 171 was not detected in the 
reaction mixture (Table 4.5.1, entry 6).  
 
TESO
I
SAr
196
TESO
I
SO2Ar
171
conditions
Ar =
N
N
N
N
Ph
 
Entry Reagent Solvent Temp. Yield (%) 
1 20 mol%(NH4)6Mo7O24•7H2O, 10 eq. H2O2 EtOH 0 ºC - rt decomp. 
2 10 mol%(NH4)6Mo7O24•7H2O, 5 eq. H2O2 EtOH 0 ºC decomp. 
3 1 mol%(NH4)6Mo7O24•7H2O, 10 eq. H2O2 EtOH/THF 1:1 0 ºC st. mat. 196 (50%) 
4 10 mol%(NH4)6Mo7O24•7H2O, 10 eq. H2O2 EtOH/DCM 1:1 0 ºC st. mat. 196 (50%) 
5 3 eq. Oxone MeOH/H2O 1:3 0 ºC - rt st. mat. 196 (50%) 
6 20 mol% La(OTf)3, 20 eq. H2O2 CH2Cl2/EtOH 9:1 0 ºC sulfoxide 
Table 4.5.1 Oxidation of sulfide 196. 
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Vedejs’115 studies on stabilisation of the peroxy-molybdenum complexes by the 
hexamethylphosphoroamide (HMPA) prompted the investigation of the initially studied 
conditions (Table 4.5.1, entry 2), but in the presence of HMPA. The performed protocol 
employing 10 mol% of ammunium molybdate hydrate with 10 equivalents of the hydrogen 
peroxide relative to the substrate 196 was premixed with HMPA (v/v). The bright yellow 
solution was then added dropwise to a 0.1 M solution of sulfide 196 in methanol at 0 ºC 
(Scheme 4.5.3). The reaction mixture was stirred for 24 hours in an ice-water bath 
providing the desired sulfone 171 upon aqueous work-up and column chromatography. 
While this procedure proved to be reliable and convenient on a small scale (up to 0.2 mmol 
of 196), no full conversion of starting material 196 and partial decomposition was 
observed when reaction was carried out on bigger quantities (>0.2 mmol of 196). 
Nonetheless, performing the reaction in parallel on an adequate scale (<0.2 mmol of 196) 
produced a satisfactory amount of sulfone 171.  
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Scheme 4.5.3 Molybdenum catalysed oxidation to sulfone 171. 
4.6   Summary 
The western hemisphere of palmerolide C, the C15-C24 subunit 171 was 
synthesised in fourteen steps in 16% overall yield starting from the Weinreb amide 
derivative of (S)-Roche ester 177. The crucial transformation to build the C18-C19 bond 
relied on Mukaiyama vinylogous aldol reaction, which allowed for controlled introduction 
of the C19 stereocentre and was compatible with a sensitive iodo-aldehyde 172. Final 
oxidation of sulfide 196 was achieved after the addition of HMPA to the ammonium 
molybdate-catalysed reaction with hydrogen peroxide.  
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5 Chapter 5 
5.1 C1-C14 and C15-C24 fragment union  
Having completed the synthesis of the C1-C14 and C15-C24 subunits 169 and 171, 
investigation of their coupling reaction began. As outlined in our retrosynthesis, the Julia-
Kocienski olefination coupling would be employed as an efficient approach to construct  
the C14 E alkene of the C14-C17 diene. 
5.1.1 Introduction to the Julia olefination 
In 1973 Julia et al. reported a process to form a C—C double bond using a phenyl 
sulfone anion and carbonyl compounds involved a sequence of several synthetic 
operations: addition, acylation of the resulting -alkoxysulfone and reductive elimination 
of the -acyloxysulfone with Na(Hg) or SmI2 (Scheme 5.1.1).116  
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1) n-BuLi
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Scheme 5.1.1 Olefination reaction between phenyl sulfone and aldehyde developed by Marc Julia. 
The modified Julia reaction developed by Julia,117 enabled the preparation of 
alkenes from benzothiazol-2-yl (BT) sulfones and aldehydes in a single step, but the 
stereochemical outcome is a direct consequence of the initial carbonyl addition (Scheme 
5.1.2). Although this first step is reversible, the formation of the anti or syn intermediate 
might be influenced by the reaction conditions. A syn intermediate could be formed as a 
result of chelation control (TS I), which occurs upon addition of the base with small 
counterions (Li) and in an apolar solvent. The addition of base with a larger counterion (K) 
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in polar solvent will promote the formation of the anti intermediate via the open transition 
state TS II.117  
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Scheme 5.1.2 Influence of the reaction conditions on modified Julia reaction with BT-sulfone. 
 
In 1993 Julia investigated the base mediated elimination of anti -hydroxy-BT-
sulfones with alkyl substituents, which decompose to the (E)- and (Z)-alkenes, with 
noticeable propensity to form the (Z)-olefins. This can be explained due to the high-energy 
conformer 197 with the gauche-like arrangement of substituents forming slower than 198 
(Scheme 5.1.3).118 The initial addition of the metallated sulfone to the carbonyl compound 
dictates the stereochemical outcome. The observed results reflected the ratio of spiro-
intermediates 197 and 198, which upon elimination of the antiperiplanar lithium 
benzylthiozolone and sulfur dioxide furnished cis- or trans-olefins. However, when -
hydroxy-BT-sulfones with R’ vinyl/aryl substituents were examined, the tendency towards 
(E)-olefin formation was observed. If equilibration of the intermediates is precluded, there 
must be different mechanism effecting predominant formation of the (E)-configured 
olefins. 
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Scheme 5.1.3 Mechanism of modified Julia reaction. 
 
This is explained by the direct loss of the lithium benzylthiozolone from 
intermediates 197 and 198 (or a similar event immediately following spirocycle opening) 
yielding zwitterionic conformers 199 and 200 (Scheme 5.1.4). Equilibration of the betaine 
intermediates towards the more energetically favoured conformer 200, provides an  
(E)-alkene product upon loss of sulfur dioxide. Unsaturated residues in R’ provide 
stabilisation for the carbenium ion present in 199/200 and therefore promote the suggested 
pathway.119   
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Scheme 5.1.4 Mechanistic rational for observed selectivity in the modified Julia reaction. 
 
The Julia-Kocienski olefination is a later modification of the Julia reaction. 
Kocienski’s studies resulted in the development of an (E)-alkene selective system utilising 
phenyltetrazolyl sulfone (PT) instead of benzothiazolyl (BT) sulfone. Later, Blakemore 
extended the library of heteroaromatic sulfones compatible with Julia reaction to 1-
isoquinolinoyl, 1-methyl-2-imidazolyl, 4-methyl-2-imidazolyl and 4-methyl-1,2,4-triazol-
3-yl sulfones.120  
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Kocienski observed that the 1-phenyl-1H-tetrazol-5-yl sulfone anion 201 was not 
prone to self-condensation, therefore it could first be deprotonated with base (201) and 
then reacted with an aldehyde (Scheme 5.1.5). This extended the scope of compatible 
carbonyl substrates, including reactions with base-sensitive aldehydes. The transient -
alkoxysulfone 202 reacts further to form spiro-intermediate 203, which breaks down via a 
Smiles rearrangement to deliver the olefinic product with extrusion of sulfur dioxide and 
lithium phenyltetrazolone. An increase in (E : Z) ratio was generally observed upon 
changing the counter-ion (Li < Na < K) of the base. In addition, an increase in polarity and 
coordinating ability of the solvent (PhMe < Et2O < THF < DME) favours formation of the 
(E)-alkene.121  
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Scheme 5.1.5 Mechanism of Julia-Kocienski reaction. 
 
In 1996, Kocienski reported the synthesis of the C10-C26 fragment 204 of 
rapamycin,122 investigating substrate dependent aspects of the selectivity in Julia 
olefination. As shown in Scheme 5.1.6, selective formation of the triene portion of 204 was 
significantly influenced by the choice of starting materials. This study demonstrated that 
while using BT-sulfone 205, the (Z)-olefin was formed preferentially, which supports the 
hypothesis that stabilised BT-sulfone anions have a tendency to form (Z)-configured 
products. When sulfone 206 was used together with conjugated aldehyde 207, formation of 
the (E)-olefin was observed with almost complete selectivity when LiHMDS was 
employed. 
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M Yield (%) E : Z 
Li 75 29 : 71 
Na 79 43 : 57 
K -- 18 : 82 
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Na 21 78 : 22 
 
Scheme 5.1.6 Substrate dependence in modified Julia reaction. 
  
5.1.2 Model system for Julia-Kocienski coupling 
Given the lengthy synthesis of aldehyde 169 it was decided to pursue model studies 
to develop the optimal conditions for the olefination reaction. Using sulfone 171 and 
benzyl-protected aldehyde 208 as a model substrate, a range of reaction conditions were 
explored as summarised in Table 5.1.1. It was initially thought that by reacting the anion of 
sulfone 171 with an excess of aldehyde 208 would assure complete formation of the 
coupled product 209 (Table 5.1.1, entry 1, 2). However, unreacted sulfone 171 was always 
recovered upon purification, delivering only small amount of the diene 209, regardless of 
the solvent used. When an excess of sulfone 171 in combination with 1.3 equivalents of 
base was reacted with a 1.0 equivalent of aldehyde 208, instant formation of the product 
209 was detected by TLC (Table 5.1.1, entry 3). Prior to the aqueous work-up the reaction 
mixture was quenched by the addition of a few drops of methanol, consequently the 
product 209 was isolated in 80% yield. Following the assignment by 
1H-1H COSY experiment, ratio of the (E)- and (Z)-isomers was determined by analysis of 
1H NMR. Diagnostic C15 resonance J value for (E,E)-diene were 15.0 and 10.8 Hz, 
whereas the (Z)-olefin showed a smaller coupling constant at 6.2 Hz, both values were 
consistent with the J coupling constants reported for (E)- and (Z)-2-methylhexa-2,4-diene 
at 14.4 and 5.6 Hz respectively.123 
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Entry 171: 208 (eq) Base (eq) Solvent Temp. (ºC) Yield (%, E:Z) 
1 1 : 1.5 NaHMDS (1.3) THF -78 to -50 10 (2 : 1) 
2 1 : 1.5 NaHMDS (1.3) DME -78 to -50 5 (2 : 1) 
3 1.5 : 1 NaHMDS (1.3) THF -78 to -50 80 (2 : 1) 
Table 5.1.1 Julia-Kocienski coupling reaction, model studies. 
5.1.3 C14-C15 bond formation via Julia-Kocienski coupling 
The optimised conditions were now translated to the real system. In the event, 
deprotonation of the sulfone 171 with NaHMDS in THF at -78 ºC was followed by 
addition of aldehyde 169 (Scheme 5.1.7). The reaction was allowed to warm to -50 ºC 
within one hour and then quenched with methanol. Aqueous work-up and subsequent 
column chromatography provided the C1-C24 carbon framework 210 of palmerolide C in 
78% yield with 7 : 1 (E : Z) selectivity. The improved selectivity compared to the model 
system might be attributed to the higher complexity and steric demand of the aldehyde 
component. Confirmation of the olefin geometry, as in the model study, was revealed upon 
the inspection of the 1H NMR spectra of 210. The J coupling constant values for the C15 
resonance were found to be 15.0 and 10.8 Hz. These values were in good agreement with 
the values reported for the analogous system in the synthesis of palmerolide A.6   
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Scheme 5.1.7 Formation of the C1-C24 carbon backbone of palmerolide C via Julia-Kocienski 
reaction. 
5.2   Advancing the palmerolide C carbon framework  
With the advanced C1-C24 intermediate 210 in hand, all that remained was to close 
the macrocyclic ring and deprotect the C8 and C9 hydroxyl groups prior to the final 
installation of the enamide side chain.  
5.2.1 Formation of the macrolactone 
The selective cleavage of the C19 triethylsilyl group in 210 was accomplished 
using HF•pyridine in pyridine.124 A reagent solution was prepared prior to the reaction by 
mixing 2 mL of hydrogenfluoride-pyridine complex with 4 mL of pyridine and 16 mL of 
THF. Column chromatography at this point enabled the separation of the C14-C15 (E,Z)-
diene from the Julia-Kocienski coupling reaction delivering pure alcohol 211 in 88% yield 
(Scheme 5.2.1).  
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Scheme 5.2.1 Selective deprotection of the triethylsilyl protecting group to form 211. 
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Tentative experimentations with ester hydrolysis using potassium 
trimethylsilanolate125 resulted in a poor yield of seco-acid 212. The reason behind this was 
related to the potassium salt formed upon the reaction, which required relatively strong 
acidic conditions to be protonated. However, presence of the acid-sensitive conjugated 
iodo-diene hindered our chance of succeeding in this approach. The initially investigated 
aqueous work-up with ammonium chloride did not result in a formation of the expected 
product. The use of an aqueous citric acid work-up gave the seco-acid 212, although a 
chromatography column to remove citrate residues was necessary. The best results were 
obtained upon quenching the reaction mixture with 0.1 M sodium hydrogen sulfate and 
subsequent addition of solid sodium sulfate. In this way, exposure to acid was minimised 
and filtration delivered the crude product without requirement for further purification by 
column chromatography. Under these optimised conditions, a mild saponification protocol 
employing potassium trimethylsilanolate125 was successfully executed and upon formation 
of the potassium salt of 211, acidic work-up with sodium hydrogen sulfate returned the 
desired seco-acid 212 (Scheme 5.2.2). 
With the seco-acid 212 in hand, macrolactonisation under Yamaguchi conditions31 
was explored. Preparation of the mixed anhydride commenced with addition of the 
trichlorobenzoyl chloride to the solution of the seco-acid 212 and triethylamine in toluene. 
Upon completion, the reaction mixture was diluted and added drop-wise over three hours 
to a 0.001 M solution of DMAP in toluene. High dilution together with slow addition are 
important modifications promoting intra- rather then intermolecular esterification of the 
activated acid. After the addition was completed the reaction mixture was allowed to stir 
for a further nine hours and subsequent purification delivered macrolactone 213 in 71% 
yield over two steps (Scheme 5.2.2).  
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Scheme 5.2.2 Formation of 213 via Yamaguchi macrolactonisation. 
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5.2.2 Final deprotection 
As we were approaching the final stages of the synthesis, deprotection of the 
remaining silyl groups was required. TBAF was chosen, as it would not affect the iodo-
diene motif and was used in the final phase of palmerolide A synthesis by Hall and de 
Brabander. Cleavage of the C8 and C9 TBS groups in 213 was accomplished with only 
five equivalents of TBAF providing the direct precursor 214 to palmerolide C in 85% yield 
(Scheme 5.2.3).  
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Scheme 5.2.3 Final deprotection to deliver diol 214. 
 
5.3   Introduction of the enamide side chain to complete palmerolide C 
At this stage, we were facing the final transformation to introduce the enamide side 
chain. In 2003, Buchwald and Jiang reported the Goldberg-like amidation reaction of vinyl 
halides using copper iodide as a catalyst and N,N’-dimethylethylenediamine as a ligand.126 
They demonstrated the generality of the procedure, where a broad range of substrates with 
primary and secondary amides were successfully coupled with mono-, di- or tri-substituted 
vinyl bromides or iodides under optimised catalytic conditions (Scheme 5.3.1).   
5 mol% CuI, 
K2CO3 or Cs2CO3
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Scheme 5.3.1 Cu(I)-catalysed formation of enamides. 
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The mechanism of this transformation is not fully understood, but computational 
calculations and kinetic experiments performed by Buchwald provide some insight38,127 
(Scheme 5.3.2). A mechanism based on the oxidative addition/reductive elimination 
involving Cu(I)/Cu(III) species is proposed. The diamine ligand coordinates the CuI (215), 
therefore, prevents the ligation of the excess amide used and leaves the activation of the 
halide-substrate as a rate-limiting step. At low concentration of diamine, muliple ligation 
of the amide on copper occurs (216). To allow formation of the most active diamine-
ligated copper(I) amidate species (217), the dissociation of the amide has to precede 
coordination to the ligand, which ultimately was identified as another rate-limiting step.  
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Scheme 5.3.2 Mechanism proposed by Buchwald. 
 
As a prelude to examining this approach, the enamide formation was investigated 
in a model system. In accord with Buchwald protocol,126 catalytic conditions were 
investigated first using iodo-alcohol 178 as a model substrate. To a mixture of 178, freshly 
prepared 3,3-dimethylacrylamide 218 was added 5 mol% of copper(I) iodide, 10 mol% of         
N,N’-dimethylethylenediamine and 1.5 equivalents of potassium carbonate in 
tetrahydrofuran. However, the conditions applied did not promote formation of 219. 
Following the disappointing results of the catalytic system, a stoichiometric amount of 
copper(I) iodide and N,N’-dimethylethylenediamine was employed. Hence, to iodo-alcohol 
178 in tetrahydrofuran was added 2 equivalents of amide 218 followed by 1.5 equivalents 
of copper(I) iodide and an excess of potassium carbonate. The order of addition of the 
reagents turned out to be important, requiring the diamine ligand as the final addition, 
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otherwise the expected product was not formed. Gratifyingly, under stoichiometric 
conditions the desired enamide 219 was produced in 63% yield (Table 5.3.1).  
OH
I
178
NH2
O CuI, K2CO3, 
THF, rt
63%
OH
H
N
219
O
+
218
MeHN NHMe
 
Entry Conditions Result 
1 5 mol% CuI, 10 mol% N,N’-dimethylethylenediamine, 1.5 eq. K2CO3, THF, rt —  
2 1.5 eq CuI, 2 eq N,N’-dimethylethylenediamine, 5 eq. K2CO3, THF, rt 63% 
Table 5.3.1 Buchwald enamide formation, model study. 
Having established the feasibility of forming the enamide under the Buchwald 
conditions, efforts turned to the coupling of 214 and 218. Direct translation of the reaction 
conditions developed during the model study onto substrate 214 promoted formation of the 
final product 3b. Due to the solubility issues, the reaction was carried out in 
dimethylformamide. Subsequent purification by column chromatography provided 3b in 
53% yield and returned unreacted starting material 214 (Scheme 5.3.3).   
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Scheme 5.3.3 Introduction of enamide to form 3 via Buchwald Cu(I)-catalysed reaction. 
5.4   Comparison of synthetic and natural palmerolide C 
Having synthesised the target molecule 3b, confirmation of its identity was now the 
focus. High resolution mass spectrometry revealed the expected ion at m/z 607.3364, 
which corresponds to the [M+Na]+ of C33H48N2O7Na and to the reported value of 
607.3367. Next, the specific optical rotation was measured at a concentration of 0.2 g/mL 
in methanol to be -19.5, which correlates with the reported -27.1 value at a concentration 
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of 0.1 g/mL of methanol. The IR spectrum of the synthetic material was in good agreement 
with the IR of the natural palmerolide C.21  
The 1H NMR data provided for the natural sample of palmerolide C 3 was acquired 
in deuterated dimethylsulfoxide. Unfortunately, due to the small quantity of the synthetic 
material produced and the difficulties associated with sample recovery from 
dimethylsulfoxide, we decided to perform our first spectroscopic experiments in a different 
solvent. The 1H and 1H-1H COSY NMR were carried out in acetonitrile and allowed for 
the structural assignment (Table 5.4.1). The initially applied parameters to obtain 13C NMR 
were not optimal and further experiments were postponed due to the availability of 
sufficient time required for the analysis, and thus data was extracted from HSQC and 
HMBC NMR spectra. 
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Proton 
No. 
Synthetic palmerolide C 
d3-MeCN 500 MHz (H) 
Synthetic palmerolide C
 
d3-MeCN 800 MHz HSQC (C) 
1 - 166.20* 
2 5.71 d (15.7) 123.26 
3 6.84-6.78 m 142.43 
4a 2.18-2.12 m 
4b 2.45-2.37 m 
32.43 
5a 2.18-2.12 m 
5b 2.33-2.24 m 
30.75 
6 5.49-5.46 m 132.6 
7 5.36 dd (15.2, 8.0) 130.08 
8 3.75-3.70 m 74.18 
9 3.47-3.43 m 75.98 
10 4.52 dt (10.4, 3.1) 75.26 
11a 1.43-1.36 m 
11b 1.54-1.45 m 
26.09 
12a 1.43-1.10 m 24.85 
13 1.93-1.84 m 31.83* 
14 5.46-5.42 m 133.24 
15 6.20 dd (14.7, 10.9) 127.95 
16 5.76 d (10.7) 128.6 
17 - 132.52* 
18a 2.20 dd (14.2, 11.1) 
18b 2.33-2.24 m 
43.15 
19 4.94 ddd (10.5, 7.7, 2.4) 75.26 
20 2.78 dt (9.85, 6.92) 37.81 
21 5.20 d (9.7) 130.94 
22 - 130.26* 
23 5.87 d (14.6) 117.18 
24 6.93 dd (14.5, 10.5) 122.33 
8-OH 3.05 s - 
9-OH 3.26 s - 
17-CH3 1.64 s 12.88 
20-CH3 0.95 d (6.7) 17.36 
22-CH3 1.76 d (1.2) 16.16 
CONH2 5.18-5.09 m 164.23* 
CONH 8.16 d (10.6) 163.4* 
2’ 5.63 s 118.13 
3’ - 154.09* 
4’ 2.16 d (1.1) 19.76 
5’ 1.86 d (1.1) 27.25 
* data from HMBC experiment. 
Table 5.4.1 
1
H and 
13
C NMR of synthetic palmerolide C 3b
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At this point, with analytical confirmation of the synthesised product in hand we 
attempted to obtain the NMR spectra in dimethylsulfoxide for a direct comparison with 
data reported for the natural palmerolide C.4,10 The obtained 1H NMR spectrum made the 
comparison possible however, it showed significant differences in signal shifts (Figure 
5.4.1, Table 5.4.2). It appeared difficult to unambiguously justify exact correlation of the 
H8 and H9 signals as the presence of significant amount of water obscured these 
resonances in the spectra for the synthetic material, but it was clear that they did not match 
the corresponding signals in the spectra for the natural sample.   
 
Figure 5.4.1 Comparison of the natural and synthetic palmerolide C 
1
H NMR in d6-DMSO 
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Proton 
No. 
Natural palmerolide C 3
 
d6-DMSO 600 MHz (H) 
Natural palmerolide C 3
 
d6-DMSO 125 MHz (C) 
Synthetic palmerolide C 3b
 
d6-DMSO 500 MHz (H) 
1 - lactone 166.9 - 
2 5.73 d (15.5) 122.0 5.76-569 m 
3 6.77 ddd (15.4, 7.5, 7.4) 149.8 6.78 dt (15.6, 7.4) 
4a 1.30 m 31.7 
4b 2.13 m  
2.08-1.93 m 
5a 1.89 m 32.2 2.26-2.22 m 
5b 1.98 m  2.03-1.97 m 
6 5.54 m 131.8 5.46-5.35 m 
7 5.58 m 131.1 5.35-5.27 m 
8 3.96 m 72.8 3.56 mobs 
9 3.56 m 75.6 3.46 mobs 
10 4.56 ddd (10.5, 7.5, 3.0) 74.2 4.42 d (10.3) 
11a 1.30 m 28.7 1.57-1.50 m 
11b 1.49 m  1.49-1.42 m 
12 1.95 m 30.1 2.21 m 
13 1.99-1.90 m 30.1 1.82-1.78 m 
14 5.46 ddd (15.0, 10.0, 5.0) 132.3 5.44-5.40 m 
15 6.08 dd (15.0, 12.0) 127.2 6.15 dd (14.1, 11.3) 
16 5.63 d (11.0) 128.8 5.76-5.69 
17 - 132.5 - 
18a 2.07 m 44.1 2.25-2.21 m 
18b 2.18 m  2.19-2.15 m 
19 4.85 ddd (10.5, 7.8, 2.8) 74.7 4.87 t (8.5) 
20 2.70 qdd (9.8, 6.7, 6.7) 37.4 2.75 m 
21 5.15 d (9.5) 130.5 5.16 d (9.5) 
22 - 133.3 - 
23 5.85 d (14.5) 117.2 5.85 d (14.5) 
24 6.85 dd (14.6, 9.0) 122.8 6.85 dd (14.0, 10.4) 
8-OH 4.62 d (5.0) - 4.68 br s 
9-OH 4.72 d (4.5) - 4.77 br s 
17-CH3 1.59 s 13.3 1.64 s 
20-CH3 0.90 d (7.0) 17.8 0.91 d (6.5) 
22-CH3 1.69 s 16.5 1.68 s 
NH2 6.37 br 157.6 6.48-6.28 m 
NH 9.85 d (10.0) 164.0 9.88 d (10.3) 
2’ 5.68 s 118.8 5.69-5.76 m 
3’ - 152.5 - 
4’ 1.82 s 27.4 1.83 s 
5’ 2.11 s 20.3 2.12 s 
Table 5.4.2 
1
H and 
13
C NMR data shifts for natural and synthetic palmerolide C.
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Our efforts to recover the synthetic sample from dimethylsulfoxide culminated in 
only small fraction of the initial material being retrieved. However, successful re-isolation 
of the natural palmerolide C allowed Baker and co-workers to carry out NMR analysis in 
acetonitrile and allowed direct comparison of the 1H NMR spectra of the synthetic 3b and 
natural sample of palmerolide C 3 (Figure 5.4.2).  
 
 
Figure 5.4.2 Comparison of the natural and synthetic palmerolide C 
1
H NMR in d3-MeCN. 
 
The observed differences in chemical shift correspond to the signals from the 
macrocyclic part of the molecule. The highlighted resonances for the H8-H10 
stereocentres, despite following a similar splitting pattern in the natural and synthetic 
spectra, do not match. On a closer inspection (Figure 5.4.3) the H2-H3 and H6-H7 methine 
protons appeared to be significantly shifted upfield. Signals corresponding to the H14 and 
H16 protons were identified at different H in both natural and synthetic spectra. The 
discrepancy in chemical shifts of the crucial resonances indicates that the proposed 
stereochemical assignment of the natural palmerolide C was incorrect.  
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Figure 5.4.3 Comparison of the natural and synthetic palmerolide C 
1
H NMR in d3-MeCN. 
5.5   Final stereochemical assignment  
Our re-examination of the experimental data for the Murata J-based analysis of the 
C8-C10 triad of the natural palmerolide C (3) revealed an error (Figure 5.5.1).21 The Baker 
group had misinterpreted the Newman projection of the J-coupling based analysis, 
suggesting the arrangement of the C8-C9 stereocentres to be syn (Figure 5.5.1, A) and the 
C9-C10 centres anti (Figure 5.5.1, B). Our interpretation indicated that the C8-C9 chiral 
centres were in fact in an anti relationship, while the arrangement of the C9-C10 
stereocentres remained anti as assigned by Baker (Figure 5.5.1).  
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Figure 5.5.1 Newman projections of palmerolide C, reported by Baker group.
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This misinterpretation of the stereochemical assignment of the C8-C10 centres had 
a consequence in the synthesis of diastereoisomer 3b presented in Figure 5.5.2 with the 
C8-C9 syn and C9-C10 anti configuration. As an outcome of our synthetic investigation 
and final data evaluation we propose the structure 3 shown in Figure 5.5.2 with revised C8-
C9 anti and C9-C10 anti stereocentres to be the absolute configuration of the natural 
palmerolide C.  
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Figure 5.5.2 Proposed and revised structures of palmerolide C. 
5.6 Summary 
In summary, the first stereochemical assignment turned out to be incorrect due to 
the mistaken interpretation of the Mosher esters analysis of the C8 stereocentre. The error 
was related to the different priority of the Mosher acid and Mosher acid chloride 
substituents consequently affecting the entire resolution of the adjacent C8-C10 centres. 
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The second assignment was shown to be incorrect due to the misinterpretation of the 
Newman projection for J-based configurational analysis. The first total synthesis of 
palmerolide C 3b helped to assign the relative and absolute configuration of this 
remarkedly interesting natural product (Figure 5.6.1). 
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Figure 5.6.1 Summary of the stereochemical outcome. 
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6 Chapter 6 
 
6.1  Summary and future work 
The first total synthesis of palmerolide C 3b has been accomplished in an efficient 
and highly convergent manner. Our synthetic strategy evolved significantly during the 
venture. The first part of the project aimed at the resolution of the putative stereochemistry 
of the adjacent C8-C10 stereocentres of the natural product 3, culminated in the synthesis 
of the four possible diastereoisomers of C7-C14 degradation fragment. The obtained data 
set was sent for comparison studies with the natural C7-C14 degradation fragment to the 
Baker group at the University of South Florida, US. The outcome of their investigation and 
comparison studies are yet to be concluded.  
The original synthetic approach towards the structure with Baker’s first 
stereochemical assignment featured a cross metathesis coupling to assemble the C1-C14 
fragment 110 and the Yamamoto vinylogous aldol reaction to advance the construction of 
the C15-C24 subunit 171. After making significant progress along these routes, lack of 
success in the attempted cross-metathesis and Yamamoto vinylogous aldol reactions forced 
the investigation of alternative synthetic plans. A revised synthetic strategy incorporated 
the secondary stereochemical assignment of the C8-C10 stereotriad, followed by 
aldol/elimination sequence to construct the C1-C14 fragment 169. At this time the 
vinylogous Mukaiyama aldol reaction was employed to form the C18-C19 bond.   
After the successful elaboration of the key subunits, the critical Julia-Kocienski 
olefination to assemble the (E,E)-diene motif provided direct access to the advanced  
C1-C24 intermediate 210 comprising the entire carbon backbone of palmerolide C with all 
of the stereocentres already incorporated. Selective deprotection, mild saponification and 
macrolactonisation under Yamaguchi conditions completed the formation of the 20-
membered macrolactone. Cleavage of the silyl groups set the stage for the Buchwald Cu 
(I)-catalysed enamide formation under stoichiometric conditions. In total the synthesis of 
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3b contains forty-one steps from commercially available materials with a longest linear 
sequence of twenty-three steps, starting from the proline-catalysed aldol reaction. The total 
synthesis of unnatural palmerolide C 3b was completed with 0.4% overall yield.  
With the stereochemical assignment of the C8-C10 stereotriad and completion of 
the total synthesis of the diastereoisomer of palmerolide C 3b, the two major goals of this 
project have been accomplished. In addition, the convergent synthetic route provided a 
working platform for the synthesis of the other members of the palmerolide family (Figure 
6.1.1). 
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O
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H
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Palmerolide C Palmerolide A
Palmerolide K Palmerolide E  
Figure 6.1.1 Synthesis of palmerolides from common intermediates. 
 
However, there are areas of our research on palmerolide C that could warrant further 
attention. First, the synthesis of palmerolide C 3 with a revised stereochemistry of the C8-
C10 stereotriad could be readily accomplished. Although, a synthetic route towards the 
C7-C14 subunit 128 with the natural product configuration has been developed, the 
coupling of the C3-C6 220 and C7-C14 128 fragments would require attention. The 
possibility of utilising the cross-metathesis approach could be revisited using C3-C6 
subunit 220 followed by incorporation of the C1-C3 enone after the coupling reaction to 
form C1-C14 subunit. Alternative plan would rely on the Zr-mediated coupling utilising 
Schwartz reagent and dimethylzinc to introduce C6-C7 alkene. Other possibility to form 
C6-C7 junction would be the addition of the lithium anion of C1-C7 alkyne 221 to 
aldehyde 127. Further exploration of the established synthetic route would provide access 
to the natural palmerolide C 3. 
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Scheme 6.1.1 Alternative route to C1-C14 fragment. 
 
Secondly, our synthesis of C15-C24 subunit 171 could be modified to provide 
access to the non-iodinated fragment of the palmerolide E and K. Finally, in a broader 
investigation, this strategy could be used for the synthesis of the other members of the 
palmerolide family and their derivatives, leading to a library of potential anticancer agents 
with unique biological properties and selective efficacy against human melanoma cancers. 
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Chapter 7 
 
7.1  General comments 
All reactions were performed in flame-dried glassware under positive pressure of Ar with 
magnetic stirring unless otherwise stated. 
 
1
H NMR spectra were recorded on a Bruker Avance 300 (300 MHz) instrument, Bruker 
Avance II 400 (400 MHz) instrument or Bruker Avance 500 (500 MHz) instrument, using 
CDCl3 (or other indicated solvent) as reference and internal deuterium lock. The chemical 
shift data for each signal are given as  in units of parts per million (ppm) relative to 
tetramethylsilane (TMS) where TMS = 0.00 ppm. The multiplicity of each signal is 
indicated by: s (singlet); br s (broad singlet); d (doublet); t (triplet); q (quartet); qn 
(quintet); sp (septet) or m (multiplet). The number of protons (n) for a given resonance is 
indicated by nH. Coupling constants (J) are quoted in Hz and are recorded to the nearest 
0.1 Hz.  
 
13
C NMR spectra were recorded on a Bruker Avance 300 (75 MHz) instrument, Bruker 
Avance II 400 (100 MHz) instrument or Bruker Avance 500 (125 MHz) instrument using 
the PENDANT sequence and internal deuterium lock. The chemical shift data for each 
signal are given as  in units of ppm relative to TMS where TMS = 0.00 ppm.  
 
19
F NMR spectra were recorded on a Bruker Avance 500 (500 MHz) instrument. 
Resonances were assigned according to chemical shift, multiplicity, and reference to the 
literature.  
 
HRMS and LRMS (High and Low resolution mass spectrometry) were recorded using a 
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Thermofisher LTQ Orbitrap XL mass spectrometer, Finnigan MAT 900 XLT mass 
spectrometer, Micromass Quattro II mass spectrometer, Waters ZQ4000 mass spectrometer 
or a Thermofisher DSQ-II mass spectrometer by EPSRC national mass spectrometry 
service (Swansea, UK) using Electron Impact (EI), Electrospray Ionisation (ES), Chemical 
Ionisation (CI), Fast Atom Bombardment (FAB), Atmospheric Pressure Chemical 
Ionisation (APCI) or Atmospheric solids analysis probe (ASAP) techniques. Other spectra 
were recorded on a Micromass LCT mass spectrometer by the University of St Andrews 
mass spectrometry service (School of Chemistry and Biomolecular Sciences). The parent 
ion (M+, [M+H]+, [M-H]+, [M+Na]+ or [M+NH4]
+) is quoted. 
 
IR spectra were recorded on a Perkin-Elmer Paragon Series 1000 FTIR spectrometer as 
thin films between sodium chloride discs or PTFE thin films as indicated. Absorption 
maxima are reported in wavenumbers (cm-1). Intensities of the maxima are quoted as 
strong (s), medium (m) or weak (w).  
 
Optical rotations were measured using an Perkin-Elmer Model 341 automatic polarimeter, 
in cells with a path length of 1 dm. The concentration (c) is expressed in g/100 mL 
(equivalent to g/0.1 dm3). Specific rotations are denoted []
D
T
 and are given in implied 
units of 10-1 deg cm
2g-1, where T is temperature in °C. 
 
X-ray analysis of single crystals was conducted by Prof. Alexandra Slawin at the 
University of St Andrews on a Rigaku Cu MM007 high brilliance generator with Saturn 92 
CCD and XStream LT accessories. 
 
Analytical thin layer chromatography (TLC) was carried out on pre-coated 0.25 mm 
Merck Kieselgel 60 F254 plates. Visualisation was by absorption of UV light, or thermal 
development after dipping in either an aqueous solution of potassium permanganate, 
potassium carbonate and sodium hydroxide, an ethanolic solution of phosphomolybdic 
acid (PMA) or a solution of ninhydrin in butan-2-ol.  
 
Flash column chromatography was carried out on silica gel 60 (E. Merck, 40-63 micron) 
or on activated aluminium oxide (Acros, 50-200 micron, neutral) as indicated, under a 
positive pressure of compressed air.  
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Kugelrohr bulb-to-bulb distillations were carried out using a Büchi Glass Oven B-585  
machine. Boiling points are the actual oven temperatures. 
 
Reagents and solvents were purified by standard means. Methanol was distilled from CaH2 
in a recycling still under nitrogen. Dichloromethane (CH2Cl2), toluene, tetrahydrofuran 
(THF) and diethyl ether (Et2O) were dried by passage through two columns of alumina 
using a MBRAUN SPS-800 solvent purification system under Ar. Anhydrous N,N’-
dimethylformamide (DMF) was purchased from Aldrich UK and dried by distillation from 
4Å molecular sieves under Ar atmosphere. Chloroform was passed through alumina 
column and dried by distillation from 4Å molecular sieves under Ar atmosphere. Triethyl 
amine (Et3N), BF3•Et2O and 2,6-lutidine were distilled from CaH2 under Ar. An L-
erythrulose hydrate solution was desiccated according to the published procedure. Dowex 
50 resin was washed with water, 3M HCl and methanol prior to use. Chemicals were 
purchased from Acros UK, Aldrich UK, Avocado UK, Fisher UK or Fluka UK. All 
reagents and solvents were purified and dried, where necessary, by standard techniques. 
Where appropriate and if not stated otherwise, all non- aqueous reactions were performed 
under an inert atmosphere of argon, using a vacuum manifold with the gas passed through 
4Å molecular sieves and self-indicating silica gel. Under reduced pressure refers to the use 
of a rotary evaporator attached to a diaphragm pump. Hexane refers to a mixture of 
hexanes and petroleum ether to the fraction boiling between 40-60 ºC. Room temperature 
(rt) refers to the temperature of approximately 25 °C.  
 
Miscellaneous, brine refers to a saturated solution of sodium chloride in deionised water. 
Reactions at -78 ºC were readily achieved with isopropanol and dry ice in a Dewar vacuum 
flask, -100 ºC was achieved with CH3OH and liquid nitrogen.  
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7.2  Preparation of reagents  
Zinc borohydride (Zn(BH4)2)
128,129 
To a round bottom flask equipped with magnetic bar at rt was added anhydrous ZnCl2 
(8.04 g, 58.9 mmol), NaBH4 (5.12 g, 135 mmol) and THF (118 mL). The reaction mixture 
was stirred for 24 h to afford the clear solution c. 0.5 M which is stable over a period of 6 
months when stored under argon at room temperature. 
 
Thexyl borane (thexylBH2)
66
  
To a round bottom flask equipped with magnetic bar at 0 ºC was added BH3•THF (10 mL, 
1M soln. in THF) and 2,3-dimethyl-2-butene (10 mL, 1M soln. in THF) was then added 
dropwise over 30 min. The reaction mixture was stirred for 1h to afford the clear solution 
c. 0.5M which is stable for a week when stored under argon in the fridge.  
 
Dicyclohexylboron chloride (c-Hex2BCl)
130
 
To a stirred solution of cyclohexene (20.0 mL, 197 mmol, distilled from CaH2) in Et2O 
(120 mL) at -10 ºC was added monochloroborane•dimethylsulfide (10.3 mL, 98.6 mmol). 
The mildly exothermic reaction was controlled by the rate of addition. The resulting 
solution was stirred at 0 ºC for 1 h. The solvent and volatiles were removed by distillation 
at atmospheric pressure and the product purified by distillation under reduced pressure to 
afford the title compound as a colourless oil (16.0 g, 76%); B.pt. 105-110 ºC at 0.5 mmHg. 
Lit. 104-105 ºC/0.5 mmHg. 
 
Lithium methoxyborohydride (LiBH3(OMe))
71-73
 
To a lithium borohydride solution (0.5 mL, 2M soln. in THF, 1.0 mmol) in THF (4.5 mL) 
at 0 ºC was added MeOH (40.5 L, 1.0 mmol). Stirring was continued for 1.5 h at rt to 
provide a colourless solution c. 0.2M which could be stored for 48 h under argon. 
 
Dicyclohexylboron chloride•Triethyamine complex (c-Hex2BCl•NEt3)
71-73
 
To a stirred solution of dicyclohexylboron chloride (120 L, 0.58 mmol) in THF (3 mL) at 
0 ºC was added Et3N (75 L, 1.02 mmol) to provide a colourless solution c. 0.19M which 
was used immediately in 1,3-syn reduction. 
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p–Methoxybenzyl trichloroacetimidate (PMBTCA)
86
 
To a solution of p-methoxybenzyl alcohol (14.0 mL, 15.6 g, 113 mmol) in CH2Cl2 (100 
mL) at -10 ºC was added aqueous solution of KOH (100 g/100 mL) and 
tetrabutylammonium hydrogen sulfate (384 mg, 1.13 mmol) followed by dropwise 
addition of trichloroacetonitrile (12.5 mL, 18.0 g, 125 mmol). The reaction mixture was 
then allowed to warmed to rt over 2 h and the layers were separated, the aqueous phase 
was extracted with CH2Cl2 (3  100 mL), the combined organic extracts were dried 
(Na2SO4), filtered and concentrated under reduced pressure. Purification by distillation 
afforded the title compound (28.0 g, 88%) as a colourless solution. B.pt. 120-145 ºC at 0.5 
mmHg. Lit. 135 ºC at 0.7 mmHg.86 1H NMR (300 MHz, CDCl3)  7.38 (2H, d, J = 8.8 Hz, 
Ar-H), 6.91 (2H, d, J = 8.8 Hz, Ar-H), 5.28 (2H, s, CH2), 3.81 (3H, s, OCH3).  
 
1-Hydroxy-1,2-benziodoxol-3(1H)-one 1-Oxide (IBX)
110
 
To a solution of Oxone (83.0 g, 0.135 mol) in deionized water (225 mL, 0.45 M) at rt was 
added 2-iodobenzoic acid (25.0 g, 0.10 mol). The reaction mixture was warmed to 70-73 
°C over 20 min and mechanically stirred at this temperature for 3 h. The suspension was 
then cooled to 5 °C and left at this temperature for 1.5 h with slow stirring. The mixture 
was filtered and the solid was repeatedly rinsed with water (6  50 mL) and acetone (2  
50 mL). The white, crystalline solid (24.0 g, 86%) was left to dry at rt for 16 h. 
1,1,1-Triacetoxy-1,1-dihyd-1,2-benziodoxol-3(1H)-one (Dess-Martin reagent)
111
  
To a solution of acetic anhydride (82.0 mL, 88.7 g, 869 mmol) and TsOH•H2O (120 mg, 
0.631 mmol) at rt was added IBX (24.0 g, 85.7 mmol) and the reaction mixture equipped 
with a drying tube was heated at 80 ºC for 2h. The mixture was then cooled in ice-water 
bath and the suspension was filtered and washed with Et2O (5  20 mL). The resulting 
white, crystalline solid (30.0 g, 83%) was quickly transferred to an argon flushed amber-
glass bottle and stored at -25 ºC. 
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(1-Methoxy-3-methylbuta-1,3-dienyloxy)-trimethylsilane (173)
131
 
To a stirred solution of diisopropylamine (8.41 mL, 60.0 mmol) in THF (50 mL) at 0 ºC 
was added n-BuLi (32.5 mL, 1.6 M soln. in hexane, 52.5 mmol) and the reaction mixture 
was stirred at 0 ºC for 15 min before cooling to -78 ºC. Methyl 3,3-dimethylacrylate (6.54 
mL, 50.0 mmol) was then added. After 1h trimethylsilyl chloride (7.61 mL, 60.0 mmol) 
was added as a solution in THF (5 mL) and the reaction mixture was warmed to 0 ºC and 
stirring continued for 1h. The reaction mixture was concentrated under reduced pressure to 
a volume of 20 mL and pentane (100 mL) was added. The suspension was filtered through 
celite and concentrated under reduced pressure. The residue was distilled under vacuum 
(bp 48 ºC at 0.75 mmHg) to give the silyl enol ether 173 as a colourless oil (7.32 g, 79%). 
1
H NMR (400 MHz; CDCl3)  4.78 (1H, dt, J = 2.7, 0.7 Hz, H-4a), 4.54 (1H, dq, J = 2.7, 
1.4 H-4b), 4.26 (1H, s, H-2), 3.57 (3H, s, OCH3), 1.93 (3H, dd, J = 1.4, 0.7 Hz, CH3), 0.23 
(9H, s, Si-(CH3)3). 
 
3-Methyl but-2-enamide (218).132  
To a suspension of 3,3-dimethylacrylic acid (5.0 g, 50 mmol) in CH2Cl2 (100 mL) at 0 ºC 
was added a catalytic amount of DMF (60 L) and oxalyl chloride (4.7 mL, 55 mmol). The 
resulting reaction mixture was stirred at 0 ºC for 15 min and then at rt for a further 90 min. 
CH2Cl2 (100 mL) at -78 ºC, which had been saturated with ammonia gas for 20 min, was 
then cannulated into the cooled to -78 ºC reaction mixture. After stirring for an additional 
20 min, the reaction mixture was quenched with water (100 mL) and the aqueous phase 
was extracted with CH2Cl2 (3  100 mL). The combined organic extracts were dried 
(Na2SO4), filtered and concentrated under reduced pressure to give 3-methyl but-2-
enamide 218 (2.8 g, 57%) as white crystals, which could be used without any further 
purification.  
1
H NMR (400 MHz, CDCl3)  5.89 (1H, br s, NH2), 5.61 (1H, dt, J = 2.7, 1.3 Hz, H-2), 
5.51 (1H, br s, NH2), 2.12 (3H, d, J = 1.3 Hz, H-4), 1.83 (3H, d, J = 1.4 Hz, CH3);  
13
C NMR (101 MHz, CDCl3)  169.3, 152.6, 117.7, 27.3, 19.9. 
 
 
      Experimental
 
 104 
7.3  Experimental procedures for Chapter 2 
 
2,2-Dimethyl-5-amino-5-hydroxymethyl-1,3-dioxane (71)
51
 
 
 
 
Trizma® base (50 g, 0.30 mol), 2,2-dimethoxypropane (40 g, 0.40 mol), CSA (2.6 g, 11 
mmol) in dimethylformamide (100 mL) were stirred at rt for 24 h. After addition of Et3N 
(2.5 mL, 18 mmol) the solvent was removed under reduced pressure. The residue was 
dissolved in EtOAc (700 mL) followed by addition of Et3N (40 mL, 0.30 mol) and stirring 
was continued for 15 min. The precipitate was filtered and washed with EtOAc. The 
filtrate was evaporated to afford 2,2-dimethyl-5-amino-5-hydroxymethyl-1,3-dioxane 71 
(37.1 g, 90%) as a colourless solid.  
1
H NMR (300 MHz, CDCl3)  3.82 (2H, d, J = 11.8 Hz, H-4a, H-6a), 3.62 (2H, d, J = 11.8 
Hz, H-4b, H-6b), 3.56 (2H, s, H-7), 3.48 (3H, s, OH, NH2), 1.45 (3H, s, C2-CH3), 1.42 
(3H, s, C2-CH3); 
13
C NMR (75 MHz, CDCl3)  98.4, 66.7, 64.2, 50.6, 25.0, 22.1. 
  
2,2-Dimethyl-1,3-dioxan-5-one (dioxanone) (63)
51
 
 
 
 
To a solution of 48 (20.0 g, 12.4 mmol) and KH2PO4 (16.9 g, 12.4 mmol) in water (200 
mL) at 5 ºC was added NaIO4 (370 mL, 0.5 M soln. in H2O, 18.5 mmol) dropwise over 2 h, 
while the temperature was maintained at 5-10 ºC. After 12 h at rt, CH2Cl2 (200 mL) was 
then added and the layers were separated. The aqueous phase was extracted with CH2Cl2  
(10  30 mL), the combined extracts were dried (MgSO4), filtered and concentrated under 
reduced pressure. Purification by distillation (bp. 25oC/1 torr) afforded 2,2-dimethyl-1,3-
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dioxan-5-one 63 (9.68 g, 60%) as a colourless oil.  
Rf 0.51 (10% EtOAc/Hexanes); 1H NMR (400 MHz, CDCl3)  4.16 (4H, s, H-4, H-6) and 
1.46 (6H, s, C2-CH3); 
13
C NMR (100 MHz, CDCl3)  208.0, 100.1, 66.8, 23.5. 
 
5-(tert-Butyldimethylsilyloxy)pentanal (69)
133
 
 
H
O
OTBS  
 
To a solution of 1,4-butanediol 23 (6.06 mL, 60.5 mmol), Et3N (3.66 mL, 26.3 mmol) and 
DMAP (246 mg, 2.00 mmol) in CH2Cl2 (30.0 mL) at rt was slowly added a solution of 
TBSCl (3.04 g, 20.1 mmol) in CH2Cl2 (10.0 mL). After 16 h, the reaction mixture was 
poured onto brine (30 mL) and layers were separated. The aqueous phase was extracted 
with CH2Cl2 (3  30 mL) and the combined organic extracts were washed with water (50.0 
mL), brine (50 mL), dried (MgSO4), filtered and concentrated under reduced pressure. 
Purification by flash column chromatography (5% EtOAc/Hexanes) provided alcohol 73 
(11.1 g, 85%) as a colourless oil. 
Rf 0.48 (50% EtOAc/Hexanes); 
1
H NMR (300 MHz, CDCl3)  3.66-3.60 (4H, m, H-1, 5), 
1.65-1.52 (4H, m, H-2, 4), 1.45-1.35 (2H, m, H-3), 0.90 (9H, s, Si-C(CH3)3), 0.05 (6H, m, 
Si-(CH3)2).  
To a solution of oxalyl chloride (0.92 mL, 11.0 mmol) in CH2Cl2 (20.0 mL) at -78 ºC was 
slowly added DMSO (1.75 mL, 24.1 mmol). After 30 min, a solution of alcohol 73 (2.18 g, 
10.1 mmol) in CH2Cl2 (20.0 mL) was added, dropwise. After 1 h, Et3N (19.1 mL, 137 
mmol) was added and the slurry was allowed to attain rt. After 1 h, saturated NH4Cl (20 
mL) solution was added and layers were separated. The aqueous phase was extracted with 
CH2Cl2 (3  40 mL) and the combined organic extracts were washed with H2O (30 mL), 
brine (30 mL), dried (MgSO4), filtered and concentrated under reduced pressure. The crude 
aldehyde 69 (1.73 g, 80%) was used without further purification. 
Rf 0.75 (25% EtOAc/Hexanes); 
1
H NMR (400 MHz, CDCl3)  9.7 (1H, t, J = 1.7 Hz, H-
1), 3.63 (2H, t, J = 6.2 Hz, H-5), 2.46 (2H, td, J = 7.29, 1.76 Hz, H-2), 1.66-1.75 (2H, m, 
H-3), 1.50-1.59 (2H, m, H-4), 0.89 (9H, s, Si-C(CH3)3), 0.05 (6H, s, Si-(CH3)2).  
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5-(Benzyloxy)pentan-1-al (76)
134
 
 
 
 
To a solution of pentane-1,5-diol (6.70 mL, 64.0 mmol) in THF (100 mL) at 0 ºC was 
added NaH (1.30 g, 54.0 mmol). The reaction mixture was stirred at 0 oC and benzyl 
bromide (4.60 mL, 34.0 mmol) in THF (20 mL) was added via cannula. After 12 h at rt, 
MeOH (10 mL) was added and the reaction mixture was concentrated under reduced 
pressure to the ca. 50 mL volume. The residue was extracted with CH2Cl2 (3  20 mL), 
washed with brine (50 mL), dried (Na2SO4), filtered and concentrated under reduced 
pressure. Purification by flash column chromatography (20-40% EtOAc/Hexanes) afforded 
product 77 (4.1 g, 66%) as a colourless oil.  
Rf 0.31 (20% EtOAc/Hexanes); 1H NMR (400 MHz, CDCl3):  7.30-7.19 (5H, m, Ar-H), 
4.43 (2H, s, OCH2Ph), 3.53 (2H, t, J = 6.52 Hz, H-5), 3.41 (2H, t, J = 6.49 Hz, H-1), 1.88 
(1H, bs, OH), 1.61-1.54 (2H, m, H-3), 1.53-1.46 (2H, m, H-2), 1.41-1.33 (2H, m, H-4). 
To a solution of oxalyl chloride (1.44 mL, 17.0 mmol) in CH2Cl2 (10.0 mL) at -78 ºC was 
added a solution of DMSO (2.64 mL, 34.0 mmol) dropwise. The reaction mixture was 
stirred at -78 ºC for 15 min and a solution of alcohol 77 (3.00 g, 15.5 mmol) in CH2Cl2 
(20.0 mL) was added. The reaction mixture was stirred at -78 ºC for an additional 15 min. 
and Et3N (10.8 mL, 77.0 mmol) was then added, and the mixture was allowed to warm to 
rt. The reaction was quenched by addition of water (30 mL) and extracted with CH2Cl2 (3 
 50 mL). The combined organic extracts were washed with saturated NH4Cl (50 mL) 
solution and brine (50 mL), dried (Na2SO4) and concentrated under reduced pressure. The 
resulting oil was purified by flash column chromatography (20% EtOAc/Hexanes) to give 
76 (1.90 g, 65%) as a colourless oil.  
Rf 0.41 (20% EtOAc/Hexanes); 1H NMR (400 MHz, CDCl3):  9.76 (1H, t, J = 1.7 Hz,  
H-1), 7.35-7.27 (5H, m, ArH), 4.49 (2H, s, OCH2Ph), 3.48 (2H, t, J = 6.1 Hz, H-5), 2.45 
(2H, td, J = 7.2, 1.7 Hz, H-2), 1.78-1.70 (2H, m, H-3) and 1.65-1.61 (2H, m, H-4). 
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(S)-4-((S)-5-(Benzyloxy)-1-hydroxypentyl)-2,2-dimethyl-1,3-dioxan-5-one (78) 
 
 
 
To a solution of dioxanone 63 (1.00 g, 7.69 mmol) in DMF (5.0 mL) at rt was added  
(S)-proline (221 mg, 1.92 mmol). The resulting mixture was stirred for 15 min and 
aldehyde 76 (880 mg, 7.69 mmol) was added. After 5 days, saturated NH4Cl (5.0 mL) 
solution was added and the layers were separated. The aqueous phase was extracted with 
EtOAc (3  10 mL) and the combined organic extracts were washed with brine (20 mL), 
dried (Na2SO4), filtered and concentrated under reduced pressure. Purification by flash 
column chromatography (10% EtOAc/Hexanes) afforded aldol product 78 (237 mg, 23%) 
as a colourless oil. 
Rf 0.21 (10% EtOAc/Hexanes);  -16.0 (c 0.10, CHCl3); IR max (thin film/cm-1) 3395, 
2912, 1736, 1652, 1392, 1225, 1197, 1067, 911; 1H NMR (400 MHz, CDCl3):  7.35-7.31 
(5H, m, Ar-H), 4.50, (2H, s, OCH2Ph), 4.25 (1H, dd, J = 17.3, 1.5 Hz, H-7A), 4.07 (1H, 
dd, J = 6.9, 1.5 Hz, H-9), 4.01 (1H, d, J = 17.3 Hz, H-7B), 3.92-3.84 (1H, m, H-10), 3.53-
3.44 (2H, t, J = 6.4 Hz, H-14), 2.97 (1H, d, J = 3.9 Hz, OH), 1.70-1.56 (6H, m, H-11, 12, 
13), 1.46 (3H, s, C-CH3), 1.42 (3H, s, C-CH3); 
13
C NMR (100 MHz, CDCl3): 211.6, 139.0, 
128.7, 127.9, 127.8, 101.3, 76.2, 73.2, 70.87, 70.69, 67.1, 32.4, 30.0, 24.2, 23.9, 22.1; 
HRMS (ES+) calcd. for C18H27O5 [M+H]
+ 323.1853, found 323.1857. 
 
(S)-4-((S)-1-Hydroxypent-4-enyl)-2,2-dimethyl-1,3-dioxan-5-one (83) 
 
 
 
To the stirred dioxanone 63 (1.00 g, 7.69 mmol) in CHCl3 (5.0 mL) at rt, heptanal 82 (0.88 
g, 7.69 mmol) was added. After 5 days, saturated NH4Cl (5.0 mL) solution was added and 
the layers were separated. The aqueous phase was extracted with EtOAc (3  10 mL) and 
the combined organic extracts were washed with brine (20 mL), dried (Na2SO4), filtered 
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and concentrated under reduced pressure. Purification by flash column chromatography 
(10% EtOAc/Hexanes) afforded aldol product 83 (0.42 g, 45%). 
Rf 0.38 (10% EtOAc/Hexanes);  -12.0 (c 0.10, CHCl3); IR max (thin film/cm-1) 3514, 
2948, 2921, 2862, 1739, 1373, 1223, 1094, 860; 1H NMR (300 MHz, CDCl3):  4.25 (1H, 
dd, J = 17.3, 1.5 Hz, H-7A), 4.07 (1H, dd, J = 6.9, 1.5 Hz, H-9), 4.01 (1H, d, J = 17.3 Hz, 
H-7B), 3.90-3.85 (1H, m, H-10), 2.95 (1H, d, J = 2.6 Hz, OH), 1.55-1.42 (2H, m, H-11), 
1.46 (3H, s, C-CH3), 1.43 (3H, s, C-CH3), 1.25-1.19 (8H, m, H-12, H-13, H-14, H-15), 
0.84-0.78 (3H, m, H-16); 13C NMR (75 MHz, CDCl3):  211.4, 101.1, 76.1, 70.7, 66.9, 
32.4, 31.9, 29.4, 25.1, 24.0, 23.6, 22.7, 14.2; HRMS (ES+) calcd. for C13H28NO4 [M + 
NH4]
+ 262.2013, found 262.2011. 
 
4-Pentenal (84)
135
 
 
 
 
Neat allyl vinyl ether 85 (4.0 g, 47 mmol) sealed in a microwave tube was heated at 160 oC 
in a microwave reactor (200 W) for 2 h to give aldehyde 84 (3.9 g, 98%) as a colourless 
oil.  
1
H NMR (400 MHz, CDCl3)  9.78 (1H, t, J = 1.6 Hz, H-1), 5.83 (1H, ddt, J = 17.1, 10.3, 
6.6 Hz, H-4), 5.08-4.98 (2H, m, H-5), 2.55-2.50 (2H, m, H-2), 2.41-2.34 (2H, m, H-3). 
 
(S)-4-((S)-1-Hydroxypent-4-enyl)-2,2-dimethyl-1,3-dioxan-5-one (86) 
 
 
 
To a solution of dioxanone 63 (1.00 g, 7.69 mmol) in CHCl3 (5.0 mL) at 0 ºC was added  
(S)-proline (221 mg, 1.92 mmol). The resulting mixture was stirred for 15 min and 
aldehyde 84 (539 mg, 6.41 mmol) was then added. After 5 days, saturated NH4Cl (5.0 mL) 
solution was added and the layers were separated. The aqueous phase was extracted with 
EtOAc (3  15 mL) and the combined organic extracts were washed with brine (20 mL), 
dried (Na2SO4), filtered and concentrated under reduced pressure. Purification by flash 
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column chromatography (10% EtOAc/Hexanes) afforded aldol product 86 (576 mg, 44%) 
as a colourless oil. 
Rf 0.26 (10% EtOAc/Hexanes); []
D
20  -4.0 (c 0.25, CHCl3); IR max (thin film/cm-1) 3411, 
2922, 1732, 1640, 1375, 1195, 1067, 911; 1H NMR (400 MHz, CDCl3)  5.82 (1H, ddt, J 
= 17.2, 10.3, 6.8 Hz, H-13), 5.06-4.94 (2H, m, H-14), 4.24 (1H, dd, J = 17.4,1.5 Hz, H-7a), 
4.08 (1H, dd, J = 7.0, 1.5 Hz, H-9), 4.01 (1H, d, J = 17.3 Hz, H-7b), 3.93-3.85 (1H, ddt, J 
= 9.1, 6.4, 3.0 Hz, H-10), 2.94-2.89 (1H, d, J = 3.9 Hz, OH), 2.34-2.22 (1H, m, H-12a), 
2.20-2.08 (1H, m, H-12b), 1.78-1.68 (1H, m, H-11a), 1.64-1.53 (1H, m, H-11b), 1.46 (3H, 
s, C-CH3) and 1.42 (3H, s, C-CH3); 
13
C NMR (100 MHz, CDCl3)  211.3, 138.4, 115.1, 
101.1, 76.0, 70.1, 66.8, 31.6, 29.4, 23.9, 23.7; HRMS (ES+) calcd. for C11H18NaO4 
[M+Na]+ 237.1097, found 237.1101. 
 
(R)-Mosher ester of 86 (87) 
 
O O
O O
7 10 14
(R)-MTPA
 
 
To a stirred mixture of alcohol 86 (10.0 mg, 46.6 mol), DCC (47.0 mg, 0.232 mmol) and 
DMAP (11.0 mg, 93.3 mol) in CH2Cl2 (1.0 mL) at rt was added (+)-(R)--methoxy--
(trifluoromethyl)-phenylacetic acid (23.0 mg, 93.3 mol) in one portion. After 16 h, the 
crude reaction mixture was directly purified by flash column chromatography (5% 
EtOAc/Hexanes) to give (R)-MTPA ester 87 (9.0 mg, 45%).  
Rf 0.56 (10% EtOAc/Hexanes); 1H NMR (400 MHz, CDCl3)  7.63-7.52 (2H, m, Ar-H), 
7.48-7.36 (3H, m, Ar-H), 5.81-5.71 (1H, m, H-13), 5.54-5.51 (1H, m, H-10), 5.04-5.01 
(1H, m, H-14a), 5.01-4.98 (1H, m, H-14b), 4.43 (1H, dd, J = 2.8, 1.5 Hz, H-9), 4.13 (1H, 
dd, J = 16.9, 1.5 Hz, H-7a), 3.93 (1H, d, J = 16.8 Hz, H-7b), 3.54 (3H, s, MTPA-OCH3) 
2.11-1.95 (2H, m, H-11), 1.791.63 (2H, m, H-12), 1.37 (3H, s, C-CH3), 1.31 (3H, s, C-
CH3); 
19
F NMR (376 MHz; CDCl3) F -71.27, -71.36, 97% de. 
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(S)-Mosher ester of 86 (88) 
 
O O
O O
7 10 14
(S)-MTPA
 
 
To a stirred mixture of alcohol 86 (5.0 mg, 23 mol), DCC (23.0 mg, 110 mol) and 
DMAP (5.0 mg, 46.0 mol) in CH2Cl2 (1.0 mL) at rt was added (+)-(S)--methoxy--
(trifluoromethyl)-phenylacetic acid (12.0 mg, 46.0 mol) in one portion. After 16 h, the 
crude reaction mixture was purified directly by flash column chromatography (5% 
EtOAc/Hexanes) to give (S)-MTPA ester 88 (6.0 mg, 60%).  
Rf 0.56 (10% EtOAc/Hexanes); 1H NMR (400 MHz, CDCl3)  7.62-7.48 (2H, m, Ar-H), 
7.46-7.36 (3H, m, Ar-H), 5.76-5.66 (1H, m, H-13), 5.48 (1H, td, J = 6.1, 2.7 Hz, H-10), 
4.98 (1H, m, H-14a), 4.94 (1H, m, H-14b), 4.57 (1H, dd, J = 3.1, 1.3 Hz, H-9), 4.20 (1H, 
dd, J = 17.0, 1.3 Hz, H-7a), 3.98 (1H, d, J = 17.0 Hz, H-7b), 3.60 (3H, s, MTPA-OCH3), 
2.05-1.87 (2H, m, H-11), 1.69-1.57 (2H, m, H-12), 1.45 (3H, s, C-CH3), 1.42 (3H, s, C-
CH3). 
 
(4S,5R)-4-((S)-1-Hydroxypent-4-en-1-yl)-2,2-dimethyl-1,3-dioxan-5-ol (92),  
(4S,5S)-4-((S)-1-Hydroxypent-4-en-1-yl)-2,2-dimethyl-1,3-dioxan-5-ol (93)  
 
      
 
Method A 
To a solution of aldol adduct 86 (50.0 mg, 0.233 mmol) in MeOH (2.0 mL) at -78 ºC was 
added NaBH4 (10.0 mg, 0.279 mmol). After 1 h the reaction mixture was quenched with 
saturated NH4Cl (5.0 mL) solution and the aqueous layer was extracted with Et2O (3  10 
mL). The combined organic extracts were dried (Na2SO4), filtered and concentrated under 
reduced pressure. The resulting residue was purified by flash column chromatography 
(10% EtOAc/Hexanes) to give compounds 92 (20.0 mg, 40 %) and 93 (7.0 mg, 14%) as 
colourless oils. 
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Method B 
To a solution of Zn(BH4)2 (5.0 mL, 0.5 M in Et2O, 2.5 mmol) at -78 ºC was added aldol 
adduct 86 (90.0 mg, 0.47 mmol). After 1 h the reaction mixture was quenched with 
saturated NH4Cl (5.0 mL) solution and the aqueous layer was extracted with Et2O (3  20 
mL). The combined organic extracts were dried (Na2SO4), filtered and concentrated under 
reduced pressure. The residue was purified by flash column chromatography (10% 
EtOAc/Hexanes) to give compounds 92 (42.0 mg, 44 %) and 93 (8.0 mg, 10%) as 
colourless oils. 
 
Method C 
To a solution of aldol adduct 86 (50.0 mg, 0.233 mmol) in CH3CN (2.0 mL) at -40 ºC was 
added Me4NBH(OAc)3 (18.0 mg, 0.689 mmol) and glacial acetic acid (0.2 mL). After 10 h 
the reaction mixture was warmed up and quenched with saturated NaHCO3 (5.0 mL) 
solution and the aqueous layer was extracted with CH2Cl2 (3  10 mL). The combined 
organic extracts were dried (Na2SO4), filtered and concentrated under reduced pressure. 
The residue was purified by flash column chromatography (10% EtOAc/Hexanes) to give 
compounds 92 (14.0 mg, 28 %) and 93 (14.0 mg, 28%) as colourless oils.  
 
92 1,3-syn: Rf 0.16 (20% EtOAc/Hexanes); []
D
20  -30.7 (c 1.8, CHCl3); IR max (thin 
film/cm-1) 3398, 2991, 2923, 1444, 1378, 1207, 1067, 914, 863; 1H NMR (400 MHz, 
CDCl3)  5.86 (1H, ddt, J = 17.1, 10.3, 6.8 Hz, H-13), 5.11-4.98 (2H, m, H-14), 3.88 (1H, 
dd, J = 11.3, 5.4 Hz, H-7a), 3.77 (2H, m, H-8, H-10), 3.61 (1H, dd, J = 11.2, 8.5 Hz, H-
7b), 3.46 (1H, dd, J = 8.7, 7.1 Hz, H-9), 3.32 (1H, br s, C8-OH), 2.49 (1H, br s, C10-OH), 
2.12-2.29 (2H, m, H-12), 1.88-1.80 (1H, m, H-11a), 1.58-1.49 (1H, m, H-11b), 1.45 (3H, s, 
C-CH3), 1.36 (3H, s, C-CH3); 
13
C NMR (100 MHz, CDCl3)  138.6, 115.3, 98.9, 75.4, 
75.0, 67.3, 64.3, 32.6, 29.7, 28.3, 19.8; HRMS (ES+) calcd. for C11H20NaO4 [M+Na]
+ 
239.1254, found 239.1254. 
 
93 1,3-anti: Rf 0.15 (20% EtOAc/Hexanes); []
D
20  +3.7 (c 1.1, CHCl3); IR max (thin 
film/cm-1) 3401, 2920, 2873, 1455, 1380, 1332, 1277, 911, 853; 1H NMR (400 MHz, 
CDCl3)  5.85 (1H, ddt, J = 17.0, 10.3, 6.7 Hz, H-13), 5.09-4.97 (2H, m, H-14), 4.02 (1H, 
dd, J = 12.4, 1.6 Hz, H-7a), 3.85 (1H, dd, J = 12.4, 2.1 Hz, H-7b), 3.82-3.76 (1H, m, H-
10), 3.72 (1H, dq, J = 8.7, 1.6 Hz, H-8), 3.62 (1H, dd, J = 6.7, 1.5 Hz, H-9), 3.19 (1H, d,  
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J = 8.7 Hz, C8-OH), 2.48 (1H, d, J = 4.5 Hz, C10-OH), 2.33-2.26 (1H, m, H-12a), 2.21-
2.13 (1H, m, H-12b), 1.77-1.68 (1H, m, H-11a), 1.61-1.51 (1H, m, H-11b), 1.44 (3H, s, C-
CH3), 1.43 (3H, s, C-CH3); 
13
C NMR (100 MHz, CDCl3)  138.5, 115.1, 99.0, 73.9, 71.0, 
65.9, 63.6, 32.0, 30.0, 29.6, 18.7; HRMS (ES+) calcd. for C11H24NO4 [M+NH4]
+ 234.1700, 
found 234.1700. 
 
((4S,5R)-5-Hydroxy-2,2-dimethyl-1,3-dioxan-4-yl)pentane-1,5-diol (94) 
 
  
 
To a solution of thexylBH2 in THF (2.0 mL, 0.5 M, 1.0 mmol) at 0 
oC was added olefin 92 
(20.0 mg, 88.0 mol) in THF (1.0 mL) dropwise. After 1 h NaOH (1.0 mL, 10% w/v) and 
30% hydrogen peroxide (1.0 mL, 30% v/v) were added. The mixture was stirred for 15 
min and the aqueous layer was saturated with anhydrous K2CO3. The organics were 
extracted with CH2Cl2 (3  5 mL), washed with brine (10.0 mL), dried (Na2SO4), filtered 
and concentrated under reduced pressure. The resulting residue was purified by flash 
column chromatography (10% EtOAc/Hexane) to give compound 94 (17.0 mg, 85%) as a 
colourless oil.  
Rf 0.11 (30% EtOAc/Hexanes); []
D
20  -32.2 (c 0.5, CHCl3); IR max (thin film/cm-1) 3367, 
2931, 2870, 1454, 1376, 1277, 1067, 859; 1H NMR (400 MHz, CDCl3)  3.88 (1H, dd, J = 
11.2, 5.4 Hz, H-7a), 3.79 (1H, td, J = 8.5, 5.4 Hz, H-8), 3.74 (1H, td, J = 7.6, 2.6 Hz, H-
10), 3.68 (2H, t, J = 5.8 Hz, H-14), 3.61 (1H, dd, J = 11.2, 8.4 Hz, H-7b), 3.46 (1H, dd, J = 
8.5, 7.1 Hz, H-9), 1.80-1.71 (1H, m, H-11a), 1.66-1.53 (4H, m, H-12, H-13), 1.52-1.45 
(1H, m, H-11b), 1.45 (3H, s, C-CH3), 1.36 (3H, s, C-CH3); 
13
C NMR (100 MHz, CDCl3)  
99.0, 75.4, 75.1, 67.2, 64.4, 62.8, 32.8, 32.2, 28.4, 21.4, 19.8; HRMS (ES+) calcd. for 
C11H22NaO5 [M+Na]
+ 257.1359, found 257.1362. 
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((4S,5S)-5-Hydroxy-2,2-dimethyl-1,3-dioxan-4-yl)pentane-1,5-diol (95) 
 
 
 
To a solution of thexylBH2 in THF (1.0 mL, 0.5 M, 0.5 mmol) at 0 
oC was added olefin 93 
(12.0 mg, 56 mol) in THF (0.5 mL) dropwise. After 1h NaOH (0.5 mL, 10% w/v) and 
30% hydrogen peroxide (0.5 mL, 30% v/v) were added. The mixture was stirred for 15 
min and the aqueous layer was saturated with anhydrous K2CO3. The organics were 
extracted with CH2Cl2 (3  5 mL), washed with brine (10.0 mL), dried (Na2SO4), filtered 
and concentrated under reduced pressure. The resulting residue was purified by flash 
column chromatography (10% EtOAc/Hexane) to give compound 95 (10.0 mg, 77%) as a 
colourless oil.  
Rf 0.10 (30% EtOAc/Hexanes); []
D
20  -2.4 (c 0.7 CHCl3); IR max (thin film/cm-1) 3365, 
2925, 2864, 1373, 1279, 1067, 976; 1H NMR (400 MHz, CDCl3)  4.02 (1H, dd, J = 12.4, 
1.6 Hz, H-7a), 3.85 (1H, dd, J = 12.4, 2.0 Hz, H-7b), 3.79-3.74 (1H, m, H-10), 3.74-3.69 
(1H, m, H-8), 3.66 (2H, t, J = 5.7 Hz, H-14), 3.61 (1H, dd, J = 6.7, 1.4 Hz, H-9), 3.32 (1H, 
d, J = 8.6 Hz, C8-OH), 2.93 (1 H, s, C10-OH), 1.69-1.56 (4H, m, H-12, H-13), 1.52-1.45 
(2H, m, H-11), 1.44 (3H, s, C-CH3), 1.43 (3H, s, C-CH3); 
13
C NMR (100 MHz, CDCl3)  
99.0, 74.0, 71.3, 65.9, 63.6, 62.8, 32.61, 32.41, 29.6, 21.9, 19.8; HRMS (ES+) calcd. for 
C11H23O5 [M+H]
+ 235.1540, found 235.1541. 
 
(2R,3S,4S)-Octane-1,2,3,4,8-pentaol (57) 
 
 
 
To a solution of triol 94 (25.7 mg, 0.109 mmol) in MeOH (1.0 mL) and water (0.1 mL) 
was added Dowex-50 resin (40.0 mg) and the reaction was refluxed (65-70 oC) for 1 h. The 
reaction mixture was then cooled to rt, filtered and concentrated under reduced pressure to 
give 57 (20.8 mg, 98%) as a colourless viscous oil. 
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Rf 0.10 (10% MeOH/CH2Cl2); []D20  -8.6 (c 0.3, MeOH); IR max (thin film/cm-1) 3239, 
2860, 1406, 1205, 1149, 799; 1H NMR (500 MHz, MeOD)  3.77 (1H, dd, J = 11.1, 3.2 
Hz, H-7a), 3.67 (2H, m, H-8, H-10), 3.61 (1H, dd, J = 11.1, 6.2 Hz, H-7b), 3.57 (2H, t, J = 
6.4 Hz, H-14), 3.47 (1H, t, J = 6.4 Hz, H-9), 1.72-1.66 (1H, m, H-11a), 1.65-1.52 (3H, m, 
H-12a, H-13), 1.51-1.37 (2H, m, H-11b, H-12b); 13C NMR (100 MHz, MeOD)  C9-76.0, 
C10-74.4, C8-73.9, C7-64.6, C14-63.0, C11-33.7, C13-33.0, C12-23.0; HRMS (ES+) 
calcd. for C8H19O5 [M+H]
+ 195.1227, found 195.1225. 
 
(2S,3S,4S)-Octane-1,2,3,4,8-pentaol (58) 
 
 
 
To a solution of triol 95 (10.0 mg, 43 mol) in MeOH (0.5 mL) and water (0.05 mL) was 
added Dowex-50 resin (30.0 mg) and the reaction was refluxed (65-70 oC) for 1 h. The 
reaction mixture was then cooled to rt, filtered and concentrated under reduced pressure to 
give 58 (7.5 mg, 90%) as a colourless viscous oil. 
Rf 0.10 (10% MeOH/CH2Cl2); []D20  -2.6 (c 0.8, MeOH); IR max (thin film/cm-1) 3358, 
2930, 2869, 1454, 1376, 1207, 1157, 1066, 858; 1H NMR (400 MHz, MeOD)  3.90 (1H, 
td, J = 6.2, 2.0 Hz, H-8), 3.62-3.60 (3H, m, H-7, H-10), 3.57 (2H, t, J = 6.4 Hz, H-14), 
3.34 (1H, dd, J = 6.5, 4.5 Hz, H-9), 1.82-1.74 (1H, m, H-11a), 1.65-1.51 (3H, m, H-12a, H-
13), 1.47-1.35 (2H, m, H-11b, H-12b); 13C NMR (100 MHz, MeOD)  C9-74.8, C10-72.6, 
C8-72.0, C7-65.0, C14-63.0, C11-34.5, C13-33.7, C12-23.0; HRMS (ES+) calcd. for 
C8H17O5 [M-H]
- 193.1081, found 193.1084. 
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(S)-4-((S)-1-((tert-Butyldimethylsilyl)oxy)pent-4-en-1-yl)-2,2-dimethyl-1,3-dioxan-5-
one (96) 
 
 
 
To a solution of alcohol 86 (100 mg, 0.47 mmol) in CH2Cl2 (5.0 mL) at -78 ºC was added 
2,6-lutidine (0.11 mL, 0.94 mmol) and TBSOTf (0.16 mL, 0.71 mmol). After 1.5 h, 
saturated NH4Cl (5.0 mL) solution and CH2Cl2 (5.0 mL) were added. The layers were 
separated and the aqueous phase was extracted with CH2Cl2 (3  10 mL). The combined 
organic extracts were dried (Na2SO4), filtered and concentrated under reduced pressure. 
Purification by flash column chromatography (5% EtOAc/Hexane) provided 96 (140 mg, 
95%) as a colourless oil. 
Rf 0.43 (10% EtOAc/Hexanes); []
D
20  -5.7 (c 1.0, CHCl3); IR max (thin film/cm-1) 2983, 
2934, 1719, 1448, 1370, 1271, 1204, 1041, 981; 1H NMR (400 MHz, CDCl3)  5.80 (1H, 
ddt, J = 16.9, 10.2, 6.7 Hz, H-13), 5.02 (1H, dt, J = 17.1, 1.6 Hz, H-14a), 4.98-4.94 (1H, 
m, H-14b), 4.25 (1H, dd, J = 2.6, 1.4 Hz, H-9), 4.21 (1H, dd, J = 16.5, 1.1 Hz, H-7a), 4.13-
4.09 (1H, m, H-10), 3.93 (1H, d, J = 16.4 Hz, H-7b), 2.23-2.10 (1H, m, H-12a), 2.09-1.97 
(1H, m, H-12b), 1.86-1.76 (1H, m, H-11a), 1.59-1.48 (1H, m, H-11b), 1.46 (3H, s, C-CH3), 
1.45 (3H, s, C-CH3), 0.89 (9H, s, Si-C(CH3)3), 0.10 (3H, s, Si-CH3), 0.09 (3H, s, Si-CH3); 
13
C NMR (100 MHz, CDCl3)  208.0, 138.5, 114.8, 100.8, 78.4, 71.5, 67.4, 32.0, 30.2, 
26.0, 24.5, 23.6, 18.3, -4.24, -4.43; HRMS (ES+) calcd. for C17H33O4Si [M+H]
+ 329.2143, 
found 329.2147. 
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(4R,5S)-4-((S)-1-((tert-Butyldimethylsilyl)oxy)pent-4-en-1-yl)-2,2-dimethyl-1,3-dioxan-
5-ol (97) 
 
 
 
To a solution of ketone 96 (84.0 mg, 0.25 mmol) in THF (2.0 mL) at -78 ºC was added  
L-selectride (0.38 mL, 1M in THF, 0.38 mmol). After 1 h the reaction mixture was 
quenched with saturated NH4Cl (10.0 mL) solution and the layers were separated. The 
aqueous layer was extracted with Et2O (3  20 mL) and the combined organic extracts 
were dried (Na2SO4), filtered and concentrated under reduced pressure. The resulting 
residue was purified by flash column chromatography (10% EtOAc/Hexanes) to give 
compound 97 (78.0 mg, 93%) as a colourless oil.  
Rf 0.42 (10% EtOAc/Hexanes); []
D
20  +2.4 (c 1.0, CHCl3); IR max (thin film/cm-1) 3389, 
2920, 2874, 1456, 1378, 1210, 1152, 850; 1H NMR (400 MHz, CDCl3)  5.82 (1H, ddt, J 
= 17.1, 10.4, 6.7 Hz, H-13), 5.05-4.94 (2H, m, H-14), 3.99 (1H, dd, J = 12.4, 1.1 Hz, H-
7a), 3.96-3.91 (1H, m, H-10), 3.85 (1H, dd, J = 12.3, 1.8 Hz, H-7b), 3.64 (2H, app d, J = 
5.9 Hz, H-8, H-9), 3.33 (1H, d, J = 7.4 Hz, OH), 2.18-2.04 (2H, m, H-12), 1.76-1.67 (1H, 
m, H-11a), 1.65-1.56 (1H, m, H-11b), 1.44 (3H, s, C-CH3), 1.43 (3H, s, C-CH3), 0.90 (9H, 
s, Si-C(CH3)3), 0.14 (3H, s, Si-CH3), 0.09 (3H, s, Si-CH3); 
13
C NMR (100 MHz, CDCl3)  
138.8, 114.6, 99.0, 72.4, 71.4, 66.3, 63.3, 32.4, 29.7, 28.4, 26.0, 18.6, 18.3, -4.46, -4.51; 
HRMS (ES+) calcd. for C17H35O4Si [M+H]
+ 331.2299, found 331.2302. 
 
(4R,5S)-4-((S)-1-((tert-Butyldimethylsilyl)oxy)-5-hydroxypentyl)-2,2-dimethyl-1,3-
dioxan-5-ol 
 
 
 
To a solution of thexylBH2 in THF (2.0 mL, 0.5 M, 1.0 mmol) at 0 
oC was added olefin 97 
(61.0 mg, 0.18 mmol) in THF (1.0 mL) dropwise. After 2 h NaOH (1.0 mL, 10% w/v) and 
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30% hydrogen peroxide (1.0 mL, 30% v/v) were added. The mixture was stirred for 15 
min and the aqueous layer was saturated with NaHCO3 and the layers were separated. The 
aqueous phase was extracted with CH2Cl2 (3  5 mL), washed with brine (10 ml), dried 
(Na2SO4), filtered and concentrated under reduced pressure. The residue was purified by 
flash column chromatography (20% EtOAc/Hexanes) to give diol (56.5 mg, 88%) as a 
colourless oil.  
Rf 0.20 (10% EtOAc/Hexanes); []
D
20  +2.2 (c 1.7, CHCl3); IR max (thin film/cm-1) 3363, 
2828, 2868, 1455, 1376, 1207, 1157, 1066, 859; 1H NMR (300 MHz, CDCl3)  3.98 (1H, 
dd, J = 12.3, 1.5 Hz, H-7a), 3.89-3.94 (1H, m, H-10), 3.84 (1H, dd, J = 12.3, 2.0 Hz, H-
7b), 3.60-3.67 (4H, m, H-8, H-9, H-14), 3.42 (1H, d, J = 7.2 Hz, C8-OH), 1.52-1.61 (6H, 
m, H-11, H-12, H-13), 1.43 (3H, s, C-CH3), 1.42 (3H, s, C-CH3), 0.89 (9H, s, Si-C(CH3)3), 
0.13 (3H, s, Si-CH3), 0.08 (3H, s, Si-CH3); 
13
C NMR (75 MHz, CDCl3)  98.8, 72.3, 71.8, 
66.2, 63.2, 62.8, 33.0, 32.8, 29.6, 25.9 (x3), 20.2, 18.5, 18.1, -4.6 (x2); HRMS (ES+) calcd. 
for C17H37O5Si [M+H]
+ 349.2405, found 349.2405. 
 
(2S,3S,4S)-Octane-1,2,3,4,8-pentaol (58) 
 
 
 
To a solution of diol (16.0 mg, 0.07 mmol) in MeOH (0.5 mL) and water (0.05 mL) was 
added Dowex-50 resin (30.0 mg) and the reaction was refluxed (65-70 oC) for 1 h. The 
reaction mixture was then cooled to rt, filtered and concentrated under reduced pressure to 
give (2R,3S,4S)-octane-1,2,3,4,8-pentaol 58 (12.0 mg, 88%) as a colourless viscous oil. 
Rf 0.10 (10% MeOH/CH2Cl2); []D20  -2.6 (c 0.8, MeOH); IR max (thin film/cm-1) 3358, 
2930, 2869, 1454, 1376, 1207, 1157, 1066; 1H NMR (400 MHz, MeOD)  3.90 (1H, td, J 
= 6.2, 2.0 Hz, H-8), 3.62-3.60 (3H, m, H-7, H-10), 3.57 (2H, t, J = 6.4 Hz, H-14), 3.34 
(1H, dd, J = 6.5, 4.5 Hz, H-9), 1.82-1.74 (1H, m, H-11a), 1.65-1.51 (3H, m, H-12a, H-13), 
1.47-1.35 (2H, m, H-11b, H-12b); 13C NMR (100 MHz, MeOD)  C9-74.8, C10-72.6, C8-
72.0, C7-65.0, C14-63.0, C11-34.5, C13-33.7, C12-23.0; HRMS (ES+) calcd. for C8H17O5 
[M-H]+ 193.1081, found 193.1084. 
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1,3-Bis[(tert-butyl)dimethylsilyloxy]propan-2-one (65)
136
 
 
 
 
To a solution of dihydroxyacetone dimer 98 (4.00 g, 22.2 mmol) in DMF (50 mL) was 
added TBSCl (15.9 g, 106 mmol) and imidazole (15.0 g, 222 mmol). After 24 h the 
reaction mixture was quenched with cold water and extracted with Et2O (5  50 mL). The 
combined organic extracts were washed with water (100 mL), brine (100 mL), dried 
(Na2SO4) and concentrated under reduced pressure. The resulting residue was filtered over 
silica gel (20% EtOAc/Hexanes) to provide ketone 65 (13.0 g, 95%) as a colourless oil. 
Rf 0.80 (10% EtOAc/Hexanes); 1H NMR (400 MHz, CDCl3)  4.42 (4H, s, H-1, H-3), 
0.92 (18H, s, Si-C(CH3)3), 0.09 (12H, s, Si-CH3). 
 
(3R,4S)-1-Hydroxypent-4-en-1-yl)-1,3-bis(tert-butyldimethylsilyloxy)-4-hydroxy-
octane-8-one (99) 
 
 
 
To a solution of ketone 65 (1.00 g, 3.14 mmol) in CHCl3 (5.0 mL) at 0 ºC was added 
aldehyde 84 (132 mg, 1.57 mmol), followed by H2O (3 vol%) and O-tBu-threonine (55.0 
mg, 0.31 mmol) and the reaction mixture was allowed to warm to rt. After 5 days water 
(5.0 mL) was added and the layers were separated. The aqueous phase was extracted with 
EtOAc (3  10 mL). The combined organic extracts were washed with brine (20 mL), 
dried (Na2SO4), filtered and concentrated under reduced pressure. Purification by flash 
column chromatography (5% EtOAc/Hexanes) afforded aldol product 99 (180 mg, 28%) 
as a colourless oil. 
Rf 0.10 (10% EtOAc/Hexanes); []
D
20  +10.0 (c 1.0, CHCl3); IR max (thin film/cm-1) 3491, 
3079, 2954, 2931, 2887, 2858, 1735, 1472, 1255, 1100, 838, 779; 1H NMR (400 MHz, 
CDCl3)  5.86-5.76 (1H, m, H-13), 5.04 (1H, dq, J = 17.1, 1.7 Hz, H-14a), 4.98 (1H, ddt, J 
= 10.2, 1.9, 1.2 Hz, H-14b), 4.48 (2H, d, J = 3.2 Hz, H-7), 4.30 (1H, d, J = 2.9 Hz, H-9), 
3.80 (1H, dddd, J = 10.1, 7.1, 6.2, 2.9 Hz, H-10), 2.32-2.21 (1H, m, H-12a), 2.19 (1H, d, J 
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= 10.0 Hz, OH), 2.17-2.08 (1H, m, H-12b), 1.60-1.55 (2H, m, H-11), 0.94 (9H, s, Si-
C(CH3)3), 0.92 (9H, s, Si-C(CH3)3), 0.10 (3H, s, Si-CH3), 0.09 (3H, s, Si-CH3), 0.09 (3H, s, 
Si-CH3), 0.07 (3H, s, Si-CH3); 
13
C NMR (100 MHz, CDCl3)  210.3, 138.0, 115.3, 79.3, 
72.5, 68.6, 33.3, 30.1, 26.0, 25.9, -4.7, -4.9, -5.3, -5.4; HRMS (ES+) calcd. for 
C20H46NO4Si2 [M + NH4]
+ 420.2960, found 420.2961. 
 
(R)-Mosher ester of 99 (100) 
 
7 10
TBSO OTBS
O O
14
(R)-MTPA
 
 
To a stirred mixture of alcohol 99 (10.0 mg, 24.8 mol), DCC (20.0 mg, 99.2 mol) and 
DMAP (6.1 mg, 50.0 mol) in CH2Cl2 (1.0 mL) at rt was added (+)-(R)--methoxy--
(trifluoromethyl)-phenylacetic acid (11.7 mg, 50.0 mol) in one portion. After 16 h, the 
crude reaction mixture was purified directly by flash column chromatography (5% 
EtOAc/Hexanes) to give (R)-MTPA ester 100 (11.0 mg, 73%).  
Rf 0.26 (10% EtOAc/Hexanes); 1H NMR (500 MHz, CDCl3)  7.50-7.54 (2H, m, Ar-H, 
MTPA), 7.37-7.41 (3H, m, Ar-H, MTPA), 5.77 (1H, ddt, J = 16.8, 10.1, 6.6 Hz, H-13), 
5.38 (1H, ddd, J = 8.3, 5.2, 2.2 Hz, H-10), 5.06-5.00 (2H, m, H-14), 4.56 (1H, d, J = 1.9 
Hz, H-9), 4.35 (1H, d, J = 18.2, H-7a), 4.28 (1H, d, J = 18.2 Hz, H-7b), 3.47 (3H, s, 
MTPA-OCH3), 2.19-2.10 (1H, m, H-12a), 2.09-2.01 (1H, m, H-12b), 1.88-1.85 (1H, m, H-
11a), 1.84-1.76 (1 H, m, H-11b), 0.91 (9H, s, Si-C(CH3)3), 0.90 (9H, s, Si-C(CH3)3), 0.08 
(3H, s, Si-CH3), 0.07 (3H, s, Si-CH3), 0.04 (3H, s, Si-CH3), 0.03 (3H, s, Si-CH3); 
19
F 
NMR (470 MHz; CDCl3)  -72.1, -72.6, 91% de. 
 
(S)-Mosher ester of 99 (101) 
 
7 10
TBSO OTBS
O O
14
(S)-MTPA
 
 
To a stirred mixture of alcohol 99 (10.0 mg, 24.8 mol), DCC (20.0 mg, 99.2 mol) and 
DMAP (6.1 mg, 50.0 mol) in CH2Cl2 (1.0 mL) at rt was added (+)-(S)--methoxy--
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(trifluoromethyl)-phenylacetic acid (11.7 mg, 50.0 mol) in one portion. After 16 h, the 
crude reaction mixture was purified directly by flash column chromatography (5% 
EtOAc/Hexanes) to give (S)-MTPA ester 101 (8.0 mg, 53%).  
Rf 0.26 (10% EtOAc/Hexanes); 1H NMR (500 MHz, CDCl3)  7.56-7.58 (2H, m, Ar-H, 
MTPA), 7.38-7.40 (3H, m, Ar-H, MTPA), 5.69 (1H, ddt, J = 16.8, 10.1, 6.6 Hz, H-13), 
5.37-5.33 (1H, m, H-10), 4.99-4.89 (2H, m, H-14), 4.67 (1H, d, J = 1.6 Hz, H-9), 4.49 (1H, 
d, J = 18.0 Hz, H-7a), 4.28 (1H, d, J = 18.0 Hz, H-7b), 3.57 (3H, s, MTPA-OCH3), 1.97-
1.86 (3H, m, H-11a, H-12), 1.72-1.64 (1H, m, H-11b), 0.92 (9H, s, Si-C(CH3)3), 0.91 (9H, 
s, Si-C(CH3)3), 0.10 (3H, s, Si-CH3), 0.08 (3H, s, Si-CH3), 0.07 (3H, s, Si-CH3), 0.04 (3H, 
s, Si-CH3). 
 
(2R,3R,4S)-1,3-Bis((tert-butyldimethylsilyl)oxy)oct-7-ene-2,4-diol (102)  
 
 
 
Method A 
To a solution of aldol adduct 99 (25.0 mg, 62 mol) in MeOH (2.0 mL) at -78 ºC was 
added NaBH4 (2.9 mg, 75 mol). After 1 h, the reaction mixture was quenched with 
saturated NH4Cl (4.0 mL) solution and the aqueous layer was extracted with Et2O (3  5 
mL). The combined organic extracts were dried (Na2SO4), filtered and concentrated under 
reduced pressure. The resulting residue was purified by flash column chromatography (5-
10% of EtOAc/Hexanes) to give inseparable mixture of compounds 102 and 103 (20.0 mg, 
80%) as a colourless oil in 10:1 syn:anti ratio.  
 
Method B 
To a solution of aldol adduct 99 (50.0 mg, 0.12 mmol) and CeCl3•7H2O (70.0 mg, 0.18 
mmol) in MeOH (2.0 mL) at -78 ºC was added NaBH4 (5.6 mg, 0.15 mmol). After 1 h the 
reaction mixture was quenched with saturated NH4Cl (4.0 mL) solution and the aqueous 
layer was extracted with Et2O (3  5 mL). The combined organic extracts were dried 
(Na2SO4), filtered and concentrated under reduced pressure. The resulting residue was 
purified by flash column chromatography (5% of EtOAc/Hexanes) to give inseparable 
      Experimental
 
 121 
mixture of compounds 102 and 103 (30.0 mg, 61%) as a colourless oil in 10:1 syn:anti 
ratio.  
 
Method C 
To a solution of aldol adduct 99 (26.0 mg, 65.0 mol) in THF (1.0 mL) at -78ºC was added 
(c-hex)2BCl•NEt3 (0.44 mL, 0.19M soln. in THF, 84.0 mol) and after stirring for 15 min, 
LiBH3OMe (0.55 mL, 0.2M soln. in THF, 0.11 mmol) was added dropwise. After 3 h the 
reaction mixture was quenched by addition of phosphate buffer pH 7 (1.0 mL), MeOH (1.0 
mL) and H2O2 (0.5 mL, 30% aqueous). After 30 min the resulting mixture was partitioned 
between H2O (5 mL) and CH2Cl2 (4  10 mL). The combined organic extracts were dried 
(Na2SO4), filtered and concentrated under reduced pressure. Purification by flash column 
chromatography (5% of EtOAc/Hexanes) provided inseparable mixture of compounds 102 
and 103 (22.0 mg, 84%) as a colourless oil in 10:1 syn:anti ratio. 
102 syn: Rf 0.15 (10% EtOAc/Hexanes); []
D
20  -6.0 (c 0.3, CHCl3); IR max (thin film/cm-
1) 3481, 2940, 2868, 1458, 1189, 1109, 840, 766; 1H NMR (500 MHz, CDCl3)  5.83 (1H, 
ddt, J = 17.0, 10.3, 6.6 Hz, H-13), 5.07-4.96 (2H, m, H-14), 3.71-3.65 (4H, m, H-7, H-8, 
H-10), 3.63-3.60 (1H, m, H-9), 2.52 (1H, br s, C8-OH), 2.35 (1H, d, J = 7.0 Hz, C10-OH), 
2.31-2.22 (1H, m, H-12a), 2.17-2.08 (1H, m, H-12b), 1.59-1.54 (2H, m, H-11), 0.92 (9H, s, 
Si-(CH3)3), 0.89 (9H, s, Si-(CH3)3), 0.14 (3H, s, Si-CH3), 0.12 (3H, s, Si-CH3), 0.07 (6H, s, 
Si-(CH3)2); 
13
C NMR (125 MHz, CDCl3)  138.5, 115.0, 74.7, 72.9, 70.9, 63.7, 33.6, 30.3, 
26.1, 26.0, 18.4, 18.3, -4.19, -4.21, -5.19, -5.24; HRMS (ES+) calcd. for C20H45O4Si2  
[M + H]+ 405.2851, found 405.2853. 
 
(2R,3R,4S)-Octane-1,2,3,4,8-pentaol (55) 
 
 
 
To a solution of thexylBH2 in THF (4.0 mL, 0.5 M, 2.0 mmol) at 0 
oC was added olefin 
102 (145 mg, 0.36 mmol) in THF (2.0 mL) dropwise. After 1 h NaOH (2.0 mL, 10% w/v) 
and hydrogen peroxide (1 mL, 30 % v/v) were added. The mixture was stirred for 15 min 
and the aqueous layer was saturated with anhydrous K2CO3. The organics were extracted 
with CH2Cl2 (3  10 mL), washed with brine (20 mL), dried (Na2SO4), filtered and 
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concentrated under reduced pressure. The resulting residue was purified by flash column 
chromatography (20% EtOAc/Hexanes) but due to the TBS-migration, the isolated 
products were directly used in the subsequent step.  
To a solution of triol in MeOH (1.0 mL) and water (0.5 mL) was added Dowex-50 resin 
(130 mg) and the reaction was refluxed (65-70 oC) for 1 h. The reaction mixture was then 
cooled to rt, filtered and concentrated under reduced pressure to give 55 (55.0 mg, 80%) as 
a colourless viscous oil. 
Rf 0.10 (10% MeOH/CH2Cl2); []D20  -2.0 (c 1.2, MeOH); IR max (thin film/cm-1) 3259, 
2923, 2899, 1321, 1196, 1127, 1060; 1H NMR (400 MHz, MeOD)  3.73-3.66 (2H, m, H-
8, H-10), 3.63 (2H, dd, J = 12.1, 5.6 Hz, H-7), 3.57 (2H, t, J = 6.5 Hz, H-14), 3.45 (1H, t, J 
= 4.0 Hz, H-9), 1.63-1.47 (6H, m, H-11, H-12, H-13); 13C NMR (100 MHz, MeOD)   
C9-74.3, C10-74.0, C8-73.4, C7-64.4, C14-62.9, C13-34.2, C11-33.6, C12-23.1; HRMS 
(ES+) calcd. for C8H18NaO5 [M+Na]
+ 217.1046, found 217.1047. 
 
Dimethyl 2,3-O-Isopropylidene-meso-tartrate
74
 
 
 
 
To a solution of dimethyl meso-tartrate 106 (1.40 g, 7.86 mmol) in DMF (10.0 mL) were 
added 2,2-dimethoxypropane (60.0 mL), p-TsOH (30.0 mg, 0.16 mmol) and the mixture 
was refluxed for 4h. The mixture was then cooled to rt and concentrated to a volume of 
~30 mL and 1M NaHCO3 (50.0 mL) was added and the layers were separated. The 
aqueous phase was extracted with CH2Cl2 (3 x 50 mL) and the combined organic extracts 
were washed with water (50 mL), brine (50 mL), dried (Na2SO4), filtered and concentrated 
under reduced pressure. Purification by flash column chromatography (5% MeOH/CH2Cl2) 
afforded dimethylketal (1.74 g, 98%). 
Rf 0.60 (10% MeOH/CH2Cl2); 
1
H NMR (300 MHz, MeOD)  4.84 (2H, s, H-2, H-3), 3.75 
(6H, s, OCH3), 1.65 (3H, d, J = 0.6 Hz, C-CH3), 1.42 (3H, d, J = 0.7 Hz, C-CH3). 
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2,3-O-Isopropylidenethreitol (107)
74
 
 
 
 
To a solution of dimethylketal (1.00 g, 4.59 mmol) in Et2O (50 mL) at 0 ºC was added 
LiAlH4 (0.384 g, 10.1 mmol). The reaction mixture was stirred at rt for 6h. Excess of 
LiAlH4 was destroyed by addition of few drops of water and the mixture was diluted with 
ether and filtered. The solid residue was washed several times with MeOH and combined 
organic filtrates were dried (Na2SO4), filtered and concentrated under reduced pressure. 
The resulting crude oil was purified by flash column chromatography (5% MeOH/CH2Cl2) 
to give diol 107 (599 mg, 81%).  
Rf 0.30 (10% MeOH/CH2Cl2); 
1
H NMR (400 MHz, CDCl3)  4.31-4.26 (2H, m, H-2, H-
3), 3.84-3.72 (4H, m, H-1, H-4), 1.46 (3H, s, C-CH3), 1.38 (3H, s, C-CH3). 
 
4-O-(tert-Butyldimethyl)silyl-2,3-O-isopropylidene-DL-erythritol
74
 
 
 
 
To a solution of diol 107 (599 mg, 3.69 mmol) in THF (10.0 mL) at 0 ºC was added NaH 
(212 mg, 60% dispersion in mineral oil, 8.86 mmol). The mixture was allowed to stir for 
15 min and TBSCl (556 mg, 3.69 mmol) was added. After 6 h, water (10.0 mL) was added 
and the layers were separated. The aqueous phase was extracted with CH2Cl2 (3  20 mL) 
and the combined organic extracts were washed with brine (40 mL), dried (Na2SO4), 
filtered and concentrated under reduced pressure. Purification by flash column 
chromatography (10% EtOAc/Hexanes) provided alcohol (897 mg, 88%) as a colourless 
oil. 
Rf 0.25 (20% EtOAc/Hexanes); 
1
H NMR (400 MHz, CDCl3)  4.35 (1H, dt, J = 7.3, 5.7 
Hz, H-3), 4.23 (1H, ddd, J = 9.1, 6.0, 4.1 Hz, H-2), 3.84-3.73 (3H, m, H-1a, H-4), 3.68 
(1H, dd, J = 10.5, 4.1 Hz, H-1b), 3.01 (1H, dd, J = 8.4, 5.6 Hz, OH), 1.41 (3H, s, C-CH3), 
1.35 (3H, s, C-CH3), 0.90 (9 H, s, Si-C(CH3)3), 0.11 (3H, s, Si-CH3), 0.10 (3H, s, Si-CH3). 
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4-O-tert-Butyldimethylsilyl-2,3-O-isopropylidene-DL-erythrose (105)
74
 
 
 
 
To a solution of oxalyl chloride (286 L, 3.38 mmol) in CH2Cl2 (20.0 mL) at -78 ºC was 
added a solution of DMSO (479 L, 6.75 mmol) in CH2Cl2 (5.0 mL) dropwise. The 
reaction mixture was stirred at -78 ºC for 15 min and a solution of alcohol (850 mg, 3.07 
mmol) in CH2Cl2 (10.0 mL) was added. The reaction mixture was stirred at -78 ºC for an 
additional 15 min. and Et3N (2.14 mL, 15.3 mmol) was then added, and the mixture was 
allowed to warm to rt. The reaction was quenched by addition of water (20.0 mL) and 
extracted with CH2Cl2 (3  30 mL). The combined organic extracts were washed with 
saturated NH4Cl (50 mL) solution and brine (50 mL), dried (Na2SO4) and concentrated 
under reduced pressure. The resulting oil was purified by flash column chromatography 
(10% EtOAc/Hexanes) to give 105 (810 mg, 96%) as a colourless oil.  
Rf 0.44 (20% EtOAc/Hexanes); 
1
H NMR (400 MHz, CDCl3)  9.68 (1H, d, J = 2.0 Hz, H-
1), 4.46 (1H, dd, J = 3.8, 2.8 Hz, H-3), 4.42 (1H, dd, J = 7.9, 2.0 Hz, H-2), 3.78 (1H, dd, J 
= 11.4, 3.8 Hz, H-4a), 3.69 (1H, dd, J = 11.4, 2.7 Hz, H-4b), 1.56 (3H, s, C-CH3), 1.38 
(3H, s, C-CH3), 0.87 (9H, s, Si-C(CH3)3), 0.05 (3H, s, Si-CH3), 0.04 (3H, s, Si-CH3). 
 
(S)-1-((4R,5S)-5-(((tert-Butyldimethylsilyl)oxy)methyl)-2,2-dimethyl-1,3-dioxolan-4-
yl)pent-4-en-1-ol (108) 
(R)-1-((4R,5S)-5-(((tert-Butyldimethylsilyl)oxy)methyl)-2,2-dimethyl-1,3-dioxolan-4-
yl)pent-4-en-1-ol (109) 
 
  
 
To a flame dried round bottom flask charged with magnesium turnings (1.09 g, 45.2 mmol) 
was added Et2O (5.0 mL) and catalytic amount of iodine. Homoallyl bromide (5.08 g, 37.7 
mmol) dissolved in THF (12.0 mL) was added dropwise as the temperature was increased 
to 50 ºC. The reaction mixture was stirred for 2 h.  
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To a solution of aldehyde 105 (0.25 g, 0.91 mmol) in THF (5.0 mL) at -40 ºC was added 
freshly prepared homoallyl magnesium bromide (1.24 mL, 2M soln. in THF, 2.73 mmol) 
via cannula. The resulting black solution was allowed to warm to -20 ºC for 1 h, and 
finally to 0 ºC for 2 h, before being quenched by the addition of saturated NH4Cl (10.0 
mL) solution and diluted with Et2O (20 mL). The organic phase was separated, and the 
aqueous layer extracted with Et2O (3  20 mL). The combined organic extracts were dried 
(Na2SO4), filtered and concentrated under reduced pressure. Purification by flash column 
chromatography (5% EtOAc/Hexanes) gave hydroxy olefins 108 (230 mg, 70%) and 109 
(80.0 mg, 28 %) as colourless oils. 
108: Rf 0.25 (20% EtOAc/Hexanes); IR max (thin film/cm-1) 3484, 2953, 2931, 2860, 
1472, 1368, 1177, 1082, 837, 779; 1H NMR (400 MHz, CDCl3)  5.81-5.91 (1H, m, H-
13), 5.05 (1H, dq, J = 17.1, 1.8 Hz, H-14a), 4.96 (1H, ddt, J = 10.2, 2.2, 1.1 Hz, H-14b), 
4.23 (1H, ddd, J = 10.2, 5.4, 3.4 Hz, H-8), 4.02 (1H, dd, J = 9.3, 5.4 Hz, H-7a), 3.93 (1H, 
dd, J = 3.1, 1.6 Hz, H-9), 3.82-3.76 (2H, m, H-10, OH), 3.57 (1H, dd, J = 10.4, 3.1 Hz, H-
7b), 2.40-2.30 (1H, m, H-12a), 2.23-2.13 (1H, m, H-12b), 1.89-1.80 (1H, m, H-11a), 1.62-
1.56 (1H, m, H-11b), 1.36 (3H, s, C-CH3), 1.33 (3H, s, C-CH3), 0.91 (9H, s, Si-C(CH3)3), 
0.12 (3H, s, Si-CH3), 0.12 (3H, s, Si-CH3); 
13
C NMR (100 MHz, CDCl3)  138.9, 114.7, 
108.5, 80.9, 68.4, 62.1, 33.3, 29.6, 28.2, 25.9, 25.5, 18.3, -5.45, -5.54; HRMS (ES+) calcd. 
for C17H35O4Si [M+H]
+ 331.2299, found 331.2303. 
 
109: Rf 0.24 (20% EtOAc/Hexanes); IR max (thin film/cm-1) 3484, 2953, 2931, 2860, 
1472, 1368, 1177, 1082, 837, 779; 1H NMR (400 MHz, CDCl3)  5.83 (1H, ddt, J = 17.0, 
10.3, 6.7 Hz, H-13), 5.04 (1H, dq, J = 17.1, 1.8 Hz, H-14a), 4.96 (1H, ddt, J = 10.1, 2.1, 
1.1 Hz, H-14b), 4.15 (1H, ddd, J = 7.2, 6.4, 4.2 Hz, H-8), 4.02 (1H, dd, J = 6.4, 3.6 Hz, H-
9), 3.91 (1H, dd, J = 10.8, 7.3 Hz, H-7a), 3.81 (1H, td, J = 8.8, 4.2 Hz, H-10), 3.72 (1H, 
dd, J = 10.8, 4.2 Hz, H-7b), 2.81 (1H, d, J = 5.1 Hz, OH), 2.30-2.26 (1H, m, H-12a), 2.18-
2.14 (1H, m, H-12b), 1.70-1.61 (2H, m, H-11), 1.47 (3H, s, C-CH3), 1.36 (3H, s, C-CH3), 
0.90 (9H, s, Si-C(CH3)3), 0.09 (6H, s, Si-(CH3)2); 
13
C NMR  (100 MHz, CDCl3) 138.5, 
114.9, 108.2, 79.8, 68.4, 61.9, 33.8, 30.2, 27.5, 26.0, 25.2, 18.4, -5.3; HRMS (ES+) calcd. 
for C17H35O4Si [M+H]
+ 331.2299, found 331.2305. 
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7-O-tert-Butyldimethylsilyl-8,9-O-isopropylidene-10-(R)-hydroxyocta-14-ol  
 
 
 
To a solution of thexylBH2 in THF (4.0 mL, 0.5 M, 2.0 mmol) at 0 
oC was added olefin 
108 (110 mg, 0.33 mmol) in THF (1.0 mL) dropwise. After 1h NaOH (0.5 mL, 10% w/v) 
and hydrogen peroxide (0.5 mL, 30 % v/v) were added. The mixture was stirred for 15 min 
and the aqueous layer was saturated with anhydrous K2CO3. The organics were extracted 
with CH2Cl2 (3  5 mL), washed with brine (15.0 mL), dried (Na2SO4), filtered and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography (10% EtOAc/Hexanes) to give diol (114 mg, 95%) as a colourless oil.  
Rf 0.16 (20% EtOAc/Hexanes); IR max (thin film/cm-1) 3448, 3409, 2950, 2930, 2858, 
1472, 1380, 1275, 1083, 837, 777; 1H NMR (400 MHz, CDCl3)  4.17-4.11 (1H, m, H-8), 
4.02 (1H, dd, J = 6.3, 3.5 Hz, H-9), 3.91 (1H, dd, J = 10.8, 7.1 Hz, H-7a), 3.81-3.77 (1H, 
m, H-10), 3.73 (1H, dd, J = 10.8, 4.1 Hz, H-7b), 3.66 (2H, t, J = 6.3 Hz, H-14), 1.66-1.56 
(6H, m, H-11, H-12, H-13), 1.47 (3H, s, C-CH3), 1.36 (3H, s, C-CH3), 0.90 (9H, s, Si-
C(CH3)3), 0.09 (6H, s, Si-(CH3)2); 
13
C NMR (100 MHz, CDCl3)  108.2, 79.8, 69.0, 63.0, 
61.8, 34.3, 32.8, 31.1, 27.5, 26.0, 25.2, 22.3, 18.4, -5.3; HRMS (ES+) calcd. for 
C17H37O5Si [M+H]
+ 349.2405, found 349.2407. 
 
(2S,3R,4S)-Octane-1,2,3,4,8-pentaol (56) 
 
 
 
To a solution of diol (90.0 mg, 0.26 mmol) in MeOH (1.0 mL) and water (0.5 mL) was 
added Dowex-50 resin (90.0 mg) and the reaction was refluxed (65-70 oC) for 1 h. The 
reaction mixture was then cooled to rt, filtered and concentrated under reduced pressure to 
give 56 (49.0 mg, 98%) as a colourless viscous oil. 
Rf 0.10 (10% MeOH/CH2Cl2); IR max (thin film/cm-1) 3342, 3244, 2926, 2911, 2860, 
1405, 1281, 1087, 1026; 1H NMR (400 MHz, MeOD)  3.82 (1H, td, J = 4.3, 1.7 Hz, H-
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10), 3.79 (1H, dd, J = 11.1, 3.5 Hz, H-7a), 3.68 (1H, ddd, J = 8.0, 5.9, 3.5 Hz, H-8), 3.61 
(1H, dd, J = 11.1, 6.0 Hz, H-7b), 3.57 (2H, t, J = 6.5 Hz, H-14), 3.36 (1H, dd, J = 10.9, 5.9 
Hz, H-9), 1.63-1.49 (5H, m, H-11, 12a, 13), 1.45-1.37 (1H, m, H-12b); 13C NMR (100 
MHz, MeOD)  C9-74.5, C10-73.2, C8-71.4, C7-65.1, C14-62.9, C11-34.5, C13-33.7, 
C12-23.4; HRMS (ES+) calcd. for C8H19O5 [M+H]
+ 195.1227, found 195.1227. 
 
7.4  Experimental procedures for Chapter 3 
(E)-Ethyl-hepta-2,6-dienoate (111)
137
 
 
 
 
To a solution of triethyl phosphonoacetate 112 (3.54 mL, 17.8 mmol), lithium chloride 
(2.01 g, 47.6 mmol) and Hünig’s base (1.88 mL, 10.8 mmol) in MeCN (40.0 mL) at rt was 
added a solution of aldehyde 84 (1.00 g, 11.9 mmol) in MeCN (5.0 mL). After 18 h, the 
reaction was quenched by addition of H2O (50.0 mL) and layers were separated. The 
aqueous phase was extracted with Et2O (3  40 mL) and the combined organic extracts 
were dried (MgSO4), filtered and concentrated under reduced pressure. Purification by 
flash column chromatography (5% Et2O/Pet. Ether) provided 19 (1.51 g, 81%) as a 
colourless oil. 
Rf 0.42 (20% Et2O/Pet. Ether); 
1
H NMR (400 MHz, CDCl3)  6.95 (1H, dt, J = 15.7, 6.7 
Hz, H-3), 5.82 (1H, dt, J = 15.6, 1.6 Hz, H-2), 5.83-5.74 (1H, m, H-6), 5.04 (1H, dq, J = 
17.1, 1.7 Hz, H-7a), 5.00 (1H, ddt, J = 10.2, 1.8, 1.2 Hz, H-7b), 4.17 (2H, q, J = 7.1 Hz, 
OCH2CH3), 2.33-2.27 (2H, m, H-4), 2.24-2.18 (2H, m, H-5), 1.27 (3H, t, J = 7.1 Hz, 
OCH2CH3). 
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(1S)-3-(tert-Butyldimethylsilyloxy)-1-(tert-butyldimethylsilyloxymethyl)-2-oxopropyl 
benzoate 119
78
 
 
 
 
To a solution of pre-dried L-erythrulose 118 (6.00 g, 50.0 mmol) in DMF (60.0 mL) was 
added TBSCl (16.6 g, 110 mmol) and imidazole (10.2 g, 150 mmol). The reaction mixture 
was then stirred at rt for 2 h and a saturated NH4Cl (100 mL) solution was added. The 
layers were separated and the aqueous phase was extracted with Et2O (3  100 mL). The 
combined organic extracts were washed with H2O (50 mL), brine (100 mL), dried 
(Na2SO4), filtered and concentrated under reduced pressure. Purification by flash column 
chromatography (2-10% EtOAc/Hexanes) provided bis-TBS-ether (12.2 g, 70%) as a 
colourless oil, which was directly used in the next step.  
Rf 0.36 (10% EtOAc/Hexanes); 
1
H NMR (400 MHz; CDCl3)  4.45 (2H, d, J = 17.9 Hz, 
H-3a), 4.44 (1H, dt, J = 6.7, 3.4 Hz, H-1), 4.38 (1H, d, J = 17.8 Hz, H-3b), 4.09 (1H, dd, J 
= 10.6, 3.3 Hz, CH2-OTBS), 3.82 (1H, dd, J = 10.6, 3.7 Hz, CH2-OTBS), 3.44 (1H, d, J = 
6.7 Hz, OH), 0.91 (9H, s, Si-C(CH3)3), 0.85 (9H, s, Si-C(CH3)3), 0.09 (3H, s, Si-CH3), 0.08 
(3H, s, Si-CH3), 0.04 (6H, s, Si-(CH3)2). 
To a solution of bis-TBS-ether (12.1 g, 34.7 mmol) in CH2Cl2 (200 mL) was added Et3N 
(6.25 mL, 44.7 mmol), DMAP (1.26 g, 10.3 mmol) and benzoyl chloride (4.40 mL, 38.0 
mmol) dropwise. The reaction mixture was then stirred at rt for 5 h and quenched with 
water (200 mL) and the layers were separated. The aqueous phase was extracted with 
CH2Cl2 (3  200 mL), and the combined organic extracts were washed with saturated 
NH4Cl (50 mL) solution, brine (100 mL), dried (Na2SO4), filtered and concentrated under 
reduced pressure. Purification by flash column chromatography (2% EtOAc/Hexanes) 
provided ketone 119 (9.34 g, 60%) as a colourless oil. 
Rf 0.68 (10% EtOAc/Hexanes); 
1
H NMR (400 MHz, CDCl3)  8.08 (2H, m, Ar-H), 7.58 
(1H, m, Ar-H), 7.46 (2H, m, Ar-H), 5.57 (1H, dd, J = 4.6, 3.6 Hz, H-1), 4.49 (2H, s, H-3), 
4.20 (1H, dd, J = 11.1, 4.6 Hz, CH2-OTBS), 4.07 (1H, dd, J = 11.1, 3.6 Hz, CH2-OTBS), 
0.93 (9H, s, Si-C(CH3)3), 0.88 (9H, s, Si-C(CH3)3), 0.11 (3H, s, Si-CH3), 0.11 (3H, s, Si-
CH3), 0.08 (3H, s, Si-CH3), 0.07 (3H, s, Si-CH3). 
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(1R,3R,4R)-3,8-Bis(tert-butyldimethylsilyloxy)-1-(tert-butyldimethylsilyloxymethyl)-4-
hydroxy-2-oxooctyl benzoate (123) 
 
 
 
To a stirred solution of ketone 119 (1.18 g, 2.62 mmol) in Et2O (20.0 mL) at -78 ºC was 
added dicyclohexylboron chloride (1.03 mL, 4.71 mmol) and Et3N (0.728 mL, 5.24 mmol) 
and the reaction mixture was stirred for 0.5 h. Aldehyde 69 (0.85 g, 3.9 mmol) in Et2O 
(10.0 mL) was then added and stirring was continued for 2 h. The reaction mixture was 
then diluted with MeOH (5.0 mL) and phosphate buffer pH 7 (5.0 mL) was added followed 
by H2O2 (5.0 mL, 30% v/v). The biphasic mixture was allowed to warm to rt and stirred 
vigorously for 10 min. The layers were separated and the aqueous phase was extracted 
with Et2O (3  30 mL), washed with brine (30 mL), dried (Na2SO4), filtered and 
concentrated under reduced pressure. Flash column chromatography (5% EtOAc/Hexanes) 
provided aldol adduct 123 (1.40 g, 81%) as a 4:1 inseparable mixture of diastereoisomers. 
Rf 0.34 (10% EtOAc/Hexanes); IR max (thin film/cm-1) 3491, 2938, 2892, 2861, 1724, 
1463, 1267, 1105, 839, 778; 1H NMR (400 MHz, CDCl3)  8.10-8.06 (2H, m, Ar-H), 7.61-
7.56 (1H, m, Ar-H), 7.48-7.43 (2H, m, Ar-H), 5.72 (1H, dd, J = 4.9, 3.5 Hz, H-7), 4.20 
(1H, d, J = 5.4 Hz, H-9), 4.15 (2H, dd, J = 4.2, 1.9 Hz, H-6), 3.92-3.86 (1H, m, H-10), 3.60 
(2H, t, J = 6.3 Hz, H-14), 3.08 (1H, d, J = 7.5 Hz, OH), 1.64-1.49 (5H, m, H-11, H-12a, H-
13), 1.49-1.37 (1H, m, H-12b), 0.93 (9H, s, Si-C(CH3)3), 0.88 (9H, s, Si-C(CH3)3), 0.87 
(9H, s, Si-C(CH3)3), 0.12 (6H, s, Si-(CH3)2), 0.10 (3H, s, Si-CH3), 0.09 (3H, s, Si-CH3), 
0.07 (3H, s, Si-CH3), 0.04 (3H, s, Si-CH3); 
13
C NMR (75 MHz, CDCl3)  205.1, 166.5, 
133.6, 130.1, 129.4, 128.6, 81.9, 79.1, 73.9, 63.2, 62.8, 32.8, 32.6, 26.1, 26.0, 25.9, 22.3, 
18.5, 18.4, 18.3, -4.4, -4.6, -5.1, -5.2; HRMS (ES+) calcd. for C34H65O7Si3 [M+H]
+ 
669.4033, found 669.4020. 
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(1R,3R,4R)-3,8-Bis(tert-butyldimethylsilyloxy)-1-(tert-butyldimethylsilyloxymethyl)-4-
(methoxybenzyl)oxy-2-oxooctyl benzoate (125) 
 
 
 
To a solution of alcohol 123 (1.40 g, 2.09 mmol) and PMBTCA (886 mg, 3.14 mmol) in 
PhMe (20.0 mL) at 0 ºC was added lanthanum (III) triflate (61.0 mg, 0.104 mmol). After 6 
h, cold hexane (40.0 mL) was added and the precipitate was filtered. The resulting mixture 
was concentrated under reduced pressure and purified by flash column chromatography 
(5% EtOAc/Hexanes) to give PMB ether 125 (1.08 g, 65%) as a colourless oil. 
Rf 0.44 (10% EtOAc/Hexanes); []D20  +7.6 (c 2.5, CHCl3); IR max (thin film/cm-1) 2933, 
2891, 2859, 1725, 1610, 1466, 1255, 1104, 837, 778, 711; 1H NMR (400 MHz, CDCl3)  
 8.08 (2H, dd, J = 8.4, 1.3 Hz, Ar-H), 7.56 (1H, s, Ar-H), 7.45 (2H, t, J = 7.7 Hz, Ar-H), 
7.19 (2H, d, J = 8.7 Hz, PMB Ar-H), 6.83 (2H, d, J = 8.7 Hz, PMB Ar-H), 5.87 (1H, t, J = 
4.5 Hz, H-7), 4.63 (1H, d, J = 3.4 Hz, H-9), 4.50 (1H, d, J = 11.2 Hz, CHaHbAr), 4.36 (1H, 
d, J = 11.2 Hz, CHaHbAr), 4.08 (2H, d, J = 4.5 Hz, H-6), 3.79 (3H, s, Ar-OCH3), 3.71 (1H, 
dt, J = 8.4, 3.3 Hz, H-10), 3.54 (2H, td, J = 6.3, 1.5 Hz, H-14), 1.73-1.63 (1H, m, H-11a), 
1.51-1.38 (4H, m, H-11b, H-12a, H-13), 1.33-1.21 (1H, m, H-12b), 0.94 (9H, s, Si-
C(CH3)3), 0.88 (9H, s, Si-C(CH3)3), 0.84 (9H, s, Si-C(CH3)3), 0.12 (3H, s, 2  Si-CH3), 
0.09 (3H, s, 2  Si-CH3), 0.05 (3H, s, Si-CH3), 0.02 (6H, s, 2  Si-CH3), 0.02 (3H, s, Si-
CH3); 
13
C NMR (100 MHz, CDCl3)  205.7, 165.6, 159.2, 133.3, 130.4, 130.0, 129.9, 
129.5, 128.5, 113.8, 81.4, 78.3, 78.0, 71.9, 63.3, 62.1, 55.3, 33.0, 29.8, 26.14, 26.12, 25.9, 
21.9, 18.51, 18.48, 18.37, -4.0, -4.8, -5.1, -5.3; HRMS (ES+) calcd. for C42H76NO8Si3 
[M+NH4]
+ 806.4873, found 806.4875. 
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(1R,3S,4R)-3,8-Bis(tert-butyldimethylsilyloxy)-1-(tert-butyldimethylsilyloxymethyl)-4-
(methoxybenzyl)oxy-octane-1,2-diol (126) 
 
 
 
To a solution of keto-ester 125 (729 mg, 0.92 mmol) in Et2O (20.0 mL) at –78 ºC was 
added LiBH4 (1.85 mL, 2M soln. in THF, 3.69 mmol) dropwise. The reaction mixture was 
stirred for 2 h and quenched with saturated NaHCO3 (50.0 mL) solution. The layers were 
separated and the aqueous phase was extracted with Et2O (3  50 mL). The combined 
organic extracts were washed with brine (50 mL), dried (Na2SO4) and concentrated under 
reduced pressure. Flash column chromatography (10% EtOAc/Hexanes) provided diol 126 
(415 mg, 66%) as a colourless oil. 
Rf 0.24 (10% EtOAc/Hexanes); []D20  +10.1 (c 0.8 CDCl3); IR max (thin film/cm-1) 3316, 
3259, 2923, 2899, 1321, 1196, 1127, 1060; 1H NMR (300 MHz, CDCl3)  7.26 (2H, d, J = 
8.6 Hz, Ar-H), 6.86 (2H, d, J = 8.7 Hz, Ar-H), 4.65 (1H, d, J = 10.8 Hz, CHaHbAr), 4.44 
(1H, d, J = 10.9 Hz, CHaHbAr), 3.96 (1H, dd, J = 4.8, 3.2, H-10), 3.80 (3H, s, Ar-OCH3), 
3.71-3.52 (7H, m, H-6, H-7, H-8, H-9, H-14), 3.19 (1H, d, J = 5.0 Hz, C8-OH), 2.95 (1H, 
d, J = 4.5 Hz, C7-OH), 1.59-1.47 (5H, m, H-11, H-12a, H-13), 1.28-1.26 (1H, m, H-12b), 
0.92 (9H, s, Si-C(CH3)3), 0.90 (18H, s, Si-C(CH3)3), 0.12 (3H, s, Si-CH3), 0.11 (3H, s, Si-
CH3), 0.07 (6H, s, 2  Si-CH3), 0.04 (6H, s, 2  Si-CH3); 13C NMR (75 MHz, CDCl3)  
159.3, 130.5, 129.6, 113.9, 82.3, 73.8, 72.7, 71.1, 70.9, 64.8, 63.3, 55.4, 33.1, 30.7, 26.15, 
26.13, 26.10, 22.5, 18.53, 18.49, 18.33, -3.9, -4.6, -5.10, -5.21; HRMS (ES+) calcd. for 
C35H72O7Si3 [M+H]
+ 687.4502, found 687.4495. 
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(3S,4S,5R)-4,9-Bis((tert-butyldimethylsilyl)oxy)-5-((4-methoxybenzyl)oxy)nonen-3-ol 
(128) 
 
 
 
To a solution of diol 126 (0.39 g, 0.58 mmol) in EtOAc (20.0 mL) was added Pb(OAc)4 
(0.41 mg, 0.58 mmol), resulting in a light yellow suspension. After 10 min of stirring, the 
mixture was filtered through a plug of silica gel, eluting with EtOAc to afford aldehyde 
127 (0.28 g, 97%) as a colourless oil immediately used without further purification.  
Rf 0.36 (10% EtOAc/Hexanes); 
1
H NMR (300 MHz, CDCl3)  9.67 (1H, d, J = 1.6 Hz, H-
8), 7.24 (2H, d, J = 8.7 Hz, Ar-H), 6.86 (2H, d, J = 8.7 Hz, Ar-H), 4.60 (1H, d, J = 11.1 
Hz, CHaHbAr), 4.47 (1H, d, J = 11.2 Hz, CHaHbAr), 4.09 (1H, dd, J = 3.6, 1.7 Hz, H-9), 
3.80 (3H, s, Ar-OCH3), 3.62 (1H, dt, J = 5.7, 2.9 Hz, H-10), 3.58 (1H, t, J = 6.1 Hz, H-14), 
1.72-1.63 (1H, m, H-11a), 1.56-1.42 (5H, m, H-11b, H-12, H-13), 0.93 (9H, s, Si-
C(CH3)3), 0.89 (9H, s, Si-C(CH3)3), 0.08 (6H, s, 2  Si-CH3), 0.04 (6H, s, 2  Si-CH3);  
13
C NMR (75 MHz, CDCl3)  203.8, 159.4, 130.4, 129.6, 113.9, 81.1, 79.6, 72.3, 63.2, 
55.4, 32.9, 30.8, 26.1, 25.9, 22.0, 18.52, 18.36, -4.58, -4.71, -5.1. 
To a solution of aldehyde 127 (370 mg, 0.72 mmol) in THF (20.0 mL) at -78 ºC was added 
vinylmagnesium bromide (6.2 mL, 0.7M soln. in THF, 4.35 mmol). The reaction mixture 
was allowed to warm up to 0 ºC over 12h. The reaction was quenched with saturated 
NH4Cl (20.0 mL) solution and the layers were separated. The aqueous phase was extracted 
with Et2O (3  50 mL) and the combined organic extracts were washed with brine (50 
mL), dried (Na2SO4), filtered and concentrated under reduced pressure. Flash column 
chromatography (5% EtOAc/Hexanes) provided allylic alcohol 128 (199 mg, 52%) as a 
colourless oil. 
Rf 0.34 (20% EtOAc/Hexanes); []D20  +15.3 (c 1.6, CHCl3); IR max (thin film/cm-1) 3364, 
2933, 2891, 2860, 1464, 1317, 1099, 837, 774; 1H NMR (400 MHz; CDCl3)  7.25 (2H, d, 
J = 8.7 Hz, Ar-H), 6.86 (2H, d, J = 8.7 Hz, Ar-H), 5.97 (1H, ddd, J = 17.3, 10.5, 6.1 Hz, H-
2), 5.30 (1H, dt, J = 17.3, 1.6 Hz, H-6a), 5.18 (1H, dt, J = 10.5, 1.5 Hz, H-6b), 4.53 (1H, d, 
J = 11.0 Hz, CHaHbAr), 4.41 (1H, d, J = 10.9 Hz, CHaHbAr), 4.26-4.22 (1H, m, H-8), 3.80 
(3H, s, Ar-OCH3), 3.75 (1H, dd, J = 4.9, 4.1 Hz, H-9), 3.59 (2H, t, J = 6.3 Hz, H-14), 3.50-
3.46 (1H, m, H-10), 2.26 (1H, d, J = 4.0 Hz, OH), 1.66-1.57 (2H, m, H-11), 1.54-1.45 (3H, 
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m, H-12a, H-13), 1.40-1.30 (1H, m, H-12b), 0.90 (9H, s, Si-C(CH3)3), 0.89 (9H, s, Si-
C(CH3)3), 0.08 (6H, s, 2  Si-CH3), 0.04 (6H, s, 2  Si-CH3); 13C NMR (100 MHz; 
CDCl3)  159.3, 137.9, 130.9, 129.5, 116.2, 113.8, 80.9, 76.8, 75.0, 72.1, 63.4, 55.4, 33.2, 
30.8, 26.15, 26.13, 22.1, 18.5, 18.4, -4.1, -4.2, -5.1; HRMS (ES+) calcd. for C29H55O5Si2 
[M+H]+ 539.3583, found 539.3598.  
 
Diethyl 2,6,10-dodecatrienedioate (135)
138
 
 
1
7
EtO
O
OEt
O  
 
To a stirred solution of Grubbs II cat. (7.60 mg, 9.27 mol) in CH2Cl2 (5.0 mL) at rt was 
added a solution of olefin 111 (57.0 mg, 0.371 mmol) and 128 (50.0 mg, 92.8 mol) in 
CH2Cl2 (5.0 mL) and the mixture was stirred for 24 h. Following concentration, the crude 
product was purified by flash column chromatography (10% EtOAc:Pet.Ether) to provide 
dimer of the olefin 176 as a colourless oil (30.0 mg, 30%) and returned unreacted olefin 
128 (20.0 mg).  
Rf 0.38 (20% EtOAc/Hexanes); 
1
H NMR (400 MHz, CDCl3)  6.94 (2H, dt, J = 15.7, 6.8 
Hz, H-3, 3’), 5.81 (2H, dt, J = 15.7, 1.6 Hz, H-2, 2’), 5.44 (2H, tt, J = 3.4, 1.7 Hz, H-6,  
H-7), 4.18 (4H, q, J = 7.1 Hz, OCH2CH3), 2.28-2.23 (4H, m, H-4, 4’), 2.18-2.14 (4H, m, 
H-5, 5’), 1.28 (6H, t, J = 7.1 Hz, OCH2CH3); 
13
C NMR (100 MHz; CDCl3)  166.8, 148.5, 
129.9, 121.8, 60.3, 32.2, 31.0, 14.4. 
 
4-(tert-Butyldimethylsilyl)oxy-butanal (145)139,140 
 
 
 
To a solution of 1,4-butanediol 146 (9.80 mL, 0.11 mol), Et3N (6.75 mL, 48 mmol) and 
DMAP (450 mg, 3.7 mmol) in CH2Cl2 (40.0 mL) at rt was slowly added a solution of 
TBSCl (5.60 g, 37.1 mmol) in CH2Cl2 (10.0 mL). After 16 h, the reaction mixture was 
poured onto brine (50.0 mL) and layers were separated. The aqueous phase was extracted 
with CH2Cl2 (3  50 mL) and the combined organic extracts were washed with water (100 
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mL), brine (50 mL), dried (MgSO4), filtered and concentrated under reduced pressure. 
Purification by flash column chromatography (5% EtOAc/Hexanes) provided alcohol (6.42 
g, 86%) as a colourless oil. 
Rf 0.43 (50% EtOAc/Hexanes); 
1
H NMR (300 MHz, CDCl3)  3.67 (4H, m, H-1, H-4), 
2.51 (1H, t, J = 5.8 Hz, OH), 1.66 (4H, m, H-2, H-3), 0.91 (9H, s, Si-C(CH3)3), 0.08 (6H, 
m, Si-(CH3)2). 
To a solution of oxalyl chloride (3.39 mL, 39.2 mmol) in CH2Cl2 (50.0 mL) at -78 ºC was 
slowly added DMSO (3.33 mL, 47.1 mmol). After 30 min, a solution of alcohol (4.00 g, 
19.6 mmol) in CH2Cl2 (20.0 mL) was added, dropwise. After 1 h, Et3N (19.1 mL, 137 
mmol) was added and the slurry was allowed to attain rt. After 1 h, saturated NH4Cl (50 
mL) solution was added and layers were separated. The aqueous phase was extracted with 
CH2Cl2 (3  40 mL) and the combined organic extracts were washed with H2O (100 mL), 
brine (100 mL), dried (MgSO4), filtered and concentrated under reduced pressure. The 
crude aldehyde 145 (3.17 g, 80%) was used without further purification. 
Rf 0.71 (25% EtOAc/Hexanes); 
1
H NMR (400 MHz, CDCl3)  9.80 (1H, t, J = 1.7 Hz, 
H-1), 3.66 (2H, t, J = 5.9 Hz, H-4), 2.51 (2H, dt, J = 7.2, 1.7 Hz, H-2), 1.87 (2H, m, H-3), 
0.89 (9H, s, Si-C(CH3)3), 0.05 (6H, m, 2  Si-CH3). 
 
(E)-Methyl-6-(tert-Butyldimethylsilyl)oxy-hex-2-enoate (147)141 
 
 
 
To a solution of triethyl phosphonoacetate 112 (4.04 mL, 20.3 mmol), lithium chloride 
(3.71 g, 87.6 mmol) and Hünig’s base (2.28 mL, 13.1 mmol) in MeCN (50.0 mL) at rt was 
added a solution of aldehyde 145 (3.15 g, 15.6 mmol) in MeCN (20.0 mL). After 18 h, 
H2O (50.0 mL) was added and the layers were separated. The aqueous phase was extracted 
with EtOAc (3  40 mL) and the combined organic extracts were dried (MgSO4), filtered 
and concentrated under reduced pressure. Purification by flash column chromatography 
(5% EtOAc/Hexanes) provided 147 (3.29 g, 77%) as a colourless oil. 
Rf 0.52 (20% EtOAc/Hexanes); 
1
H NMR (400 MHz, CDCl3)  6.95 (1H, dt, J = 15.6, 6.9 
Hz, H-3), 5.85 (1H, dt, J = 15.6, 1.6 Hz, H-2), 4.15 (2H, q, J = 7.1 Hz, OCH2CH3), 3.60 
(2H, t, J = 7.1 Hz, H-6), 2.3 (2H, m, H-4), 1.65 (2H, m, H-5), 1.25 (3H, t, J = 7.1 Hz, 
OCH2CH3), 0.90 (9H, s, Si-C(CH3)3), 0.05 (6H, s, Si-(CH3)2). 
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(E)-Ethyl 6-hydroxyhex-2-enoate
142
 
 
 
 
To a solution of TBS ether 147 (2.00 g, 7.3 mmol) in MeOH/CH2Cl2 (1:4, 20.0 mL) at 0 ºC 
was added (±)-CSA (170 mg, 0.73 mmol). After 1.5 h, saturated NaHCO3 (20.0 mL) 
solution and CH2Cl2 (20.0 mL) were added and the layers were separated. The aqueous 
phase was extracted with CH2Cl2 (3  30 mL) and the combined organic extracts were 
dried (Na2SO4), filtered and concentrated under reduced pressure. Purification by flash 
column chromatography (10% EtOAc/Hexanes) provided alcohol (1.13 g, 98%) as a 
colourless oil.  
Rf 0.22 (20% EtOAc/Hexanes); 
1
H NMR (300 MHz, CDCl3)  6.97 (1H, dt, J = 15.6, 7.0, 
H-3), 5.84 (1H, dt, J = 15.6, 1.6 Hz, H-2), 4.18 (2H, q, J = 7.1 Hz, OCH2CH3), 3.67 (2H, t, 
J = 6.4 Hz, H-6), 2.34-2.27 (2H, m, H-4), 1.77-1.68 (2H, m, H-5), 1.28 (3H, t, J = 7.1 Hz, 
OCH2CH3). 
 
(E)-Ethyl 6-oxohex-2-enoate (143)
95
 
 
 
 
To a solution of oxalyl chloride (820 L, 9.74 mmol) in CH2Cl2 (10.0 mL) at -78 ºC was 
slowly added DMSO (830 L, 11.7 mmol). After 30 min, a solution of alcohol (768 mg, 
4.87 mmol) in CH2Cl2 (10.0 mL) was added, dropwise. After 1 h, Et3N (3.36 mL, 24.1 
mmol) was added and the slurry was allowed to attain rt. After 1 h, a saturated NH4Cl 
(20.0 mL) solution was added and the layers were separated. The aqueous phase was 
extracted with CH2Cl2 (3  30 mL) and the combined organic extracts were washed with 
H2O (50 mL), brine (50 mL), dried (MgSO4), filtered and concentrated under reduced 
pressure. Purification by flash column chromatography (5% Et2O/Pet. Ether) provided 
aldehyde 143 (660 mg, 87%) as a colourless oil.  
Rf 0.31 (15% EtOAc/Hexanes); 
1
H NMR (300 MHz, CDCl3)  9.80 (1H, d, J = 1.0 Hz,  
H-6), 6.94 (1H, dt, J = 15.7, 6.6 Hz, H-3), 5.85 (1H, dt, J = 15.7, 1.5 Hz, H-2), 4.18 (2H, q, 
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J = 7.1 Hz, OCH2CH3), 2.67-2.62 (2H, m, H-4), 2.57-2.52 (2H, m, H-5), 1.28 (3H, t, J = 
7.1 Hz, OCH2CH3). 
 
(S)-4-((S)-1-((4-Methoxybenzyl)oxy)pent-4-en-1-yl)-2,2-dimethyl-1,3-dioxan-5-one 
(148) 
 
 
 
To a solution of alcohol 86 (0.84 g, 3.96 mmol) and PMBTCA (1.67 g, 5.94 mmol) in 
toluene (10.0 mL) at 0 ºC was added lanthanum(III)triflate (116 mg, 0.198 mmol). After 6 
h, cold hexane (40.0 mL) was added and the precipitate was filtered. The resulting mixture 
was concentrated under reduced pressure and purified by flash column chromatography 
(10% EtOAc/Hexanes) to afford 148 (1.02 g, 77%) as a colourless oil. 
Rf 0.51 (20% EtOAc/Pet. Ether); []D20  -9.3 (c 0.6, CHCl3); IR max (thin film/cm-1) 3074, 
3033, 2997, 2935, 2855, 2836, 1723, 1613, 1585, 1526, 1464, 1247, 1035, 821; 1H NMR 
(300 MHz, CDCl3)  7.27 (2H, d, J = 9.2 Hz, Ar-H), 6.87 (2H, d, J = 8.7 Hz, Ar-H), 5.77 
(1H, dddd, J = 17.1, 10.1, 7.1, 6.2 Hz, H-13), 5.03-4.93 (2H, m, H-14), 4.61 (1H, d, 
J = 11.2 Hz, CHaHbAr), 4.50 (1H, d, J = 11.2 Hz, CHaHbAr), 4.42 (1H, dd, J = 3.1, 1.5 Hz, 
H-9), 4.23 (1H, dd, J = 16.7, 1.5 Hz, H-7a), 3.96 (1H, d, J = 16.7 Hz, H-7b), 3.88 (1H, dt, 
J = 9.4, 3.2 Hz, H-10), 3.80 (3H, s, Ar-OCH3), 2.29-2.16 (1H, m, H-12a), 2.12-1.98 (1H, 
m, H-12b), 1.86 (1H, m, H-11a), 1.46 (3H, s, C-CH3), 1.45 (3H, s, C-CH3), 1.50-1.39 (1H, 
m, H-11b); 13C NMR (75 MHz; CDCl3)  208.8, 159.7, 138.7, 130.7, 130.1, 129.8, 115.3, 
114.2, 101.2, 76.3, 72.6, 67.5, 55.7, 30.4, 30.0, 24.7, 23.7; HRMS (ES+) calcd. for 
C19H28O5 [M+H]
+ 335.1853, found 335.1855. 
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(3S,4S)-1,3-Dihydroxy-4-((4-methoxybenzyl)oxy)oct-7-en-2-one (150) 
 
 
 
To a solution of acetonide 148 (280 mg, 0.854 mmol) in MeOH (8.5 mL) at rt was added               
p-toluenesulfonic acid monohydrate (16.0 mg, 0.085 mmol). After 3.5 h of stirring, Et3N 
(0.36 mL, 2.56 mmol) was added and the mixture was concentrated under reduced 
pressure. The resulting residue was purified by flash column chromatography (30% 
EtOAc/Hexanes) to give diol 150 (234 mg, 92%) as a colourless oil. 
Rf  0.11 (30% EtOAc/Hexanes); []D20  +3.7 (c 3.7, CHCl3); IR max (thin film/cm-1) 3446, 
2936, 2839, 1717, 1627, 1586, 1516, 1249, 1029, 823; 1H NMR (300 MHz, CDCl3)  7.24 
(2H, d, J = 8.8 Hz, Ar-H), 6.90 (2H, d, J = 8.7 Hz, Ar-H), 5.77 (1H, dddd, J = 17.14, 
10.16, 7.02, 6.23 Hz, H-13), 5.07-4.95 (2H, m, H-14), 4.54-4.31 (5H, m, CHaHbAr, H-7, 
H-9), 3.81 (3H, s, Ar-OCH3), 3.67 (1H, ddd, J  = 7.9, 4.9, 3.9 Hz, H-10), 3.04 (1H, dd, J = 
5.8, 4.8 Hz, C7-OH), 2.83 (1H, d, J = 4.8 Hz, C9-OH), 2.25-2.06 (2H, m, H-12), 1.88-1.75 
(1H, m, H-11a), 1.44-1.54 (1H, m, H-11b); 13C NMR (75 MHz, CDCl3)  211.8, 159.8, 
137.9, 129.8, 129.4, 115.5, 114.2, 79.8, 75.9, 71.9, 67.8, 55.5, 29.2, 29.0; HRMS (ES+) 
calcd. for C16H26NO5 [M+NH4]
+ 312.1805, found 312.1809. 
 
(2S,3S)-Methyl 2-hydroxy-3-((4-methoxybenzyl)oxy)hept-6-enoate (149) 
 
        
 
To a solution of diol 150 (190 mg, 0.645 mmol) in THF/H2O (2:1, 20.0 mL, 0.033 M), at rt 
was added H5IO6 (220 mg, 0.968 mmol). After 24 h, Et2O (20.0 mL) was added and the 
layers were separated and the aqueous phase was extracted with Et2O (3  30 mL). The 
combined organic extracts were washed with water (20 mL), brine (20 mL), dried 
(Na2SO4), filtered and concentrated under reduced pressure.  
To a suspension of the resulting residue and K2CO3 (110 mg, 0.774 mmol) in DMF (8.0 
mL) at rt was added MeI (50 L, 0.774 mmol). After 1 h, water (10.0 mL) was added, and 
the reaction mixture was extracted with Et2O (3  30 mL). The combined organic layers 
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were washed with water (20 mL), brine (20 mL), dried (Na2SO4), filtered and concentrated 
under reduced pressure. The residue was purified by flash column chromatography (10% 
EtOAc/Hexanes) to give methyl ester 149 (120 mg, 64%).  
Rf 0.8 (30% EtOAc/Hexanes); []D20  -2.5 (c 2.5 CHCl3); IR max (thin film/cm-1) 3480, 
2999, 2953, 2838, 1739, 1613, 1520, 1441, 1249, 1174, 1095, 1034, 821; 1H NMR (400 
MHz, CDCl3)  7.26 (2H, d, J = 8.8 Hz, Ar-H), 6.88 (2H, d, J = 8.8 Hz, Ar-H), 5.76 (1H, 
dddd, J = 17.0, 10.4, 6.8, 6.4 Hz, H-13), 5.03-4.94 (2H, m, H-14), 4.61 (1H, d, J = 11.3 
Hz, CHaHbAr), 4.51 (1H, d, J = 11.3 Hz, CHaHbAr), 4.39 (1H, dd, J = 5.5, 3.0 Hz, H-9), 
3.81 (3H, s, Ar-OCH3), 3.80 (3H, s, C8-OCH3), 3.71 (1H, ddd, J = 9.0, 4.0, 3.0 Hz, H-10), 
2.85 (1H, d, J = 5.6 Hz, C9-OH), 2.27-2.14 (1H, m, H-12a), 2.13-1.99 (1H, m, H-12b), 
1.89-1.74 (1H, m, H-11a), 1.52-1.40 (1H, m, H-11b); 13C NMR (100 MHz, CDCl3)  
 173.2, 159.4, 138.1, 130.3, 129.7, 115.2, 114.0, 79.9, 72.6, 72.3, 55.4, 52.7, 29.9, 29.6; 
HRMS (ES+) calcd. for C16H26NO5 [M+NH4]
+ 312.1805, found 312.1808. 
 
(2S,3S)-Methyl-2-((tert-butyldimethylsilyl)oxy)-3-((4-methoxybenzyl)oxy)hept-6-
enoate (153) 
 
 
 
To a solution of alcohol 149 (140 mg, 0.476 mmol) in CH2Cl2 (5.0 mL) at -78 ºC was 
added 2,6-lutidine (111 L, 0.952 mmol) and TBSOTf (164 L, 0.714 mmol). After 2 h, 
saturated NH4Cl (5.0 mL) solution and CH2Cl2 (5.0 mL) were added and the layers were 
separated. The aqueous phase was extracted with CH2Cl2 (3  10 mL) and the combined 
organic extracts were dried (Na2SO4), filtered and concentrated under reduced pressure. 
Purification by flash column chromatography (5-10% EtOAc/Hexanes) provided TBS 
ether 153 (190 mg, 98%) as a colourless oil. 
Rf 0.16 (20% EtOAc/Hexanes); []D20  -10.2 (c 0.5, CHCl3); IR max (thin film/cm-1) 2954, 
2930, 2858, 1756, 1730, 1514, 1275, 1153, 1122, 837, 779; 1H NMR (400 MHz, CDCl3)  
7.24 (2H, d, J = 8.8 Hz, Ar-H), 6.86 (2H, d, J = 8.8 Hz, Ar-H), 5.82-5.72 (1H, m, H-13), 
5.01-4.92 (2H, m, H-14), 4.57 (1H, d, J = 11.0 Hz, CHaHbAr), 4.44 (1H, d, J = 11.0 Hz, 
CHaHbAr), 4.30 (1H, d, J = 4.6 Hz, H-9), 3.80 (3H, s, Ar-OCH3), 3.72 (3H, s, C8-OCH3), 
3.68 (1H, ddd, J = 8.3, 4.6, 3.7 Hz, H-10), 2.24-2.14 (1H, m, H-12a), 2.12-2.02 (1H, m,  
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H-12b), 1.80-1.70 (1H, m, H-11a), 1.65-1.56 (1H, m, H-11b), 0.91 (9H, s, Si-C(CH3)3), 
0.07 (6H, s, Si-(CH3)2); 
13
C NMR (100 MHz, CDCl3)  172.9, 159.3, 138.5, 130.6, 129.7, 
114.9, 113.8, 80.5, 74.3, 72.2, 55.4, 51.9, 30.0, 29.6, 25.8, 18.4, -4.97, -5.08; HRMS (ES+) 
calcd. for C22H40NO5Si [M+NH4]
+ 426.2670, found 426.2667. 
 
(2S,3S)-Methyl-2-((tert-butyldimethylsilyl)oxy)-7-hydroxy-3-((4-methoxybenzyl)oxy)-
heptanoate (154) 
 
 
 
To a solution of thexylBH2 in THF (4.0 mL, 0.5 M, 2.0 mmol) at 0 
oC was added olefin 
153 (200 mg, 0.489 mmol) in THF (2.0 mL) dropwise. After 1h NaOH (2.0 mL, 10% w/v) 
and H2O2 (2 mL, 30% v/v) were added. The mixture was stirred for 30 min and the 
aqueous layer was saturated with anhydrous K2CO3. The organics were extracted with 
CH2Cl2 (3  10 mL), washed with brine (30 mL), dried (Na2SO4), filtered and concentrated 
under reduced pressure. The residue was purified by flash column chromatography (10% 
EtOAc/Hexane) to give alcohol 154 (200 mg, 96%) as a colourless oil.  
Rf 0.38 (20% EtOAc/Hexane); []D20  -11.8 (c 0.8, CHCl3); IR max (thin film/cm-1) 3446, 
2951, 2930, 2857, 1750, 1514, 1247, 1207, 1155, 1035, 837, 779; 1H NMR (400 MHz, 
CDCl3)  7.23 (2H, d, J = 8.7 Hz, Ar-H), 6.85 (2H, d, J = 8.7 Hz, Ar-H), 4.57 (1H, d, J = 
11.1 Hz, CHaHbAr), 4.43 (1H, d, J = 11.1 Hz, CHaHbAr), 4.30 (1H, d, J = 4.5 Hz, H-9), 
3.79 (3H, s, Ar-OCH3), 3.71 (3H, s, C8-OCH3), 3.67-3.63 (1H, m, H-10), 3.59 (2H, t, J = 
6.3 Hz, H-14), 1.72-1.60 (2H, m, H-11a, H-13a), 1.57-1.46 (2H, m, H-11b, H-13b), 1.39-
1.29 (2H, m, H-12), 0.90 (9H, s, Si-C(CH3)3), 0.06 (6H, s, 2  Si-CH3); 13C NMR (100 
MHz, CDCl3)  173.0, 159.3, 130.5, 129.7, 113.8, 80.9, 74.3, 72.3, 63.0, 55.4, 52.0, 32.8, 
30.4, 25.8, 21.6, 18.4, -4.95, -5.08; HRMS (ES+) calcd. for C22H42NO6Si [M+NH4]
+ 
444.2776, found 444.2779. 
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(2S,3S)-Methyl-2,7-bis((tert-butyldimethylsilyl)oxy)-3-((4-methoxybenzyl)oxy)-
heptanoate (155) 
 
 
 
To a solution of TBSCl (85.0 mg, 0.564 mmol) and imidazole (40.0 mg, 0.587 mmol) in 
DMF (1.0 mL) at 0 ºC was added a solution of alcohol 154 (200 mg, 0.468 mmol) in DMF 
(2.0 mL). After 12 h, a saturated NH4Cl (5.0 mL) solution was added and the layers were 
separated. The aqueous phase was extracted with CH2Cl2 (3  5 mL). The combined 
organic extracts were washed with H2O (10 mL), brine (10 mL), dried (Na2SO4), filtered 
and concentrated under reduced pressure. Purification by flash column chromatography 
(2% EtOAc/Hexanes) provided bis-TBS-ether 155 (230 mg, 92%) as a colourless oil. 
Rf 0.72 (20% EtOAc/Hexane); []D20  -11.8 (c 0.8, CHCl3); IR max (thin film/cm-1) 2951, 
2929, 2896, 2857, 1756, 1514, 1249, 1203, 1150, 1103, 820, 776; 1H NMR (400 MHz, 
CDCl3)  7.23 (2H, d, J = 8.7 Hz, Ar-H), 6.85 (2H, d, J = 8.7 Hz, Ar-H), 4.55 (1H, d, J = 
11.0 Hz, CHaHbAr), 4.44 (1H, d, J = 11.0 Hz, CHaHbAr), 4.28 (1H, d, J = 4.8 Hz, H-9), 
3.79 (3H, s, Ar-OCH3), 3.71 (3H, s, C8-OCH3), 3.65 (1H, ddd, J = 8.0, 4.6, 3.5 Hz, H-10), 
3.57 (2H, t, J = 6.3 Hz, H-14), 1.68-1.57 (1H, m, H-11a), 1.52-1.44 (3H, m, H-11b, H-12), 
1.37-1.25 (2H, m, H-13), 0.90 (9H, s, Si-C(CH3)3), 0.89 (9H, s, Si-C(CH3)3), 0.06 (6H, s, 2 
 Si-CH3), 0.04 (6H, s, 2  Si-CH3); 13C NMR (100 MHz, CDCl3)  173.0, 159.3, 130.7, 
129.7, 113.8, 81.2, 74.4, 72.3, 63.2, 55.4, 51.9, 33.1, 30.6, 26.1, 25.8, 21.8, 18.5, 18.4, -4.9, 
-5.08, -5.12; HRMS (ES+) calcd. for C28H56NO6Si2 [M+NH4]
+ 558.3641, found 558.3635. 
 
(2S,3S)-2,7-Bis((tert-butyldimethylsilyl)oxy)-N-methoxy-3-((4-methoxybenzyl)oxy)-N-
methylheptanamide (156) 
 
 
 
To a solution of methylester 155 (0.851 g, 1.57 mmol) and N,O-dimethyl hydroxylamine 
hydrochloride (0.228 g, 2.35 mmol) in THF (50.0 mL) at -30 ºC was slowly added  
i-PrMgCl (3.54 mL, 2M soln. in THF, 7.08 mmol). The reaction mixture was allowed to 
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attain 0 ºC. After 6 h a saturated NH4Cl (50.0 mL) solution was added and the layers were 
separated. The aqueous phase was extracted with Et2O (3  30 mL) and the combined 
organic extracts were dried (Na2SO4), filtered and concentrated under reduced pressure. 
Purification by flash column chromatography (10% EtOAc/Hexanes) provided Weinreb 
amide 156 (870 mg, 97%) as a colourless oil.  
Rf 0.57 (20% EtOAc/Hexane); []D20  -6.6 (c 0.6, CHCl3); IR max (thin film/cm-1) 2950, 
2928, 2856, 1670, 1514, 1250, 1203, 1148, 1103, 823, 775; 1H NMR (300 MHz, CDCl3)  
7.19 (2H, d, J = 8.8 Hz, Ar-H), 6.82 (2H, d, J = 8.8 Hz, Ar-H), 4.63-4.51 (1H, m, H-9), 
4.43 (1H, d, J = 10.7 Hz, CHaHbAr), 4.41 (1H, d, J = 10.7 Hz, CHaHbAr), 3.78 (3H, s, Ar-
OCH3), 3.70 (1H, td, J = 7.4, 3.2 Hz, H-10), 3.62-3.59 (5H, m, N-OCH3, H-14), 3.21 (3H, 
s, N-CH3), 1.79-1.65 (1H, m, H-11a), 1.62-1.45 (4H, m, H-11b, H-12, H-13a), 1.44-1.37 
(1H, m, H-13b), 0.89 (9H, s, Si-C(CH3)3), 0.88 (9H, s, Si-C(CH3)3), 0.06 (3H, s, Si-CH3), 
0.05 (3H, s, Si-CH3), 0.04 (6H, s, 2  Si-CH3); 13C NMR (75 MHz, CDCl3)  159.2, 130.9, 
129.7, 113.7, 80.8, 73.0, 63.4, 55.4, 33.3, 31.1, 26.1, 25.9, 21.4, 18.5, 18.3, -4.7, -4.97,  
-5.11; HRMS (ES+) calcd. for C29H56O6NSi2 [M+H]
+ 570.3641, found 570.3638. 
 
(3S,4S)-3,8-Bis((tert-butyldimethylsilyl)oxy)-4-((4-methoxybenzyl)oxy)octan-2-one 
(144) 
 
 
 
To a solution of Weinreb amide 156 (848 mg, 1.56 mmol) in THF (20.0 mL) at 0 ºC was 
added MeMgBr (2.1 mL, 3.0 M soln. in THF, 6.25 mmol). The reaction mixture was 
stirred at 0 ºC for 1 h and quenched with saturated NH4Cl (20.0 mL) solution. The reaction 
mixture was allowed to warm to rt and H2O (5.0 mL) was added to dissolve the precipitate, 
and the layers were separated. The aqueous phase was extracted with Et2O (3  20 mL) 
and the combined organic extracts were dried (Na2SO4), filtered and concentrated under 
reduced pressure. Purification of the residue by flash column chromatography (5% 
EtOAc/Hexanes) afforded product 144 (785 mg, 96%) as a colourless oil.  
Rf 0.75 (20% EtOAc/Hexanes); []D20  -9.7 (c 0.8, CHCl3); IR max (thin film/cm-1) 2954, 
2856, 1714, 1514, 1249, 1209, 1149, 1102, 837, 776; 1H NMR (400 MHz, CDCl3)  7.25 
(2H, d, J = 8.6 Hz, Ar-H), 6.86 (2H, d, J = 8.5 Hz, Ar-H), 4.61 (1H, d, J = 11.2 Hz, 
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CHaHbAr), 4.45 (1H, d, J = 11.1 Hz, CHaHbAr), 4.10 (1H, d, J = 3.5 Hz, H-9), 3.80 (3H, s, 
Ar-OCH3), 3.57 (3H, dd, J = 7.9, 4.5 Hz, H-10, H-14), 2.19 (3H, s, H-7), 1.64-1.56 (1H, m, 
H-11a), 1.50-1.42 (3H, m, H-11b, H-13), 1.35-1.22 (2H, m, H-12), 0.93 (9H, s, Si-
C(CH3)3), 0.88 (9H, s, Si-C(CH3)3), 0.08 (3H, s, Si-CH3), 0.05 (3H, s, Si-CH3), 0.03 (6H, s, 
2  Si-CH3). 13C NMR (100 MHz, CDCl3)  211.8, 159.3, 130.5, 129.6, 113.8, 81.8, 80.7, 
72.4, 63.2, 55.4, 33.0, 30.4, 27.4, 26.1, 25.9, 22.0, 18.5, 18.3, -4.6, -5.0, -5.1; HRMS (ES+) 
calcd. for C28H56NO5Si2 [M+NH4]
+ 542.3692, found 542.3687. 
 
(9S,10S,E)-Ethyl-9,14-bis((tert-butyldimethylsilyl)oxy)-6-hydroxy-10-((4-methoxy-
benzyl)oxy)-8-oxotetradec-2-enoate (157) 
 
 
 
To a stirred solution of ketone 144 (320 mg, 0.610 mmol) in Et2O (15.0 mL) at -78 ºC was 
added dicyclohexylboron chloride (240 L, 1.09 mmol) and Et3N (170 L, 1.21 mmol) 
and the reaction mixture was stirred for 0.5 h. Aldehyde 143 (143 mg, 0.91 mmol) in Et2O 
(5.0 mL) was then added. After 2 h the reaction mixture was diluted with MeOH (3.0 mL), 
phosphate buffer pH 7 (3.0 mL) and H2O2 (3 mL, 30% v/v). The biphasic mixture was 
allowed to warm to RT and stirred vigorously for 10 min. The layers were separated and 
the aqueous phase was extracted with Et2O (3  10 mL). The combined organic extracts 
were washed with brine (20 mL), dried (NaSO4), filtered and concentrated under reduced 
pressure. Flash column chromatography (10% EtOAc/Hexanes) gave aldol adduct 157 
(373 mg, 90%) as an inconsequential 1.6 : 1 mixture of diastereoisomers. 
Rf 0.48 (20% EtOAc/Hexanes); IR max (thin film/cm-1) 3513, 2954, 2856, 1720, 1653, 
1514, 1250, 1172, 1100, 1040, 837, 778; 1H NMR (400 MHz, CDCl3)  7.22 (2H, d, J = 
8.7 Hz, Ar-H), 6.98-6.87 (2H, m, H-3), 6.84 (2H, d, J = 8.7 Hz, Ar-H), 5.77-5.87 (2H, m, 
H-2), 4.57 (1H, d, J  = 11.1 Hz, CHaHbAr), 4.46 (1H, d, J  = 11.1 Hz, CHaHbAr), 4.17 (2H, 
q, J = 7.1 Hz, OCH2CH3), 4.08 (2H, d, J = 3.9 Hz, H-9), 4.02-3.91 (1H, m, H-6), 3.79 (3H, 
s, Ar-OCH3), 3.59-3.54 (3H, m, H-10, H-14), 3.06 (1H, d, J = 3.3 Hz, C6-OH), 2.81-2.67 
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(2H, m, H-7), 2.64-2.48 (2H, m, H-4), 2.32-2.19 (4H, m, H-5, H-11), 1.61-1.38 (4H, m, H-
12, H-13), 1.27 (3H, t, J = 7.1 Hz, OCH2CH3), 0.92 (9H, s, Si-C(CH3)3), 0.88 (9H, s, Si-
C(CH3)3), 0.07 (6H, s, 2  Si-CH3), 0.02 (6H, s, 2  Si-CH3); 13C NMR (75 MHz, CDCl3) 
 214.3, 166.7, 159.4, 148.7, 130.2, 129.7, 121.8, 113.9, 81.9, 80.5, 72.5, 66.9, 63.1, 60.3, 
55.4, 45.9, 34.9, 32.9, 30.3, 28.3, 26.1, 25.9, 21.9, 18.5, 18.2, 14.4, -4.6, -4.9, -5.1; HRMS 
(ES+) calcd. for C36H68NO8Si2 [M+NH4]
+ 698.4478, found 698.4477. 
 
(2E,6E,9S,10S)-Ethyl-9,14-bis((tert-butyldimethylsilyl)oxy)-10-((4-methoxybenzyl)-
oxy)-8-oxotetradeca-2,6-dienoate (142) 
 
 
 
Method A 
To a stirred solution of aldol product 157 (350 mg, 0.514 mmol) in CH2Cl2 (5.0 mL) at -10 
ºC was added a solution of Martin’s sulfurane (518 mg, 0.771 mmol) in CH2Cl2 (5.0 mL). 
The resulting pale yellow mixture was stirred for 1 h and the residual solvent was removed 
under reduced pressure to yield the crude product as a pale yellow oil. Purification by flash 
column chromatography (5-10% EtOAc/Hexanes) furnished the compound 142 as a 
colourless oil (320 mg, 95%). 
 
Method B 
To a solution of aldol product 157 (80 mg, 0.117 mmol) in CH2Cl2 (2.0 mL) at 0 ºC was 
added Et3N (40 L, 0.292 mmol) and mesyl chloride (20 L, 0.258 mmol) and the reaction 
mixture was allowed to attained rt, DBU (90 L, 0.585 mmol) was then added and the 
reaction was stirred for 16 h before quenching with saturated NH4Cl (5.0 mL) solution. 
The layers were separated and the aqueous phase was extracted with CH2Cl2 (3  10 mL) 
and the combined organic extracts were washed with brine (20 mL), dried (Na2SO4), 
filtered and concentrated under reduced pressure. The resulting residue was purified by 
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flash column chromatography (5-10% EtOAc/Hexanes) to give product 142 (46.0 mg, 
62%) as a colourless oil. 
 Rf 0.65 (20% EtOAc/Hexane); []D20  -10.0 (c 3.0, CHCl3); IR max (thin film/cm-1) 2954, 
2929, 2856, 1724, 1514, 1250, 1172, 1098, 1040, 837, 775; 1H NMR (400 MHz, CDCl3)  
7.23 (2H, d, J = 8.5 Hz, Ar-H), 6.93 (2H, dt, J = 15.7, 6.4 Hz, H-3, H-6), 6.85 (2H, d, J = 
8.6 Hz, Ar-H), 6.66 (1H, d, J = 15.8 Hz, H-7), 5.84 (1H, d, J = 15.7 Hz, H-2), 4.57 (1H, d, 
J = 11.1 Hz, CHaHbAr), 4.44 (1H, d, J = 11.2 Hz, CHaHbAr), 4.23 (1H, d, J = 4.0 Hz, H-9), 
4.18 (2H, q, J = 7.1 Hz, OCH2CH3), 3.80 (3H, s, Ar-OCH3), 3.56 (3H, m, H-10, H-14), 
2.41-2.30 (4H, m, H-4, H-5), 1.65-1.54 (1H, m, H-11a), 1.52-1.41 (4H, m, H-11b, H-12, 
H-13a), 1.28 (4H, t, J = 7.1 Hz, OCH2CH3, H-13b), 0.92 (9H, s, Si-C(CH3)3), 0.89 (9H, s, 
Si-C(CH3)3), 0.07 (3H, s, Si-CH3), 0.03 (6H, s, 2  Si-CH3), 0.02 (3H, s, Si-CH3);  
13
C NMR (100 MHz, CDCl3)  200.7, 166.4, 159.2, 147.1, 145.8, 130.5, 129.7, 126.5, 
122.4, 113.8, 81.6, 79.9, 72.3, 63.2, 60.4, 55.4, 33.0, 31.0, 30.5, 26.1, 25.9, 22.0, 18.5, 
18.3, 14.4, -4.7, -4.9, -5.1; HRMS (ES+) calcd. for C36H66NO7Si2 [M+NH4]
+ 680.4372, 
found 680.4370. 
 
(2E,6E,8S,9R,10S)-9,14-bis((tert-butyldimethylsilyl)oxy)-8-hydroxy-10-((4-
methoxybenzyl)oxy)tetradeca-2,6-dienoate (163) 
 
 
 
To a solution of enone 142 (480 mg, 0.724 mmol) in MeOH (20.0 mL) was added 
CeCl3•7H2O (405 mg, 1.08 mmol) before reaction mixture was cooled to -78 ºC and 
NaBH4 (33 mg, 0.868 mmol) was added. The reaction was stirred for 1h before quenching 
with saturated NaHCO3 (20.0 mL) solution and the layers were separated. The aqueous 
phase was extracted with Et2O (3  10 mL) and the combined organic extracts were 
washed with brine (20 mL), dried (Na2SO4), filtered and concentrated under reduced 
pressure. The crude product was purified by flash column chromatography (10% 
EtOAc/Hexanes) to give allylic alcohol 163 (445 mg, 90%) as a colourless oil. 
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Rf 0.56 (20% EtOAc/Hexane); []D20  -4.1 (c 1.1, CHCl3); IR max (thin film/cm-1) 3251, 
2926, 2847, 1810, 1719, 1513, 1302, 1250, 1205, 1148, 833, 777; 1H NMR (500 MHz, 
CDCl3)  7.24 (2H, d, J = 8.6 Hz, Ar-H), 6.97 (1H, dt, J = 15.6, 6.6 Hz, H-3), 6.86 (2H, d, 
J = 8.7 Hz, Ar-H), 5.84 (1H, dt, J = 15.6, 1.4 Hz, H-2), 5.68-5.74 (1H, m, H-6), 5.54 (1H, 
dd, J = 15.5, 5.7 Hz, H-7), 4.49 (1H, d, J = 10.7 Hz, CHaHbAr), 4.44 (1H, d, J = 10.8 Hz, 
CHaHbAr), 4.17 (2H, q, J = 7.1 Hz, OCH2CH3), 4.10-4.14 (1H, m, H-8), 3.79 (3H, s, Ar-
OCH3), 3.66 (1H, dd, J = 4.9, 4.2 Hz, H-9), 3.60 (2H, t, J = 6.2 Hz, H-14), 3.48 (1H, m,  
H-10), 3.25 (1H, d, J = 6.2 Hz, C8-OH), 2.31-2.27 (2H, m, H-4), 2.24-2.21 (2H, m, H-5), 
1.64-1.54 (2H, m, H-11), 1.54-1.45 (3H, m, H-13, H-12a), 1.41-1.32 (1H, m, H-12b), 1.28 
(3H, t, J = 7.1 Hz, OCH2CH3 ), 0.90 (9H, s, Si-C(CH3)3), 0.89 (9H, s, Si-C(CH3)3), 0.09 
(3H, s, Si-CH3), 0.07 (3H, s, Si-CH3), 0.05 (6H, s, 2  Si-CH3); 13C NMR (125 MHz, 
CDCl3)  166.7, 159.4, 148.4, 131.1, 130.8, 130.3, 129.7, 121.9, 113.9, 81.1, 75.4, 73.3, 
72.2, 63.3, 60.3, 55.4, 33.2, 31.9, 31.0, 30.2, 26.13, 26.1, 21.6, 18.5, 18.3, 14.4, -4.0, -4.3,  
-5.1; HRMS (ES+) calcd. for C36H66NO7Si2 [M+NH4]
+ 680.4372, found 680.4370. 
 
(R)-Mosher ester of 163 (164) 
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To a stirred mixture of alcohol 163 (10.0 mg, 15 mol), DCC (13.0 mg, 61 mol) and 
DMAP (3.7 mg, 31 mol) in CH2Cl2 (1.0 mL) at rt was added (+)-(R)--methoxy--
(trifluoromethyl)-phenylacetic acid (7.0 mg, 30 mol) in one portion. After 16 h, the crude 
reaction mixture was purified directly by flash column chromatography (5% 
EtOAc/Hexanes) to give (R)-MTPA ester 164 (12.0 mg, 92%) as a colourless oil.  
Rf 0.66 (20% EtOAc/Hexanes); 1H NMR (400 MHz, CDCl3)  7.56-7.54 (2H, m, Ph-H), 
7.36 (3H, m, Ph-H), 7.21 (2H, d, J = 8.6 Hz, Ar-H), 6.92 (1H, dt, J = 15.7, 6.3 Hz, H-3), 
6.85 (2H, d, J = 8.6 Hz, Ar-H), 5.81 (1H, dd, J = 15.8, 1.3 Hz, H-2), 5.82-5.74 (1H, m, H-
6), 5.55 (1H, d, J = 1.5 Hz, H-8), 5.58-5.50 (1H, m, H-7), 4.27 (1H, d, J = 10.7 Hz, 
CHaHbAr), 4.22 (1H, d, J = 10.7 Hz, CHaHbAr), 4.17 (2H, q, J = 7.1 Hz, OCH2CH3), 3.80 
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(3H, s, Ar-OCH3), 3.76 (1H, td, J = 3.3, 1.7 Hz, H-9), 3.57-3.54 (2H, m, H-14), 3.54 (3H, 
s, OCH3), 3.25 (1H, q, J = 5.3 Hz, H-10), 2.26-2.18 (4H, m, H-4, H-5), 1.52-1.45 (2 H, m, 
H-11), 1.46-1.39 (2H, m, H-13), 1.27 (3H, t, J = 7.1 Hz, OCH2CH3), 1.20-1.26 (2H, m, H-
12), 0.89 (9H, s, Si-C(CH3)3), 0.85 (9H, s, Si-C(CH3)3), 0.04 (3H, s, Si-CH3), 0.04 (6H, s, 
2  Si-CH3), 0.00 (3H, s, Si-CH3). 
 
(S)-Mosher ester of 163 (165) 
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To a stirred mixture of alcohol 163 (5.0 mg, 7.7 mol), DCC (6.3 mg, 31 mol) and 
DMAP (1.8 mg, 15 mol) in CH2Cl2 (1.0 mL) at rt was added (+)-(S)--methoxy--
(trifluoromethyl)-phenylacetic acid (3.5 mg, 15 mol) in one portion. After 16 h, the crude 
reaction mixture was purified directly by flash column chromatography (5% 
EtOAc/Hexanes) to give (S)-MTPA ester 165 (5.0 mg, 75%).  
Rf 0.66 (20% EtOAc/Hexanes); 1H NMR (500 MHz, CDCl3)  7.54 (2H, d, J = 8.3 Hz, Ph-
H), 7.40-7.34 (3H, m, Ph-H), 7.22 (2H, d, J = 8.7 Hz, Ar-H), 6.91 (1H, dt, J = 15.7, 6.5 
Hz, H-3), 6.84 (2H, d, J = 8.7 Hz, Ar-H), 5.81 (1H, d, J = 15.7 Hz, H-2), 5.67 (1H, dt, J = 
15.4, 6.3 Hz, H-6), 5.60 (1H, dd, J = 7.5, 2.9 Hz, H-8), 5.44 (1H, dd, J = 16.0, 7.4 Hz, H-
7), 4.31 (1H, d, J = 10.7 Hz, CHaHbAr), 4.29 (1H, d, J = 10.7 Hz, CHaHbAr), 4.17 (2H, q, 
J = 7.1 Hz, OCH2CH3), 3.79 (3H, s, Ar-OCH3), 3.79-3.76 (1H, m, H-9), 3.57 (3H, t, J = 
6.2 Hz, H-14), 3.50 (3H, s, OCH3), 3.31 (1H, td, J = 5.9, 3.5 Hz, H-10), 2.24-2.19 (2H, m, 
H-4), 2.19-2.13 (2H, m, H-5), 1.51-1.42 (2H, m, H-11), 1.27 (3H, t, J = 7.2 Hz, 
OCH2CH3), 1.21-1.27 (4H, m, H-12, H-13), 0.89 (9H, s, Si-C(CH3)3), 0.85 (9H, s, Si-
C(CH3)3), 0.05 (3H, s, Si-(CH3)2), 0.04 (6H, s, 2  Si-CH3), 0.02 (3H, s, Si-(CH3)2). 
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(2E,6E,8S,9S,10S)-Ethyl-8,9,14-tris((tert-butyldimethylsilyl)oxy)-10-((4-methoxy-
benzyl)oxy)tetradeca-2,6-dienoate (166) 
 
 
 
To a solution of alcohol 163 (450 mg, 0.677 mmol) in CH2Cl2 (10.0 mL) at -78 ºC was 
added 2,6-lutidine (160 L, 1.35 mmol) and TBSOTf (233 L, 1.01 mmol). After 4 h, 
saturated NH4Cl (20.0 mL) solution and CH2Cl2 (20.0 mL) were added. The aqueous layer 
was extracted with CH2Cl2 (3  20 mL) and the combined organic extracts were dried 
(Na2SO4), filtered and concentrated under reduced pressure. Purification by flash column 
chromatography (5% EtOAc/Hexanes) provided TBS ether 166 (460 g, 87%) as a 
colourless oil. 
Rf 0.9 (20% EtOAc/Hexanes); []D20  -16.3 (c 1.4, CHCl3); IR max (thin film/cm-1) 2952, 
2933, 2893, 2858, 1723, 1512, 1466, 1252, 1101, 1043, 836, 777; 1H NMR (300 MHz, 
CDCl3)  7.25 (2H, d, J = 8.7 Hz, Ar-H), 6.95 (1 H, dt, J = 15.7, 6.5 Hz, H-3), 6.85 (2H, d, 
J = 8.8 Hz, Ar-H), 5.82 (1H, dt, J = 15.7, 1.4 Hz, H-2), 5.58-5.56 (2H, m, H-6, H-7), 4.52 
(1H, d, J = 11.1 Hz, CHaHbAr), 4.25 (1H, d, J = 11.1 Hz, CHaHbAr), 4.18 (2H, q, J = 7.1 
Hz, OCH2CH3), 4.11-4.08 (1H, m, H-8), 3.87 (1H, dd, J = 4.9, 1.5 Hz, H-9), 3.80 (3H, s, 
Ar-OCH3), 3.55 (2H, t, J = 6.5 Hz, H-14), 3.45-3.42 (1H, m, H-10), 2.28-2.19 (4H, m, H-4, 
H-5), 1.47-1.42 (4H, m, H-11, H-13), 1.28 (3H, t, J = 7.1 Hz, OCH2CH3), 1.26-1.16 (2H, 
m, H-12), 0.91 (9H, s, Si-C(CH3)3), 0.90 (9H, s, Si-C(CH3)3), 0.88 (9H, s, Si-C(CH3)3), 
0.07 (3H, s, Si-CH3), 0.07 (3H, s, Si-CH3), 0.06 (3H, s, Si-CH3), 0.04 (3H, s, Si-CH3), 0.03 
(6H, s, 2  Si-CH3); 13C NMR (75 MHz; CDCl3)  166.7, 159.0, 148.4, 131.4, 130.9, 
129.4, 128.9, 121.9, 113.7, 79.7, 74.7, 71.3, 63.6, 60.3, 55.4, 33.3, 32.1, 31.0, 30.9, 26.14, 
26.11, 26.06, 22.7, 18.5, 18.4, 18.3, 14.4, -4.2, -4.3, -4.5, -4.6, -5.09, -5.11; HRMS (ES+) 
calcd. for C42H82NO7Si3 [M+NH4]
+ 796.5394, found 796.5394. 
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(2E,6E,8S,9S,10S)-Ethyl 8,9,14-tris((tert-butyldimethylsilyl)oxy)-10-
hydroxytetradeca-2,6-dienoate (167) 
 
 
 
To a solution of PMB ether 166 (150 mg, 0.192 mmol) in CH2Cl2 (2.0 mL) and phosphate 
buffer pH 7 (0.1 mL) at 0 oC was added DDQ (65.0 mg, 0.288 mmol). The reaction 
mixture was stirred for 1 h before quenching with saturated NaHCO3 (5.0 mL) solution and 
the layers were separated. The aqueous phase was extracted with CH2Cl2 (3  10 mL), 
washed with brine (20 mL), dried (Na2SO4), filtered and concentrated under reduced 
pressure. Purification by flash column chromatography (5% EtOAc/Hexanes) provided 
alcohol 167 (110 mg, 88 % yield) as a colourless oil. 
Rf 0.76 (15% EtOAc/Hexanes); []D20  -24.4 (c 1.0, CHCl3); IR max (thin film/cm-1) 3418, 
2921, 2847, 1719, 1277, 1126, 835, 766; 1H NMR (300 MHz, CDCl3)  7.00-6.90 (1H, m, 
H-3), 5.86-5.80 (1H, m, H-2), 5.69-5.67 (2H, m, H-6, H-7), 4.31-4.27 (1H, m, H-8), 4.17 
(2H, q, J = 7.1 Hz, OCH2CH3), 3.91 (1H, s, C10-OH), 3.63-3.57 (3H, m, H-10, H-14), 3.40 
(1H, dd, J = 8.5, 4.2 Hz, H-9), 2.31-2.26 (4H, m, H-4, H-5), 1.57-1.51 (4H, m, H-12, H-
13), 1.35-1.27 (2H, m, H-11), 1.27 (3H, t, J = 7.1 Hz, OCH2CH3), 0.90 (9H, s, Si-
C(CH3)3), 0.88 (9H, s, Si-C(CH3)3), 0.87 (9H, s, Si-C(CH3)3), 0.09 (3H, s, Si-CH3), 0.08 
(6H, s, 2  Si-CH3), 0.05 (3H, s, Si-CH3), 0.03 (6H, s, 2  Si-CH3); 13C NMR (75 MHz, 
CDCl3)  166.7, 148.3, 130.8, 128.6, 122.0, 76.7, 75.5, 72.6, 63.6, 60.3, 33.8, 33.3, 32.1, 
30.9, 26.2, 25.95, 25.91, 21.5, 18.6, 18.2, 18.1, 14.4, -4.0, -4.5, -4.6, -4.9, -5.1; HRMS 
(ES+) calcd. for C34H74O6NSi3 [M+NH4]
+ 676.4818, found 676.4802. 
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(2E,6E,8S,9S,10S)-Ethyl 8,9,14-tris((tert-butyldimethylsilyl)oxy)-10-(carbamoyloxy)-
tetradeca-2,6-dienoate (168) 
 
 
 
To a stirred solution of alcohol 167 (45.0 mg, 0.683 mol) in CH2Cl2 (4.0 mL) was added 
trichloroacetyl isocyanate (16.3 L, 0.136 mmol) at 0 ºC and the reaction was stirred at rt 
for 1 h. CH2Cl2 (2.0 mL) and an excess amount of Al2O3 was added and the resulting 
suspension was stirred overnight. The suspension was filtered, concentrated under reduced 
pressure and purified by flash column chromatography (10-20% EtOAc/Hexanes) to give 
carbamate 168 (34.0 mg, 72%) as a colourless oil. 
Rf 0.29 (10% EtOAc/Hexanes); []D20  -18.5 (c 0.8, CHCl3); IR max (thin film/cm-1) 3276, 
3138, 2926, 2852, 1723, 1283, 1150, 977, 835, 775; 1H NMR (400 MHz, CDCl3)  6.95 
(1H, dt, J = 15.6, 6.5 Hz, H-3), 5.83 (1H, dt, J = 15.6, 1.5 Hz, H-2), 5.61-5.59 (2H, m, H-6, 
H-7), 4.92-4.88 (1H, m, H-10), 4.46 (2H, br s, NH2), 4.18 (2H, q, J = 7.1 Hz, OCH2CH3), 
4.11-4.08 (1H, m, H-8), 3.77 (1H, dd, J = 5.1, 2.4 Hz, H-9), 3.57 (2H, td, J = 6.6, 1.4 Hz, 
H-14), 2.31-2.25 (2H, m, H-4), 2.23-2.19 (2H, m, H-5), 1.60-1.55 (2H, m, H-11), 1.51-
1.44 (2H, m, H-13), 1.28 (3H, t, J = 7.1 Hz, OCH2CH3), 1.28-1.22 (2H, m, H-12), 0.91 
(9H, s, Si-C(CH3)3), 0.90 (9H, s, Si-C(CH3)3), 0.88 (9H, s, Si-C(CH3)3), 0.07 (3H, s, Si-
CH3), 0.05 (3H, s, Si-CH3), 0.05 (3H, s, Si-CH3), 0.03 (6H, s, Si-(CH3)2), 0.01 (3H, s, Si-
CH3); 
13
C NMR (100 MHz, CDCl3)  166.7, 156.5, 148.4, 131.0, 129.4, 121.9, 77.4, 76.1, 
74.9, 63.3, 60.3, 33.1, 32.0, 30.9, 29.5, 26.13, 26.06, 26.04, 22.1, 18.36, 18.34, 14.4, -4.3, -
4.35, -4.4, -4.5, -5.1; HRMS (ES+) calcd. for C35H72NO7Si3 [M+H]
+ 702.4611, found 
702.4614 
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(2E,6E,8S,9S,10S)-Ethyl 8,9-bis((tert-butyldimethylsilyl)oxy)-10-(carbamoyloxy)-14-
hydroxytetradeca-2,6-dienoate (170) 
 
 
 
To a solution of tris-tert-butyldimethylsilyl ether 168 (130 mg, 0.185 mmol) in 
MeOH/CH2Cl2 (1:6, 5.0 mL) at 0 ºC was added (±)-CSA (4.3 mg, 18.5 mol). After 1.5 h, 
saturated NaHCO3 (5.0 mL) solution and CH2Cl2 (5.0 mL) were added and the layers were 
separated. The aqueous phase was extracted with CH2Cl2 (3  5 mL) and the combined 
organic extracts were dried (Na2SO4), filtered and concentrated under reduced pressure. 
Purification by flash column chromatography (10-20% EtOAC/Hexanes) provided alcohol 
170 (100 mg, 93%) as a colourless oil.  
Rf 0.26 (30% EtOAc/Hexanes); []D20  -15.0 (c 0.2, CHCl3); IR max (thin film/cm-1) 3466, 
3364, 2979, 2929, 2854, 1714, 1366, 1312, 1278, 1188, 1128, 835, 775; 1H NMR (400 
MHz, CDCl3)  6.95 (1H, dt, J = 15.7, 6.6 Hz, H-3), 5.83 (1H, dt, J = 15.7, 1.4 Hz, H-2), 
5.60 (2H, m, J = 2.2 Hz, H-6, 7), 4.92-4.88 (1H, m, H-10), 4.53-4.42 (2H, br s, NH2), 4.18 
(2H, q, J = 7.1 Hz, OCH2CH3), 4.11-4.08 (1H, m, H-8), 3.78 (1H, dd, J = 5.2, 2.4 Hz, H-
9), 3.61 (2H, t, J = 6.6 Hz, H-14), 2.31-2.27 (2H, m, H-4), 2.24-2.21 (2H, m, H-5), 1.61-
1.52 (4H, m, H-11, H-13), 1.45-1.37 (2H, m, H-12), 1.28 (3H, t, J = 7.1 Hz, OCH2CH3), 
0.91 (9H, s, Si-C(CH3)3), 0.90 (9H, s, Si-C(CH3)3), 0.07 (3H, s, Si-CH3), 0.05 (6H, s, 2  
Si-CH3), 0.01 (3H, s, Si-CH3); 
13
C NMR (100 MHz, CDCl3)  166.8, 156.5, 148.5, 130.9, 
129.4, 121.9, 77.4, 75.8, 74.8, 63.0, 60.3, 32.8, 32.0, 30.8, 29.5, 26.05, 26.03, 21.9, 18.36, 
18.33, 14.4, -4.33, -4.35, -4.4, -4.5; HRMS (ES+) calcd. for C29H58NO7Si2 [M+H]
+ 
588.3746, found 588.3743. 
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(2E,6E,8S,9S,10S)-Ethyl 8,9-bis((tert-butyldimethylsilyl)oxy)-10-(carbamoyloxy)-14-
oxotetradeca-2,6-dienoate (169) 
 
 
 
To a solution of alcohol 170 (40.0 mg, 68 mol) in CH2Cl2 (5.0 mL) at 0 ºC was added 
NaHCO3 (28.0 mg, 0.34 mmol) followed by Dess-Martin periodinane (86.0 mg, 0.20 
mmol). The reaction mixture was stirred at 0 ºC for 1.5 h, and quenched by addition of 
cold hexane (5.0 mL) and cold toluene (5.0 mL). CH2Cl2 was then removed under reduced 
pressure and the resultant white suspension was filtered through Celite and washed with 
excess hexanes. The filtrate was concentrated under reduced pressure and purification by 
flash column chromatography (10-20% EtOAc/Hexanes) provided aldehyde 169 (31.0 mg, 
80%) as a colourless oil. 
Rf 0.38 (30% EtOAc/Hexanes); []D20  -22.2 (c 3.0, CHCl3); IR max (thin film/cm-1) 3361, 
2954, 2929, 2896, 2857, 1722, 1655, 1253, 1124, 836, 776; 1H NMR (400 MHz, C6D6)  
9.32 (1H, t, J = 1.5 Hz, H-14), 7.01 (1H, dt, J = 15.6, 6.5 Hz, H-3), 5.90-5.86 (1H, m, H-
2), 5.71 (1H, dd, J = 15.5, 5.5 Hz, H-7), 5.64-5.59 (1H, m, H-6), 5.17 (1H, dt, J = 9.5, 2.5 
Hz, H-10), 4.25 (1H, td, J = 5.4, 0.9 Hz, H-8), 4.05 (2H, q, J = 7.1 Hz, OCH2CH3), 4.01 
(1H, dd, J = 5.3, 2.2 Hz, H-9), 2.02-1.96 (6H, m, H-4, H-5, H-13), 1.73-1.67 (3H, m, H-11, 
H-12a), 1.56-1.47 (1H, m, H-12b), 1.05 (9H, s, Si-C(CH3)3), 1.03 (9H, s, Si-C(CH3)3), 
1.03-1.00 (3H, t, J = 7.1 Hz, OCH2CH3), 0.19 (3H, s, Si-CH3), 0.16 (3H, s, Si-CH3), 0.13 
(3H, s, Si-CH3), 0.12 (3H, s, Si-CH3); 
13
C NMR (100 MHz, C6D6)  200.7, 166.1, 156.7, 
148.1, 131.0, 130.2, 122.5, 78.1, 75.4, 75.1, 60.1, 43.5, 31.9, 30.9, 29.2, 26.3, 26.2, 18.65, 
18.60, 18.52, 14.4, -4.18, -4.25, -4.28, -4.31; HRMS (ES+) calcd. for C29H56NO7Si2 
[M+H]+ 586.3590, found 586.3589. 
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7.5  Experimental procedures for Chapter 4 
(S)-Methyl-3-((tert-butyldimethylsilyl)oxy)-2-methylpropanoate
73
 
 
 
 
To a stirred solution of methyl (S)-3-hydroxy-2-methylpropionate 177 (17.1 g, 145 mmol) 
and imidazole (14.8 g, 217 mmol) in CH2Cl2 (300 mL) at 0 ºC was added TBSCl (26.2 g, 
174 mmol) in portions. The reaction was stirred at rt for 12 h and quenched by addition of 
saturated NaHCO3 (300 mL) solution. The aqueous phase was extracted with CH2Cl2 (4  
200 mL) and the combined organic extracts were washed with brine (300 mL), dried 
(MgSO4), filtered and concentrated under reduced pressure. Purification by flash column 
chromatography (10% EtOAc/Hexanes) provided compound (32.0 g, 95%) as a colourless 
oil.  
Rf 0.52 (20% EtOAc/Hexanes); 
1
H NMR (400 MHz, CDCl3)  3.77 (1H, dd, J = 9.7, 6.9 
Hz, H-3a), 3.68 (3H, s, OCH3), 3.65 (1H, dd, J = 10.0, 6.0 Hz, H-3b), 2.73-2.53 (1H, m, H-
2), 1.13 (3H, d, J = 7.0 Hz, CH3), 0.87 (9H, s, Si-C(CH3)3), 0.02 (6H, s, 2  Si-CH3). 
 
(S)-3-((tert-Butyldimethylsilyl)oxy)-N-methoxy-N-2-dimethylpropanamide (179)
73
 
 
 
 
To a stirred slurry of ester (32.0 g, 137 mmol) and Weinreb salt (20.0 g, 205 mmol) in 
THF (300 mL) was added i-PrMgCl (205 mL, 2 M soln. in THF, 415 mmol) dropwise, 
such that the internal temperature did not exceed -15 ºC. After 1 h at -10 ºC, saturated 
NH4Cl (400 mL) solution was added and layers were separated. The aqueous phase was 
extracted with Et2O (3  300 mL) and the combined organic extracts were dried (MgSO4), 
filtered and concentrated under reduced pressure. Purification by flash column 
chromatography (5-20% Et2O/Hexanes) afforded the Weinreb amide 179 (30.0 g, 84%) as 
a colourless oil.  
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Rf 0.52 (20% EtOAc/Hexanes); 
1
H NMR (400 MHz, CDCl3)  3.83 (1H, dd, J = 9.5, 8.2 
Hz, H-3a), 3.70 (3H, s, N-OCH3), 3.52 (1H, dd, J = 9.5, 6.1 Hz, H-3b), 3.19 (3H, s, N-
CH3), 3.19-3.09 (1H, m, H-2), 1.06 (3H, d, J = 6.9 Hz, CH3), 0.86 (9H, s, Si-C(CH3)3), 
0.04 (3H, s, Si-CH3), 0.03 (3H, s, Si-CH3). 
 
(S)-3-((tert-Butyldimethylsilyl)oxy)-2-methylpropanal (176)
73
 
 
 
 
To a stirred solution of Weinreb amide 179 (5.00 g, 19.1 mmol) in THF (50.0 mL) at -78 
ºC was added DIBAL-H (38.3 mL, 1M soln. in Hexane, 38.3 mmol). After 1h at this 
temerature the mixture was cannulated into stirred solution of potassium sodium tartrate 
(250 mL) salt, further stirred vigorously for 1 h and extracted with Et2O (3  150 mL). The 
combined organic extracts were dried (MgSO4), filtered and concentrated under reduced 
pressure. The resultant pale yellow oil was used without purification in the next step. 
Rf 0.62 (20% EtOAc/Hexanes); 
1
H NMR (300 MHz, CDCl3)  9.74 (1H, d, J = 1.6 Hz,  
H-1), 3.86 (1H, dd, J = 10.2, 5.2 Hz, H-3a), 3.80 (1H, dd, J = 10.2, 6.3 Hz, H-3b), 2.60-
2.47 (1H, m, H-2), 1.09 (3H, d, J = 7.0 Hz, CH3), 0.87 (9H, s, Si-C(CH3)3), 0.05 (6H, s, 2  
Si-CH3).  
 
(2E,4R)-Ethyl 5-((tert-butyldimethylsilyl)oxy)-2,4-dimethylpent-2-enoate (181)
143
 
 
 
 
To a slurry of anyhydrous Ba(OH)2 (4.76 g, 27.8 mmol) in THF (50.0 mL) was added 
triethylphosphonate (5.50 g, 23.1 mmol) and the resulting mixture stirred at rt for 45 min. 
A solution of aldehyde 176 (3.13 g, 15.4 mmol) in THF (50.0 mL) and H2O (1.25 mL) was 
then added via cannula and the reaction mixture was stirred for a further 16 h. The reaction 
was then quenched with saturated NH4Cl (100 mL) solution and layers were separated. 
The aqueous phase was extracted with Et2O (3  100 mL). The combined organic extracts 
were dried (MgSO4), filtered and concentrated under reduced pressure. Flash column 
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chromatography (10% EtOAc/Hexanes) afforded enoate 181 (3.27 g, 76%) as a colourless 
oil in 7:1 E:Z ratio.  
Rf 0.48 (10% EtOAc/Hexanes); 
1
H NMR (300 MHz, CDCl3)  6.55 (1H, dq, J = 9.9, 1.4 
Hz, H-3), 4.22-4.14 (2H, q, J = 7.1 Hz, OCH2CH3), 3.51-3.43 (2H, m, H-5), 2.68 (1H, dq, 
J = 9.9, 6.6 Hz, H-4), 1.85 (3H, d, J = 1.4 Hz, C2-CH3), 1.28 (3H, t, J = 7.1 Hz, 
OCH2CH3), 1.00 (3H, d, J = 6.7 Hz, C4-CH3), 0.87 (9H, s, Si-C(CH3)3), 0.03 (3H, s, Si-
CH3), 0.02 (3H, s, Si-CH3). 
 
(2E,4R)-5-((tert-Butyldimethylsilyl)oxy)-2,4-dimethylpent-2-en-1-ol (182)
143
 
 
 
 
To a stirred solution of enoate 181 (2.80 g, 9.77 mmol) in THF (40.0 mL) at -78 ºC was 
added DIBAL-H (19.5 mL, 1M soln. in hexane, 19.5 mmol). After 1h at this temperature 
the mixture was cannulated into stirred solution of potassium sodium tartrate (150 mL) 
salt, further stirred vigorously for 1 h and extracted with Et2O (3  100 mL). The combined 
organic extracts were dried (MgSO4), filtered and concentrated under reduced pressure. 
Flash column chromatography (10% EtOAc/Hexanes) afforded E-alcohol 182 (1.93 g, 
81%) as a colourless oil.  
Rf 0.28 (20% EtOAc/Hexanes); 
1
H NMR (300 MHz, CDCl3)  5.18 (1H, dq, J = 9.4, 1.3, 
H-3), 3.99 (2H, dd, J = 6.0, 0.9 Hz, H-1), 3.45 (1H, dd, J = 9.8, 6.1, H-5a), 3.36 (1H, dd, J 
= 9.8, 7.2 Hz, H-5b), 2.58 (1H, dq, J = 9.3, 6.7 Hz, H-4), 1.69 (3H, d, J = 1.4 Hz, C2-CH3), 
0.95 (3H, d, J = 6.7 Hz, C4-CH3), 0.88 (9H, s, Si-C(CH3)3), 0.03 (6H, s, 2  Si-CH3). 
 
(2E,4R)-5-((tert-Butyldimethylsilyl)oxy)-2,4-dimethylpent-2-enal (175) 
 
 
 
To a solution of alcohol 182 (500 mg, 2.04 mmol) in CH2Cl2 (20.0 mL) at 0 ºC was added 
NaHCO3 (859 mg, 10.2 mmol) followed by Dess-Martin periodinane (2.60 g, 6.13 mmol). 
The reaction mixture was stirred at 0 ºC for 1.5 h, and quenched by addition of cold hexane 
(40.0 mL) and cold toluene (10.0 mL) and CH2Cl2 was then removed under reduced 
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pressure. The resultant white suspension was filtered through short pad of silica gel and 
Celite, eluting with 20% EtOAc/Hexanes. The filtrate was concentrated under reduced 
pressure to provide aldehyde 175 (440 mg, 90%) as a colourless oil which was 
immediately used without further purification. 
Rf 0.42 (10% EtOAc/Hexane); 
1
H NMR (300 MHz, CDCl3)  9.40 (1H, s, H-23), 6.32 
(1H, dq, J = 9.7, 1.3 Hz, H-21), 3.59 (1H, dd, J = 9.9, 6.0 Hz, H-19a), 3.54 (1H, dd, J = 
9.9, 6.5 Hz, H-19b), 2.89 (1H, ddd, J = 12.6, 9.7, 6.6 Hz, H-20), 1.77 (3H, d, J = 1.4 Hz, 
C22-CH3), 1.06 (3H, d, J = 6.8 Hz, C20-CH3), 0.87 (9H, s, Si-C(CH3)3), 0.04 (3H, s, Si-
CH3), 0.03 (3H, s, Si-CH3). 
 
(2R,3E,5E)-6-Iodo-2,4-dimethylhexa-3,5-dien-1-ol (178) 
 
 
 
To a solution of flame-dried CrCl2 (1.12 g, 9.07 mmol) in THF (11.0 mL) at rt was added a 
solution of aldehyde 175 (220 mg, 0.907 mmol) and CHI3 (1.07 g, 2.72 mmol) in 1,4-
dioxane (65.0 mL). The reaction mixture was stirred for 2 h before it was quenched with 
saturated NaHCO3 (50.0 mL) solution. The resulting mixture was diluted with EtOAc (200 
mL), filtered through a short pad of Celite and washed with EtOAc (250 mL). The layers 
were separated and the aqueous phase was extracted with EtOAc (3  50 mL). The 
combine organic extracts were dried (Na2SO4), filtered and concentrated under reduced 
pressure. The crude material was directly subjected to TBAF deprotection.  
Rf 0.8 (10% EtOAc/Hexanes); 
1
H NMR (400 MHz, CDCl3)  7.03 (1H, dd, J = 14.6, 0.8 
Hz, H-23), 6.15 (1H, dd, J = 14.6, 0.6 Hz, H-24), 5.27 (1H, d, J = 9.5 Hz, H-21), 3.43 (2H, 
qd, J = 10.6, 6.5 Hz, H-19), 2.64 (1H, m, H-20), 1.74 (3H, d, J = 1.3 Hz, C22-CH3), 0.97 
(3H, d, J = 6.7 Hz, C20-CH3), 0.88 (9H, s, Si-C(CH3)3), 0.03 (3H, s, Si-CH3), 0.02 (3H, s, 
Si-CH3). 
To a solution of crude 185 (332 mg, 0.907 mmol) in THF (10.0 mL) at 0 ºC was added 
TBAF (9.1 mL, 1 M in THF, 0.907 mmol). The reaction mixture was allowed to warm to rt 
and stirred for 12h. The reaction mixture was diluted with Et2O (10.0 mL), poured onto 
water (20.0 mL) and the layers were separated. The aqueous phase was extracted with 
Et2O (3  20 mL) and the combined organic extracts were washed with brine (20 mL), 
dried (Na2SO4), filtered and concentrated under reduced pressure. Purification by flash 
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column chromatography (10% EtOAc/Hexanes) provided iodo-alcohol 178 (200 mg, 90%) 
as a pale yellow oil.  
Rf 0.32 (10% EtOAc/Hexane); []D20  +40.8 (c 0.7, CHCl3); IR max (thin film/cm-1) 3374, 
2959, 2926, 2870, 1726, 1707, 1451, 1178, 1035, 1018, 960, 752; 1H NMR (400 MHz, 
CDCl3)  7.06 (2H, dd, J = 14.7, 0.8 Hz, H-23), 6.22 (1H, dd, J = 14.7, 0.6 Hz, H-24), 5.27 
(1H, dt, J = 9.6, 0.6 Hz, H-21), 3.55-3.49 (1H, m, H-19a), 3.44-3.39 (1H, m, H-19b), 2.78-
2.67 (1H, m, H-20), 1.78 (3H, d, J = 1.3 Hz, C22-CH3), 0.98 (3 H, d, J = 6.7 Hz, C20-
CH3); 
13
C NMR (100 MHz, C6D6)  149.6, 136.5, 136.0, 74.5, 67.6, 35.7, 16.8, 12.5; 
HRMS (ES+) calcd. for C8H14I1O [M+H]
+ 253.0084, found 253.0079. 
 
(2R,3E,5E)-6-Iodo-2,4-dimethylhexa-3,5-dienal (172) 
 
 
 
To a solution of alcohol 178 (300 mg, 1.19 mmol) in CH2Cl2 (40.0 mL) at 0 ºC was added 
NaHCO3 (499 mg, 5.95 mmol) followed by Dess-Martin periodinane (1.51 g, 3.57 mmol). 
The reaction mixture was stirred at 0 ºC for 1.5 h and quenched by addition of cold hexane 
(50.0 mL) and cold toluene (10.0 mL). CH2Cl2 was then removed under reduced pressure 
and the resulting white suspension was filtered through Celite and short pad of silica gel 
(20% EtOAc/Hexanes) and concentrated under reduced pressure to provide aldehyde 172 
(267 mg, 90%) as pale yellow oil. The resultant compound was immediately used without 
further purification.  
Rf 0.46 (10% EtOAc/Hexanes); 
1
H NMR (400 MHz, C6D6)  9.05 (1H, d, J = 1.6, H-19), 
6.81 (1H, dd, J = 14.7, 0.8 Hz, H-23), 5.91 (1H, dd, J = 14.7, 0.6 Hz, H-24), 4.73 (1H, ddt, 
J = 9.2, 1.3, 0.7 Hz, H-21), 2.69 (1H, ddd, J = 9.0, 7.1, 1.8 Hz, H-20), 1.19 (3H, d, J = 1.3 
Hz, C22-CH3), 0.79 (3H, d, J = 6.9 Hz, C20-CH3). 
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(2E,5R,6R,7E,9E)-Methyl-5-hydroxy-10-iodo-3,6,8-trimethyldeca-2,7,9-trienoate 
(189) 
(2E,5S,6R,7E,9E)-Methyl-5-hydroxy-10-iodo-3,6,8-trimethyldeca-2,7,9-trienoate  
 
       
 
To a stirred solution of aldehyde 172 (200 mg, 0.799 mmol) and silyl ketene acetal 173 
(253 mg, 1.36 mmol) containing CaH2 (513 mg, 12.2 mmol) in CH2Cl2 (40.0 mL) at -95ºC 
was added BF3•OEt2 (5.0 mL, 0.5M soln. in CH2Cl2, 2.39 mmol) dropwise. After 20 min, 
the reaction mixture was allowed to warm to -80 ºC and a further aliquot of BF3•OEt2 (5.0 
mL, 0.5M soln. in CH2Cl2, 2.39 mmol) was added. After 20 min the reaction mixture was 
quenched by the slow addition of saturated NaHCO3 (50.0 mL) solution and allowed to 
warm to rt. The layers were separated and the aqueous phase was extracted with CH2Cl2 (3 
 50 mL). The combined organic extracts were dried (Na2SO4), filtered and concentrated 
under reduced pressure. Purification by flash column chromatography (1-10% 
EtOAc/Hexanes) provided a mixture of aldol products (210 mg, 70%) as colourless oils in 
6:1 syn:anti ratio for E isomer and 3:1 syn:anti ratio for Z isomer.  
189 E-syn: Rf 0.26 (10% EtOAc/Hexanes); []D20  +17.7 (c 1.0, CHCl3); IR max (thin 
film/cm-1) 3475, 2948, 1715, 1644, 1435, 1223, 1151, 1059, 950; 1H NMR (400 MHz, 
C6D6)  6.92 (1H, dd, J = 14.7, 0.8 Hz, H-23), 5.91 (1H, dd, J = 14.7, 0.5 Hz, H-24), 5.80 
(1H, dd, J = 2.1, 1.2 Hz, H-16), 4.89 (1H, d, J = 10.0 Hz, H-21), 3.44 (3H, s, OCH3), 3.16-
3.23 (1H, m, H-19), 2.21-2.11 (1H, m, H-20), 2.18 (H, d, J = 1.2 Hz, C17-CH3), 1.95 (1H, 
dd, J = 13.4, 2.3 Hz, H-18a), 1.75 (1H, dd, J = 13.7, 9.8 Hz, H-18b), 1.31 (3H, d, J = 1.2 
Hz, C22-CH3), 0.87 (3H, d, J = 6.7 Hz, C20-CH3); 
13
C NMR (100 MHz, C6D6)  166.6, 
157.2, 149.8, 136.5, 134.8, 118.1, 74.7, 73.1, 50.6, 46.7, 39.4, 19.0, 16.2, 12.1; HRMS 
(ES+) calcd. for C14H25I1NO3 [M+NH4]
+ 382.0874, found 382.0869. 
 
E-anti: Rf 0.27 (10% EtOAc/Hexanes); []D20  +5.5 (c 0.2, CHCl3); IR max (thin film/cm-1) 
3496, 2948, 2926, 1711, 1646, 1436, 1227, 1152, 949, 839; 1H NMR (400 MHz, C6D6)  
6.95 (1H, dd, J = 14.7, 0.8 Hz, H-23), 5.92 (1H, dd, J = 14.7, 0.6 Hz, H-24), 5.80 (1H, q, J 
= 1.2 Hz, H-16), 5.12 (1H, d, J = 10.0 Hz, H-21), 3.43 (3H, s, OCH3), 3.24 (1H, dq, J = 
8.2, 4.2 Hz, H-19), 2.20 (3H, d, J = 1.3 Hz, C17-CH3), 2.17-2.14 (1H, m, H-20), 1.85 (1H, 
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dd, J = 4.1, 0.9 Hz, H-18a), 1.85-1.84 (1H, m, H-18b), 1.32 (3H, d, J = 1.3 Hz, C22-CH3), 
0.77 (3H, d, J = 6.7 Hz, C20-CH3); 
13
C NMR (100 MHz, C6D6)  166.7, 157.0, 149.8, 
135.6, 135.2, 118.1, 74.7, 72.8, 50.6, 46.4, 38.7, 19.1, 17.1, 12.1; HRMS (ES+) calcd. for 
C14H25I1NO3 [M+NH4]
+ 382.0874, found 382.0871. 
 
(2Z,5R,6R,7E,9E)-Methyl 5-hydroxy-10-iodo-3,6,8-trimethyldeca-2,7,9-trienoate  
 
 
 
(Z)-syn: Rf 0.29 (10% EtOAc/Hexanes); []D20  +20.7 (c 1.7, CHCl3); IR max (thin film/cm-
1) 3450, 3442, 2970, 2926, 1714, 1651, 1447, 1280, 1180, 1015, 949, 867; 1H NMR (500 
MHz, C6D6)  6.98 (1H, d, J = 14.7 Hz, H-23), 5.90 (1H, d, J = 14.6 Hz, H-24), 5.77 (1H, 
d, J = 1.2 Hz, H-16), 5.14 (1H, d, J = 10.0 Hz, H-21), 3.47 (1H, dtd, J = 10.4, 7.1, 2.9 Hz, 
H-19), 3.28 (3H, s, OCH3), 3.19 (1H, d, J = 7.4 Hz, OH), 2.98 (1H, dd, J = 12.6, 10.6 Hz, 
H-18a), 2.44 (1H, dt, J = 10.0, 6.7 Hz, H-20), 2.15 (1H, dd, J = 12.6, 2.5 Hz, H-18b), 1.54 
(3H, d, J = 1.3 Hz, C17-CH3), 1.39 (3H, d, J = 1.1 Hz, C22-CH3), 1.09 (3H, d, J = 6.7 Hz, 
C20-CH3); 
13
C NMR (125 MHz, C6D6)  168.5, 158.7, 150.0, 137.3, 134.7, 118.1, 74.8, 
74.3, 51.0, 41.1, 39.7, 25.5, 16.6, 12.2; HRMS (ES+) calcd. for C14H22I1O3 [M+H]
+ 
365.0608, found 365.0612. 
 
(R)-Mosher ester of 189 (192) 
 
24
19
I
O
OMe
O
15
(R)-MTPA
 
 
To a stirred mixture of alcohol 189 (20.0 mg, 54.9 mol), DCC (45.0 mg, 219 mol) and 
DMAP (13.0 mg, 109 mol) in CH2Cl2 (2.0 mL) at rt was added (+)-(R)--methoxy--
(trifluoromethyl)-phenylacetic acid (26.0 mg, 109 mol) in one portion. After 12 h, the 
crude reaction mixture was directly purified by flash column chromatography (5% 
EtOAc/Hexanes) to give (R)-MTPA ester 192 (30.0 mg, 94%).  
Rf 0.46 (10% EtOAc/Hexanes); 
1
H NMR (400 MHz; CDCl3)  7.48 (2H, d, J = 8.3 Hz, 
Ph-H), 7.43-7.37 (3H, m, Ph-H), 7.01 (1H, dd, J = 14.7, 0.8 Hz, H-23), 6.28 (1H, dd, J = 
      Experimental
 
 159 
14.7, 0.5 Hz, H-24), 5.61 (1H, d, J = 1.2 Hz, H-16), 5.26 (1H, dd, J = 9.9, 0.6 Hz, H-21), 
5.23 (1H, dt, J = 7.7, 5.8 Hz, H-19), 3.66 (3H, s, OCH3), 3.46 (3H, d, J = 1.0 Hz, MTPA-
OCH3), 2.82 (1H, dq, J = 9.8, 6.6 Hz, H-20), 2.42 (1H, s, H-18a), 2.41 (1H, dd, J = 2.5, 0.8 
Hz, H-18b), 2.17 (3H, d, J = 1.3 Hz, C17-CH3), 1.74 (3H, d, J = 1.3 Hz, C22-CH3), 1.03 
(3H, d, J = 6.8 Hz, C20-CH3). 
 
(S)-Mosher ester of 189 (193) 
 
24
19
I
O
OMe
O
15
(S)-MTPA
 
 
To a stirred mixture of alcohol 189 (20.0 mg, 54.9 mol), DCC (45.0 mg, 219 mol) and 
DMAP (13.0 mg, 109 mol) in CH2Cl2 (2.0 mL) at rt was added (+)-(S)--methoxy--
(trifluoromethyl)-phenylacetic acid (26.0 mg, 109 mol) in one portion. After 12 h, the 
crude reaction mixture was purified directly by flash column chromatography (5% 
EtOAc/Hexanes) to give (S)-MTPA ester 193 (25.0 mg, 78%).  
Rf 0.46 (10% EtOAc/Hexanes); 
1
H NMR (400 MHz, CDCl3)  7.49-7.47 (2H, m, Ph-H), 
7.37-7.41 (3H, m, Ph-H), 6.92 (1H, dd, J = 14.7, 0.7 Hz, H-23), 6.23 (1H, dd, J = 14.7, 0.5 
Hz, H-24), 5.68 (1H, q, J = 1.1 Hz, H-16), 5.23 (1H, dt, J = 7.2, 6.1 Hz, H-19), 5.14 (1H, 
d, J = 10.4 Hz, H-21), 3.68 (3H, s, OCH3), 3.51 (3H, d, J = 1.2 Hz, MTPA-OCH3), 2.73 
(1H, dq, J = 9.9, 6.6 Hz, H-20), 2.45 (1H, d, J = 0.8 Hz, H-18a), 2.43 (1H, m, H-18b), 2.19 
(3H, d, J = 1.3 Hz, C17-CH3), 1.67 (3H, d, J = 1.3 Hz, C22-CH3), 0.94 (3H, d, J = 6.8 Hz, 
C20-CH3). 
 
(2E,5R,6R,7E,9E)-Methyl-10-iodo-3,6,8-trimethyl-5-((triethylsilyl)oxy)deca-2,7,9-
trienoate (194) 
 
 
 
To a solution of alcohol 189 (250 mg, 0.686 mmol) in CH2Cl2 (7.0 mL) at -78 ºC was 
added 2,6-lutidine (240 L, 2.06 mmol) and TESOTf (250 L, 1.10 mmol). After 4 h, 
saturated NH4Cl (15.0 mL) solution and CH2Cl2 (15.0 mL) were added and the layers were 
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separated. The aqueous layer was extracted with CH2Cl2 (3  20 mL) and the combined 
organic extracts were dried (Na2SO4), filtered and concentrated under reduced pressure. 
Purification by flash column chromatography (5% EtOAc/Hexanes) provided TES ether 
194 (230 mg, 96%) as a colourless oil. 
Rf 0.73 (10% EtOAc/Hexanes); []D20  +33.6 (c 0.5, CHCl3); IR max (thin film/cm-1) 2953, 
2911, 2876, 1720, 1647, 1435, 1223, 1150, 1087, 1008, 739, 725; 1H NMR (300 MHz, 
C6D6)  7.02 (1H, dd, J = 14.6, 0.7 Hz, H-23), 5.93 (1H, d, J = 14.6 Hz, H-24), 5.87 (1H, 
q, J = 1.1 Hz, H-16), 5.12 (1H, dd, J = 9.7, 0.4 Hz, H-21), 3.64 (1H, dt, J = 6.6, 5.4 Hz, H-
19), 3.44 (3H, s, OCH3), 2.46-2.39 (1H, m, H-20), 2.25 (3H, d, J = 1.3 Hz, C17-CH3), 
2.08-2.10 (1H, td, J = 6.10, 0.95 Hz, H-18a), 2.07 (1 H, d, J = 0.8 Hz, H-18b), 1.36 (3H, d, 
J = 1.2 Hz, C22-CH3), 0.96 (6H, m, 3  Si-CH2CH3), 0.89 (3H, d, J = 6.8 Hz, C20-CH3), 
0.56 (9H, m, 3  Si-CH2CH3); 13C NMR (75 MHz, C6D6)  166.6, 156.5, 149.9, 137.2, 
134.4, 118.7, 74.7, 74.5, 50.6, 46.9, 38.5, 19.5, 15.6, 12.1, 7.2, 5.6; HRMS (ES+) calcd. for 
C20H40INO3Si [M+NH4]
+ 496.1738, found 496.1734. 
 
(2E,5R,6R,7E,9E)-10-Iodo-3,6,8-trimethyl-5-((triethylsilyl)oxy)deca-2,7,9-trien-1-ol 
(195) 
 
 
 
To a stirred solution of enoate 194 (330 mg, 0.689 mmol) in THF (40.0 mL) at -78 ºC was 
added DIBAL-H (1.4 mL, 1M soln. in hexane, 1.38 mmol). After 1h at this temerature the 
mixture was added via cannula into a stirred solution of potassium sodium tartrate (50.0 
mL) salt, further stirred vigorously for 1 h and extracted with Et2O (3  100 mL). The 
combined organic extracts were dried (MgSO4), filtered and concentrated under reduced 
pressure. Flash column chromatography (10% EtOAc/Hexanes) afforded alcohol 195 (250 
mg, 81%) as a colourless oil.  
Rf 0.29 (20% EtOAc/Hexanes); []D20  +18.5 (c 0.7, CHCl3); IR max (thin film/cm-1) 3342, 
2955, 2911, 1457, 1003, 948, 744, 725; 1H NMR (400 MHz, C6D6)  7.07 (1H, dd, J = 
14.6, 0.8 Hz, H-23), 5.93 (1H, dd, J = 14.6, 0.6 Hz, H-24), 5.38 (1H, ddd, J = 7.8, 5.4, 1.2 
Hz, H-16), 5.27 (1H, d, J = 9.8 Hz, H-21), 3.94 (2H, d, J = 6.8 Hz, H-15), 3.67 (1H, td, J = 
6.2, 4.7 Hz, H-19), 2.50 (1H, ddd, J = 9.8, 6.8, 4.7, H-20), 2.14 (2H, qd, J = 13.6, 6.2 Hz, 
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H-18), 1.51 (3H, t, J = 0.6 Hz, C17-CH3), 1.41 (3H, d, J = 1.3 Hz, C22-CH3), 0.97-1.01 
(6H, m, 3  Si-CH2CH3)3, C20-CH3), 0.58 (9H, m, 3  Si-CH2CH3); 13C NMR (100 MHz, 
C6D6)  150.0, 138.3, 135.0, 133.9, 129.0, 74.7, 74.2, 59.3, 45.9, 37.8, 16.9, 15.1, 12.1, 
7.3, 5.6; HRMS (ES+) calcd. for C19H40INO2Si [M+NH4]
+ 468.1789, found 468.1787. 
 
5-(((2E,5R,6R,7E,9E)-10-Iodo-3,6,8-trimethyl-5-((triethylsilyl)oxy)deca-2,7,9-trien-1-
yl)thio)-1-phenyl-1H-tetrazole (196) 
 
 
 
To a stirred solution of alcohol 195 (130 mg, 0.288 mmol), in THF (30.0 mL) at 0 ºC was 
added 1H-mercaptophenyltetrazole (66.0 mg, 0.378 mmol), PPh3 (99.0 mg, 0.378 mmol) 
followed by DIAD (74.0 L, 0.378 mmol) dropwise. The reaction mixture was allowed to 
warm to rt for 1.5 h, before a saturated NH4Cl (20.0 mL) solution and Et2O (30.0 mL) were 
added. The layers were separated and the aqueous phase was extracted with Et2O (3  50 
mL). The combined organic extracts were dried (Na2SO4), filtered and concentrated under 
reduced pressure. Purification by flash column chromatography (10% EtOAc/Hexanes) 
gave sulfide 196 (140 mg, 80 %) as a colourless oil. 
Rf 0.62 (10% EtOAc/Hexanes) []D20  +58.5 (c 1.0, CHCl3); IR max (thin film/cm-1) 3068, 
2955, 2911, 2875, 1597, 1500, 1384, 1234, 1092, 1015, 950, 759, 742, 725; 1H NMR (400 
MHz, C6D6)  7.17-7.19 (2H, m, Ar-H), 7.05 (1H, dd, J = 14.6, 0.7 Hz, H-23), 6.87-6.93 
(3H, m, Ar-H), 5.95 (1H, dd, J = 14.6, 0.5 Hz, H-24), 5.37 (1H, td, J = 7.9, 1.1 Hz, H-16), 
5.22 (1H, dt, J = 9.8, 0.5 Hz, H-21), 3.90 (2H, qd, J = 14.6, 7.9 Hz, H-15), 3.62 (1H, td, J 
= 6.2, 4.7 Hz, H-19), 2.42 (1H, ddd, J = 9.7, 6.8, 4.6 Hz, H-20), 2.07 (2H, ddt, J = 20.2, 
13.9, 6.6 Hz, H-18), 1.58 (3H, d, J = 1.3 Hz, C17-CH3), 1.40 (3H, d, J = 1.2 Hz, C22-
CH3), 0.96 (6H, s, 3  Si-CH2CH3), 0.92 (3H, d, J = 6.8 Hz, C20-CH3), 0.53-0.58 (9H, m, 
3  Si-CH2CH3); 13C NMR (100 MHz, C6D6)  154.1, 150.0, 139.8, 138.0, 134.3, 134.0, 
129.64, 129.61, 123.9, 120.8, 74.5, 74.3, 45.8, 37.7, 31.6, 16.9, 15.0, 12.1, 7.3, 5.6; HRMS 
(ASAP) calcd. for C26H40IN4OSSi [M+H]
+ 611.1731, found 611.1729. 
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5-(((2E,5R,6R,7E,9E)-10-Iodo-3,6,8-trimethyl-5-((triethylsilyl)oxy)deca-2,7,9-trien-1-
yl)sulfonyl)-1-phenyl-1H-tetrazole (171) 
 
 
 
A mixture of ammonium molybdate (1.6 mg, 1.31 mol), hydrogen peroxide (0.15 mL, 
1.31 mmol, 30% v/v) and HMPA (0.15 mL) was stirred at 0 ºC for 15 min. The resulting 
bright yellow solution was added dropwise to a solution of sulfide 196 (80.0 mg, 0.131 
mmol) in MeOH (2.0 mL) at 0 ºC. After 21 h, the reaction mixture was diluted with MeOH 
(2.0 mL), and H2O (10.0 mL) was added and the layers were separated. The aqueous phase 
was extracted with CH2Cl2 (3  10 mL) and the combined organic extracts were dried 
(Na2SO4), filtered and concentrated under reduced pressure. Purification by flash column 
chromatography (5% Acetone/Hexanes) provided sulfone 171 (79.0 mg, 95%) as a 
colourless oil.  
Rf 0.43 (20% Acetone/Hexanes); []D20  +33.6 (c 0.5, CHCl3); IR max (thin film/cm-1) 
3069, 2955, 2925, 2875, 1498, 1461, 1343, 1156, 1107, 1015, 950, 761, 739; 1H NMR 
(400 MHz, C6D6)  7.26-7.33 (2H, m, Ar-H), 7.05 (1H, dd, J = 14.6, 0.8 Hz, H-23), 6.85-
6.86 (3H, m, Ar-H), 5.94 (2H, dd, J = 14.6, 0.5 Hz, H-24), 5.29 (1H, td, J = 7.9, 0.9 Hz, H-
16), 5.22 (1H, d, J = 9.3 Hz, H-21), 4.08 (2H, dd, J = 7.9, 3.0 Hz, H-15), 3.62 (1H, td, J = 
6.5, 4.1 Hz, H-19), 2.38-2.35 (1H, m, H-20), 2.10 (1H, dd, J = 13.6, 6.9 Hz, H-18a), 2.01 
(1H, dd, J = 13.6, 6.1 Hz, H-18b), 1.50 (3H, d, J = 1.2 Hz, C17-CH3), 1.39 (3H, d, J = 1.2 
Hz, C22-CH3), 0.88-1.01 (6H, m, 3  Si-CH2CH3), 0.86 (3H, d, J = 6.7 Hz, C20-CH3), 
0.46-0.60 (9H, m, 3  Si-CH2CH3); 13C NMR (100 MHz, C6D6)  154.0, 149.8, 146.8, 
136.6, 134.8, 133.5, 131.0, 129.4, 125.4, 111.0, 74.6, 72.6, 56.2, 45.9, 39.2, 17.0, 16.3, 
12.1, 7.2, 6.9; HRMS (ES+) calcd. for C26H40IN5O3SSi [M+NH4]
+ 660.1895, found 
660.1893. 
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7.6  Experimental procedures for Chapter 5 
(((1E,3E,5R,6R,8E,10E)-16-(Benzyloxy)-1-iodo-3,5,8-trimethylhexadeca-1,3,8,10-
tetraen-6-yl)oxy)triethylsilane (209) 
 
 
 
To a solution of sulfone 171 (10.0 mg, 15.7 mol) in THF (1.0 mL) at -78 ºC was added 
NaHMDS (12 L, 2M soln. in THF, 12.5 mol). After 5 min, a solution of aldehyde 208 
(3.0 mg, 10.5 mol) in THF (0.5 mL) was added dropwise and the reaction mixture was 
allowed to warm to -60 ºC. After 1 h, MeOH (0.5 mL) was added followed by saturated 
NH4Cl (5.0 mL) solution and the reaction mixture was warmed to rt. The layers were 
separated and the aqueous phase was extracted with Et2O (3  5 mL). The combined 
organic extracts were washed with brine (10 mL), dried (Na2SO4), filtered and 
concentrated under reduced pressure. Purification by flash column chromatography (5% 
EtOAc/Hexanes) provided alkene 209 (5.0 mg, 80%) as a colourless oil, in 2:1 E:Z ratio.  
Rf 0.65 (10% EtOAc/Hexanes); IR max (thin film/cm-1) 3367, 3184, 2919, 1675, 1277, 
1181, 1106, 676, 611; 1H NMR (400 MHz, C6D6)  7.32 (2H, d, J = 6.9 Hz, Ar-H), 7.20 
(3H, m, Ar-H), 7.08 (1H, dd, J = 14.6, 0.8 Hz, H-23), 6.35 (1H, ddt, J = 14.9, 10.7, 1.4 Hz, 
H-15), 5.97 (1H, d, J = 11.0 Hz, H-16), 5.93 (1H, dd, J = 14.6, 0.6 Hz, H-24), 5.61 (1H, dt, 
J = 14.8, 7.2 Hz, H-14), 5.29 (1H, d, J = 10.4 Hz, H-21), 4.35 (2H, s, CHaHbAr), 3.73 (1H, 
td, J = 6.2, 4.8 Hz, H-19), 3.34-3.28 (2H, m, H-9), 2.57-2.50 (1H, m, H-20), 2.29-2.17 (2H, 
m, H-18), 2.09-2.04 (2H, m, H-13), 1.72 (3H, d, J = 0.9 Hz, C17-CH3), 1.61-1.55 (2H, m, 
H-10), 1.42 (3H, d, J = 1.3 Hz, C22-CH3), 1.33-1.40 (4H, m, H-11, H-12), 0.97-1.05 (9H, 
m, 3  Si-CH2CH3)3, C20-CH3), 0.57-0.65 (9H, m, 3  Si-CH2CH3); 13C NMR (100 MHz, 
C6D6)  150.1, 138.4, 133.9, 133.4, 132.4, 128.7, 128.6, 127.7, 127.6, 127.1, 125.0, 75.0, 
74.0, 73.0, 70.5, 46.4, 38.0, 33.4, 30.2, 29.9, 26.3, 17.3, 15.3, 12.1, 7.4, 5.6; HRMS (ES+) 
calcd. for C32H55INO2Si [M+NH4]
+ 640.3041, found 640.3038. 
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(2E,6E,8S,9S,10S,14E,16E,19R,20R,21E,23E)-Ethyl 8,9-bis((tert-butyldimethylsilyl)-
oxy)-10-(carbamoyloxy)-24-iodo-17,20,22-trimethyl-19-((triethylsilyl)oxy)tetracosa-
2,6,14,16,21,23-hexaenoate (210) 
 
 
 
To a solution of sulfone 171 (57.0 mg, 89 mol) in THF (3.0 mL) at -78 ºC was added 
NaHMDS (36.0 L, 2 M in THF, 71.7 mol). After 5 min, a solution of aldehyde 169 
(35.0 mg, 59.7 mol) in THF (2.0 mL) was added dropwise and the reaction mixture was 
allowed to warm to -50 ºC. After 1 h, MeOH (1.0 mL) was added followed by saturated 
NH4Cl (30.0 mL) solution and the reaction mixture was warmed to rt. The layers were 
separated and the aqueous phase was extracted with Et2O (3  20 mL). The combined 
organic extracts were washed with brine (30 mL), dried (Na2SO4), filtered and 
concentrated under reduced pressure. Purification by flash column chromatography (5% 
EtOAc/Hexanes) provided alkene 210 (46.0 mg, 78%) as a colourless oil in 7:1 E:Z ratio.  
Rf 0.65 (10% EtOAc/Hexanes); []D20  +35.0 (c 3.5, CHCl3); IR max (thin film/cm-1) 2953, 
2911, 2876, 1720, 1647, 1435, 1223, 1150, 1087, 1008, 739, 725; 1H NMR (400 MHz, 
C6D6)  7.08 (1H, dd, J = 14.6, 0.7 Hz, H-23), 7.00 (1H, dt, J = 15.6, 6.5 Hz, H-3), 6.37 
(1H, dd, J = 15.0, 10.8 Hz, H-15), 5.99-5.95 (1H, m, H-14), 5.95 (1H, dd, J = 14.6, 0.5 Hz, 
H-24), 5.89-5.84 (1H, m, H-2), 5.75 (1H, dd, J = 15.6, 5.8 Hz, H-7), 5.67-5.57 (2H, m, H-
6, H-16), 5.32 (1H, d, J = 9.7 Hz, H-21), 5.27-5.23 (1H, m, H-10), 4.28 (1H, t, J = 5.3 Hz, 
H-8), 4.07 (2H, q, J = 7.1 Hz, OCH2CH3), 4.03 (1H, dd, J = 5.0, 2.1 Hz, H-9), 3.74 (1H, td, 
J = 6.2, 4.6 Hz, H-19), 2.55 (1H, m, H-20), 2.22 (2H, m, H-18), 2.00-1.94 (4H, m, H-4, H-
5), 1.91-1.80 (2H, m, H-11), 1.72 (3H, d, J = 0.8 Hz, C17-CH3), 1.76-1.65 (2H, m, H-13), 
1.60-1.51 (2H, m, H-12), 1.44 (3H, d, J = 1.2 Hz, C22-CH3), 1.06 (9H, s, Si-C(CH3)3), 
1.05 (9H, s, Si-C(CH3)3), 1.06-0.98 (12H, m, C20-CH3, OCH2CH3, Si-(CH2CH3)3), 0.64-
0.57 (9H, m, Si-(CH2CH3)3), 0.20 (3H, s, Si-CH3), 0.19 (3H, s, Si-CH3), 0.14 (3H, s, Si-
CH3), 0.13 (3H, s, Si-CH3); 
13
C NMR (100 MHz, C6D6)  166.0, 156.6, 150.1, 148.0, 
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138.5, 133.8, 133.2, 132.5, 131.3, 130.0, 128.7, 127.3, 122.4, 78.2, 75.58, 75.56, 74.9, 
74.0, 60.0, 46.4, 37.8, 33.4, 32.0, 31.0, 29.8, 26.4, 26.32, 26.26, 18.62, 18.56, 17.3, 15.1, 
14.4, 12.1, 7.4, 5.6, -4.1, -4.18, -4.22, -4.3; HRMS (ES+) calcd. for C48H92IN2O7Si3 
[M+NH4]
+ 1019.5252, found 1019.5258. 
 
(2E,6E,8S,9S,10S,14E,16E,19R,20R,21E,23E)-Ethyl 8,9-bis((tert-butyldimethylsilyl)-
oxy)-10-(carbamoyloxy)-19-hydroxy-24-iodo-17,20,22-trimethyltetracosa-
2,6,14,16,21,23-hexaenoate (211) 
 
 
 
To a solution of 210 (5.0 mg, 0.499 mol) in THF (2.0 mL) at 0 ºC was added a buffered 
solution of pyridine hydrofluoride (0.2 mL, stock solution prepared from 0.5 mL of 
pyridine hydrofluoride, 1.0 mL of pyridine, and 4.0 mL of THF) dropwise. After stirring 
for 1h, the reaction was quenched by the addition of saturated NaHCO3 (5.0 mL) solution, 
diluted with Et2O (15.0 mL) and brine (10.0 mL), and finally extracted with Et2O (3  10 
mL). The combined organic extracts were dried (Na2SO4), filtered and concentrated under 
reduced pressure. Purification by flash column chromatography (10% EtOAc/Hexanes) 
gave alcohol 211 (3.9 mg, 88%) as a colourless oil.  
Rf 0.30 (20% EtOAc/Hexane); []D20  +30.6 (c 1.0, CHCl3); IR max (thin film/cm-1) 3509, 
3370, 2955, 2975, 2857, 1723, 1655, 1472, 1463, 1255, 1126, 837, 776; 1H NMR (400 
MHz, C6D6)  7.04 (1H, dt, J = 15.7, 6.4 Hz, H-3), 6.97 (1H, dd, J = 14.6, 0.7 Hz, H-23), 
6.34 (1H, dd, J = 15.0, 10.8 Hz, H-15), 5.95-5.86 (2H, m, H-2, H-16) 5.91 (1H, dd, J = 
14.6, 0.5 Hz, H-24), 5.76 (1H, dd, J = 15.5, 5.6 Hz, H-7), 5.66-5.59 (2H, m, H-6, H-14), 
5.28 (1H, ddd, J = 9.3, 3.2, 2.3 Hz, H-10), 5.10 (1H, d, J = 9.9 Hz, H-21), 4.29 (1H, t, J = 
4.9 Hz, H-8), 4.09-4.02 (1H, m, H-9) 4.06 (2H, J = 7.1 Hz, OCH2CH3), 3.69 (2H, br s, 
NH2), 3.38 (1H, ddd, J = 9.7, 7.0, 2.7 Hz, H-19), 2.41 (1H, dt, J = 10.0, 6.7 Hz, H-20), 
2.22-2.17 (2H, m, H-13), 2.14 (1H, dd, J = 13.8, 2.4 Hz, H-18a), 2.04-1.94 (4H, m, H-4, 
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H-5), 1.91 (1H, dd, J = 13.9, 10.0 Hz, H-18b), 1.89-1.82 (2H, m, H-11), 1.70-1.57 (5 H, m, 
H-12), 1.62 (3H, s, C17-CH3), 1.40 (3H, d, J = 1.2 Hz, C22-CH3), 1.08-1.05 (3H, mobs, 
C20-CH3), 1.07 (9H, s, Si-C(CH3)3), 1.06 (9H, s, Si-C(CH3)3), 1.03 (3H, t, J = 7.1 Hz, 
OCH2CH3), 0.21 (3H, s, Si-CH3), 0.19 (3H, s, Si-CH3), 0.15 (3H, s, Si-CH3), 0.14 (3H, s, 
Si-CH3); 
13
C NMR (100 MHz, C6D6)  166.1, 156.3, 150.1, 148.2, 137.4, 134.5, 133.6, 
132.9, 131.3, 130.0, 128.7, 127.2, 122.4, 78.2, 75.5, 75.4, 74.2, 72.8, 60.1, 46.3, 39.3, 33.3, 
32.0, 31.0, 29.6, 26.3, 26.2, 26.13, 18.62, 18.55, 16.7, 16.51, 14.4, 12.1, -4.15, -4.19, -4.23, 
-4.26; HRMS (ES+) calcd. for C42H78IN2O7Si2 [M+NH4]
+ 905.4387, found 905.4394. 
 
(2E,6E,8S,9S,10S,14E,16E,19R,20R,21E,23E)-8,9-Bis((tert-butyldimethylsilyl)oxy)-10-
(carbamoyloxy)-19-hydroxy-24-iodo-17,20,22-trimethyltetracosa-2,6,14,16,21,23-
hexaenoic acid (212) 
 
 
 
To a solution of ethyl ester 211 (14.0 mg, 15.7 mol) in Et2O (1.0 ml) was added 
potassium trimethylsilanolate (6.1 mg, 47.3 mol) in one portion. The slightly yellowish 
solution was stirred at rt for 24 h and then quenched by addition of NaHSO4 (100 L, 0.1 
M), buffered with Na2SO4, filtered and concentrated under reduced pressure. The resulting 
crude residue was dried under high vacuum and immediately used in the next step. 
Rf 0.23 (30% EtOAc/Hexane and drop of AcOH); 
1
H NMR (400 MHz, C6D6)  7.14-7.08 
(1H, m, H-3), 7.00 (1 H, dd, J = 14.6, 0.8 Hz, H-23), 6.42-6.32 (1H, m, H-15), 6.15 (1H, d, 
J = 15.5 Hz, H-2), 6.00 (1H, d, J = 10.8 Hz, H-16), 5.92 (1H, d, J = 14.6 Hz, H-24), 5.81-
5.74 (1H, m, H-7), 5.71-5.67 (1H, m, H-6), 5.61 (1H, dd, J = 14.7, 7.4 Hz, H-14), 5.30-
5.27 (1H, m, H-10), 5.20 (1H, d, J = 10.6 Hz, H-21), 4.31-4.26 (1H, m, H-8), 4.06 (1H, dd, 
J = 5.3, 2.2 Hz, H-9), 3.53-3.46 (1H, m, H-19), 2.52-2.43 (1H, m, H-20), 2.24-2.14 (3H, m, 
H-13, H-18a), 2.15-2.08 (2H, m, H-4), 2.08-2.00 (3H, m, H-5, H-18b), 1.91-1.82 (2H, m, 
H-11), 1.69 (3H, s, C17-CH3), 1.68-1.66 (2H, m, H-12), 1.43 (3H, d, J = 1.2 Hz, C22-
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CH3), 1.12 (3H, d, J = 6.7 Hz, C20-CH3), 1.08 (9H, s, Si-C(CH3)3), 1.07 (9H, s, Si-
C(CH3)3), 0.22 (3H, s, Si-CH3), 0.20 (3H, s, Si-CH3), 0.16 (3H, s, Si-CH3), 0.15 (3H, s, Si-
CH3). 
 
(2R,4E,6E,11S,12S,13S,14E,18E)-12,13-Bis((tert-butyldimethylsilyl)oxy)-2-((R,3E,5E)-
6-iodo-4-methylhexa-3,5-dien-2-yl)-4-methyl-20-oxooxacycloicosa-4,6,14,18-tetraen-
11-yl carbamate (213) 
 
 
 
To a stirred solution of acid 212 (13.0 mg, 15.1 mol) in toluene (1.0 mL) at rt was added 
Et3N (42.0 l, 0.302 mmol) and 2,4,6-trichlorobenzoyl chloride (35.0 L, 0.226 mmol). 
After 1h, the reaction mixture was diluted with toluene (4.0 mL) and added over 3 h to a 
stirred solution of DMAP (74.0 mg, 0.604 mmol) in toluene (10.0 mL). The reaction 
mixture was stirred for 12 h and then quenched with NaHCO3 (15.0 mL) solution. The 
layers were separated and the aqueous layer extracted with CH2Cl2 (3  15 mL). The 
combined organic extracts were dried (Na2SO4), filtered and concentrated under reduced 
pressure. Purification by flash column chromatography (10% EtOAc/Hexanes) gave 
macrolactone 213 (9.0 mg, 71%) as a colourless oil.  
Rf 0.44 (20% EtOAc/Hexane); []D20  +1.2 (c 0.9, CHCl3); IR max (thin film/cm-1) 3510, 
3368, 3017, 2930, 2858, 1724, 1652, 1596, 1465, 1385, 1256, 1123, 1034, 973, 837, 776; 
1
H NMR (400 MHz, C6D6)  6.94-6.87 (1H, mobs, H-3), 6.93 (1H, dd, J = 14.7, 0.7 Hz, H-
23), 6.27 (1H, dd, J = 15.5, 11.1 Hz, H-15), 5.96-5.83 (2H, mobs, H-2, H-16), 5.91 (1H, dd, 
J = 14.6, 0.5 Hz, H-24), 5.68-5.63 (2H, m, H-6, H-7), 5.53 (1H, ddd, J = 14.6, 9.3, 4.8 Hz, 
H-14), 5.19 (1H, dt, J = 10.3, 2.1 Hz, H-10), 5.12 (1H, ddd, J = 10.4, 7.6, 3.1 Hz, H-19), 
4.97 (1H, d, J = 10.0 Hz, H-21), 4.21-4.16 (1H, m, H-8), 4.11 (1H, dd, J = 6.9, 1.8 Hz, H-
9), 3.64 (2H, br s, NH2), 2.67-2.77 (1H, m, H-20), 2.37-2.27 (1H, m, H-13a), 2.18-2.09 
(2H, m, H-18), 2.00-1.89 (4H, m, H-4, H-5), 1.89-1.86 (1H, m, H-13b), 1.86-1.81 (2H, m, 
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H-11), 1.80-1.66 (2H, m, H-12), 1.65 (3H, s, C17-CH3), 1.36 (3H, d, J = 1.2 Hz, C22-
CH3), 1.10 (9H, s, Si-C(CH3)3), 1.04 (9H, s, Si-C(CH3)3), 0.95 (3H, d, J = 6.7 Hz, C20-
CH3), 0.21 (3H, s, Si-CH3), 0.21 (3H, s, Si-CH3), 0.14 (3H, s, Si-CH3), 0.10 (3H, s, Si-
CH3). 
13
C NMR (125 MHz, C6D6)  165.4, 156.1, 149.7, 147.4, 135.4, 133.0, 131.58, 
131.39, 130.3, 129.2, 128.1 (obs), 127.5, 123.3, 78.3, 76.6, 75.5, 74.9, 74.3, 43.4, 37.5, 
32.16, 31.98, 31.1, 30.2, 26.5, 26.4, 25.2, 18.71, 18.66, 17.2, 16.6, 12.1, -3.6, -3.7, -3.8, -
4.2; HRMS (ES+) calcd. for C40H68INO6Si2Na [M+Na]
+ 864.3522, found 864.3528.  
 
N-((1E,3E,5R)-6-Hydroxy-3,5-dimethylhexa-1,3-dien-1-yl)-3-methylbut-2-enamide 
(219) 
 
 
 
To a mixture of vinyl iodide 178 (100 mg, 0.396 mmol), amide 218 (78.6 mg, 0.793 
mmol), flame-dried K2CO3 (328 mg, 2.37 mmol) and CuI (113 mg, 0.594 mmol) in THF 
(20.0 mL) at rt was added N,N’-dimethylethylenediamine (128 L, 1.18 mmol). The 
reaction mixture was stirred for 1 h before it was concentrated under reduced pressure. The 
resulting residue was diluted with EtOAc (10.0 mL), filtered through a pad of Celite®, 
washed with EtOAc (10.0 mL) and concentrated under reduced pressure. Purification by 
flash column chromatography afforded enamide 219 (50.0 mg, 63%) as a colourless oil, in 
5:1 E:Z ratio.  
Rf 0.56 (10% EtOAc/Hexane); IR max (thin film/cm-1) 3425, 2982, 2935, 1718, 1655, 
1315, 1272, 1157, 1041, 981; 1H NMR (400 MHz, CDCl3)  7.78 (1H, d, J = 10.4, N-H), 
6.99 (1H, dd, J = 14.4, 10.5 Hz, H-23), 5.81 (1H, dd, J = 14.5, 0.6 Hz, H-24), 5.60 (1H, dt, 
J = 2.6, 1.3 Hz, H-27), 5.06 (1H, d, J = 9.5 Hz, H-21), 3.48-3.42 (1H, m, H-19a), 3.38-3.32 
(1H, m, H-19b), 2.74-2.66 (1H, m, H-20), 2.17 (3H, d, J = 1.2 Hz, H-29), 1.84 (3H, d, J = 
1.2 Hz, -CH3), 1.77 (3H, d, J = 1.2, C22-CH3), 0.93 (3H, d, J = 6.7 Hz, C20-CH3);  
13
C NMR (100 MHz, CDCl3)  164.0, 153.9, 133.9, 131.9, 121.5, 117.8, 117.5, 67.8, 35.7, 
27.5, 20.1, 17.2, 13.0; HRMS (ES+) calcd. for C13H22NO2 [M+H]
+ 224.1645, found 
224.1646. 
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(2R,4E,6E,11S,12R,13S,14E,18E)-12,13-Dihydroxy-2-((R,3E,5E)-6-iodo-4-
methylhexa-3,5-dien-2-yl)-4-methyl-20-oxooxacycloicosa-4,6,14,18-tetraen-11-yl 
carbamate (214) 
 
 
 
To a solution of bis-TBS-ether 213 (9.00 mg, 10.7 mol) in THF (1.0 mL) at 0 ºC was 
added TBAF (54.0 L, 1 M soln. in THF, 54.0 mol). The reaction was stirred for 2 h, 
quenched with cold water (1.0 mL) and the layers were separated. The aqueous phase was 
extracted with EtOAc (3  5 mL) and the combined organic extracts were dried (Na2SO4), 
filtered and concentrated under reduced pressure. Purification by flash column 
chromatography (50-100% EtOAc/Pet.Ether) provided diol 214 (5.5 mg, 85%) as a white 
flakes.  
Rf 0.39 (5% MeOH/CH2Cl2); []D20  +9.6 (c 0.5, CHCl3); IR max (thin film/cm-1) 3432, 
2923, 2851, 1713, 1651, 1461, 1391, 1276, 1060, 1020, 972; 1H NMR (500 MHz, C6D6)  
6.93 (1H, d, J = 14.5 Hz, H-23), 6.86 (1H, dt, J = 15.6, 5.9 Hz, H-3), 6.33 (1H, dd, J = 
14.9, 11.2 Hz, H-15), 5.96-5.92 (1H, m, H-16), 5.92 (1H, d, J = 14.7 Hz, H-24), 5.83 (1H, 
d, J = 15.8 Hz, H-2), 5.57 (1H, dt, J = 14.6, 5.4 Hz, H-6), 5.47-5.39 (2H, m, H-7, H-14), 
5.19-5.13 (1H, m, H-19), 5.00-4.93 (2H, m, H-10, H-21), 4.17-3.98 (2H, br s, NH2), 3.91 
(1H, t, J = 7.0 Hz, H-8), 3.68 (1H, br s, H-9), 2.69 (1H, dt, J = 10.1, 7.0 Hz, H-20), 2.30-
2.22 (1H, m, H-13a), 2.12-2.18 (2H, m, H-18), 1.91-1.97 (1H, m, H-13b), 1.89-1.77 (4H, 
m, H-4, H-5), 1.77-1.71 (1H, m, H-11a), 1.73 (3H, s, C17-CH3), 1.71-1.68 (1H, m, H-11b), 
1.67-1.62 (1H, m, H-12a), 1.35 (3H, d, J = 0.9 Hz, C22-CH3), 1.34-1.28 (1H, m, H-12b), 
0.92 (3H, d, J = 6.8 Hz, C20-CH3); 
13
C NMR (125 MHz, C6D6)  165.6, 157.0, 149.5, 
147.9, 135.3, 135.1, 132.3, 131.93, 131.90, 130.2, 128.4, 127.3, 122.9, 75.9, 75.4, 74.82, 
74.72, 72.8, 42.8, 37.5, 31.8, 31.6, 30.3, 27.1, 24.7, 16.9, 16.6, 12.0; HRMS (ES+) calcd. 
for C28H40INO6Na [M+Na]
+ 636.1785, found 636.1787.   
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9,10-bis-epi-palmerolide (3b) 
 
 
 
To a mixture of vinyl iodide 214 (4.0 mg, 6.52 mol), amide 218 (1.9 mg, 19.5 mol), 
K2CO3 (4.5 mg, 32.6 mol, flame-dried) and CuI (2.5 mg, 13.0 mol) in degassed DMF 
(0.6 mL) was added N,N’-dimethylethylenediamine (19.5 μL, 0.01 M soln. in DMF, 19.5 
mol) at rt. The reaction mixture was stirred for 1 h before it was diluted with EtOAc (5.0 
mL), filtered through a pad of Celite®, washed with EtOAc (5.0 mL) and concentrated 
under reduced pressure. Purification by flash column chromatography (2% MeOH/CH2Cl2) 
afforded enamide 3 (2.0 mg, 53%) as a white solid and recovered starting material (1.5 mg, 
39%).  
Rf 0.31 (5% MeOH/CH2Cl2); []D20  -19.5 (c 0.2, MeOH); IR max (thin film/cm-1) 3319, 
2943, 2831, 1730, 1717, 1609, 1514, 1449, 1358, 1165, 1099, 1022, 783;  
1
H NMR (500 MHz; CD3CN)  8.14 (1H, d, J = 10.5 Hz, NH), 6.93 (1H, dd, J = 14.5, 
10.6 Hz, H-24), 6.84-6.78 (1H, m, H-3), 6.20 (1H, dd, J = 14.7, 10.9 Hz, H-15), 5.87 (1H, 
d, J = 14.6 Hz, H-23), 5.76 (1H, d, J = 10.7 Hz, H-16), 5.71 (1H, d, J = 15.7 Hz, H-2), 5.62 
(1H, s, H-2’), 5.49-5.46 (1H, m, H-6), 5.46-5.42 (1H, m, H-14), 5.36 (1H, dd, J = 15.2, 8.0 
Hz, H-7), 5.20 (1H, d, J = 9.7 Hz, H-21), 5.05-5.16 (2H, m, NH2), 4.94 (1H, ddd, J = 10.5, 
7.7, 2.4 Hz, H-19), 4.52 (1H, dt, J = 10.4, 3.1 Hz, H-10), 3.75-3.70 (1H, m, H-8), 3.47-3.43 
(1H, m, H-9), 3.17 (1H, d, J = 4.0 Hz, C9-OH), 3.11 (1H, d, J = 3.3 Hz, C8-OH), 2.78 (1H, 
dt, J = 9.85, 6.92 Hz, H-20), 2.45-2.37 (1H, m, H-4a), 2.33-2.24 (2H, m, H-18a, H-5a), 
2.20 (1H, dd, J = 14.2, 11.1 Hz, H-18b), 2.16 (3H, s, H-4’), 2.18-2.12 (2H, m, H-4b, H-
5b), 1.93-1.84 (2H, m, H-13), 1.86 (3H, s, H-5’), 1.74 (3H, s, C22-CH3), 1.68 (3H, s, C17-
CH3), 1.54-1.45 (1H, m, H-11a), 1.43-1.36 (2H, m, H-11b, H-12a), 1.17-1.10 (1H, m, H-
12b), 0.94 (3H, d, J = 6.7 Hz, C20-CH3). 
1
H NMR (500 MHz; DMSO)  9.88 (1H, d, J = 10.3 Hz, NH), 6.85 (1H, dd, J = 14.0, 10.4 
Hz, H-24), 6.78 (1H, dt, J = 15.6, 7.4 Hz, H-3), 6.48-6.28 (2H, m, NH2), 6.15 (1H, dd, J = 
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14.1, 11.3 Hz, H-15), 5.85 (1H, d, J = 14.5 Hz, H-23), 5.69-5.76 (3H, m, H-2, H-16, H-2’), 
5.46-5.35 (2H, m, H-6, H-14), 5.35-5.27 (1H, m, H-7), 5.16 (1H, d, J = 9.5 Hz, H-21), 4.87 
(1H, t, J = 8.5 Hz, H-19), 4.77 (1H, s, C9-OH), 4.68 (1H, s, C8-OH), 4.42 (1H, d, J = 10.3 
Hz, H-10), 3.56 (1H, obs, H-9), 3.46 (1H, obs, H-8), 2.75 (1H, m, H-20), 2.14-2.25 (2H, 
m, H-18), 2.12 (3H, s, H-5’), 2.26-2.22 (1H, m, H-5a), 2.21 (2H, m, H-12), 2.08-1.93 (3H, 
m, H-4, H-5b), 1.83 (3H, s, H-4’), 1.82-1.78 (2H, m, H-13), 1.68 (3H, s, C22-CH3), 1.64 
(3H, s, C17-CH3), 1.57-1.49 (1H, m, H-11a), 1.49-1.42 (1H, m, H-11b), 0.91 (3H, d, J = 
6.5 Hz, C20-CH3). 
13
C NMR (HSQC, HMBC, CD3CN)  166.2, 164.2, 164.4, 154.1, 142.4, 133.2, 132.6, 
132.5, 130.9, 130.3, 130.1, 128.6, 127.9, 123.3, 122.3, 118.1, 117.2, 76.0, 75.3, 75.26, 
74.2, 43.1, 37.8, 32.4, 31.8, 30.7, 27.25, 26.1, 24.8, 19.8, 17.4, 16.2, 12.9; HRMS (ES+) 
calcd. for C33H48N2NaO7 [M+Na]
+ 607.3359, found 607.3364.  
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Appendix: Selected 
1
H and 
13
C NMR spectra 
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